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INTRODUCTION
Kidneys are paired structures that lie in the retroperitoneum. Each kidney contains approxi-
mately 1,000,000 glomeruli, which are small balls of capillaries (diameter 0.1 mm) through 
which the blood is ﬁ ltered. Glomeruli are present only in the cortex (Figure 1).
The functions of the kidneys are: 1) excretion of toxins and waste products (urea, cre-
atinine, and many others); 2) maintaining homeostasis (balance) in the body’s volume and 
chemistry; 3) production of hormones (erythropoietin, vitamin D, angiotensin). Blood ﬂ ows 
into the glomerulus via the aﬀ erent arteriole and out via the eﬀ erent arteriole. Approximately 
20-25% of the plasma that enters the glomerulus is ﬁ ltered through the capillary wall into the 
urinary space. The capillary wall functions as a ﬁ ltration barrier allowing the passage of water 
and small molecules (toxins, salts) into the urinary space while keeping cells and proteins in 
the capillary loop. The glomerular capillary wall is composed of three components: the fenes-
trated endothelium which lines the capillaries; the glomerular basement membrane, a thin 
sheet composed of negatively charged extracellular matrix proteins; the visceral epithelial 
cells, which are also called podocytes because of their characteristic interdigitating foot pro-
cesses that cover the GBM. The ﬁ ltered plasma is ﬁ rst collected in Bowman’s space, covered 
by Bowman’s capsule which is lined by the parietal epithelial cells (PECs), and subsequently 
transported via the tubular system to the ureter. The ﬁ ltration barrier is believed to be a 
size-selective and charge-selective ﬁ lter. Recent studies have made important contributions 
to our understanding of the role of the various constituents of this barrier. The fenestrated 
endothelium, which lines the capillary wall, is critically dependent on vascular endothelial 
growth factor (VEGF), produced by the adjacent podocytes [1;2]. The glomerular basement 
membrane is an acellular matrix with a thickness of 300 to 350 nm that provides structural 
support for the capillary wall. Its main components are type IV collagen, proteoglycans, lam-
inin, and nidogen. Anionic sites in the glomerular basement membrane are believed to be 
located on the heparan sulfate and chondroitin sulfate side chains of perlecan and agrin. The 
anionic charges have been thought to be important for the restricted passage of negatively 
charged proteins. However, genetically engineered mice whose glomerular basement mem-
brane contains heparan sulfate–deﬁ cient perlecan or lacks agrin do not have proteinuria but 
are sensitive with respect to albumin overload [3]. S-laminin/laminin beta 2 is a major compo-
nent of adult renal glomerular basement membrane (GBM), and mutant mice that lack beta 
2, develop massive proteinuria [4]. More recently, the podocyte is being recognized as the 
most important determinant of capillary wall permeability. The podocyte is a terminally dif-
ferentiated cell with a complex structure and is composed of primary processes which form 
interdigitating extensions that form the characteristic foot processes which rest on the GBM. 
The foot processes are connected by a tiny membrane, the so-called slit diaphragm. The slit 
diaphragm complex is composed of several proteins that contribute to the structure of the 
slit diaphragm, connect the diaphragm to the intracellular actin cytoskeleton, and participate 
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Figure 1. Filtration System of the kidney. The kidneys contain glomeruli in the renal cortex (Panel A). Arterioles enter Bowman’s capsule 
and form the glomerular tuft; the cappillary wall functions as a ﬁ lter. The ﬁ ltered plasma is collected in Bowman’s space and then further 
transported to the proximal tubules (B). The capillary wall is composed of fenestrated endothelium, the glomerular basement membrane and a 
layer of podocytes (C). Panel D shows a cross section through the capillary wall with the fenestrated endothelium at the bottom, the glomerular 
basement membrane with overlying podocyte foot processes. In between these processes the slit diaphragm complex is located (D). Reprinted 
with permission [5].
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in podocytic signalling processes (Figure 2). Well-known examples of slit diaphragm complex 
proteins are nephrin, podocin, α-actinin-4 and CD2AP. Most of these proteins are essential for 
a functional slit diaphragm and maintenance of glomerular permselectivity, since mutation 
or inactivation of the corresponding genes causes proteinuria [5]. Thus, proteinuria is consid-
ered to be predominantly caused by alterations of the slit diaphragm complex. Proteinuria 
is mostly accompanied by disturbances of the architecture of the foot processes, so called 
eﬀ acement.
Figure 2. The Slit-Diaphragm Complex. Components which form the Filter; From the opposite foot processes nephrin molecules form a 
central density with pores, a zipper-like structure which probably maintains the width of the slit. Nephrin also interact with other proteins in 
the slit, such as FAT1 and FAT2. Nephrin interact with the intracellular podocin and CD2-associated protein (CD2AP). These molecules presumably 
connect the slit-diaphragm protein complex with ZO-1 and actin strands. Reprinted with permission [5].
12
C
ha
p
te
r 1
This can be illustrated by scanning electron microscopy (Figure 3) and by transmission 
electron microscopy (Figure 4). Proteinuria is a hallmark of glomerular diseases and an inde-
pendent predictor of renal function deterioration. Histologically, renal insuﬃ  ciency is charac-
terised by glomerulosclerosis and tubulo-interstitial ﬁ brosis. Focal segmental glomeruloscle-
rosis (FSGS) has become one of the most common glomerular diseases. In its classical form 
FSGS is characterized by mesangial sclerosis, obliteration of glomerular capillaries, formation 
Figure 3. Scanning electron microscopy pictures of 
podocytes on glomerular capillaries. The interdigitating 
foot processes are nicely illustrated. The inset shows 
podocyte eﬀ acement.
Figure 4. Transmission electron microscopy 
pictures of podocyte foot processes resting on the 
GBM. The arrowheads point to the slit diaphragm. 
The lower picture illustrates podocyte eﬀ acement.
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of adhesions between the glomerular tuft and Bowman’s capsule, podocyte hypertrophy, 
hyalinosis of the vessel wall and intracapillary foam cells. Notably, FSGS is merely a descrip-
tive diagnosis, and not a disease entity. FSGS may be secondary to glomerular hyperﬁ ltration 
and thus the result of longstanding and ongoing glomerular injury ending with chronic renal 
disease. Recently, various morphological variants have been deﬁ ned and a classiﬁ cation has 
been proposed to better address the diversity of FSGS [6]. 
Five light microscopic variants of FSGS were deﬁ ned: the perihilar variant (lesions predomi-
nantly located at the vascular pole), the tip variant (the presence of lesions located at the 
urinary pole), the cellular variant (characterized by endocapillary hypercellularity), the col-
lapsing variant (collapse of the glomerular tuft associated with epithelial cell hypertrophy 
and hyperplasia), and ﬁ nally FSGS not otherwise speciﬁ ed (NOS), if lesions do not ﬁ t into one 
of the above mentioned categories (Figure 5).
All morphological variants are accompanied by some degree of epithelial cell proliferation, 
being minimal or absent in the perihilar variant and often very prominent in the cellular and 
collapsing variant (Figure 6). In recent studies the podocytes have received a central role in 
the pathogenesis of FSGS [7]. Normal podocytes are unable to proliferate and to compensate 
for damaged neighbouring podocytes. Studies by Kriz and co-workers in various rat models 
of FSGS indicated loss of podocytes and adherence of the parietal epithelial cell (PEC) to 
the naked GBM as the critical event in the formation of FSGS lesions [8;9]. The adhesions 
allow ﬁ ltration of proteins to the periglomerular space and this process is held responsible 
for the periglomerular ﬁ brosis and tubulointerstitial ﬁ brosis that typically accompanies FSGS. 
These studies can not explain the pathogenesis of the more cellular FSGS lesions. The collaps-
ing variant of FSGS is the prototypical example. Studies in collapsing FSGS have suggested 
that the proliferating cells are podocytes that have lost their podocyte markers, and have 
Figure 5. FSGS not otherwise speciﬁ ed (NOS).
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regained the ability to proliferate [10-14]. This is the concept of the dediﬀ erentiated dys-
regulated podocyte. Based on these ﬁ ndings epithelial hyperplasia, which is also commonly 
observed in ‘active’ FSGS lesions other than collapsing lesions, is generally considered to be 
the result of proliferation of dediﬀ erentiated podocytes.
AIMS OF THE STUDY
The studies presented in this thesis were aimed at:
1) Unraveling mechanisms of proteinuria
2) Evaluating the role of glomerular epithelial cells in FSGS
Mechanisms of proteinuria
We have used the anti-aminopeptidase-A mouse model to study mechanisms of proteinuria 
[15-17]. This model is characterized by a massive and acute albuminuria, induced by a single 
intravenous injection of a combination of two mAbs directed against speciﬁ c epitopes of 
mouse aminopeptidase-A (APA). APA (EC 3.4.11.7) is a membrane bound zinc metalloprote-
ase which, in mouse kidney, is expressed on podocytes, epithelial cells of the proximal con-
voluted tubules and, to a lesser extent, on the endothelial cells of the peritubular capillaries 
and the smooth muscle cells of the media of arteries. APA is involved in the degradation of 
peptides. It’s best-known substrate is angiotensin II (Ang II), the most active component of 
the renin–angiotensin system. APA inactivates Ang II by hydrolyzing the N-terminal aspartyl 
residue, thus forming angiotensin III (Ang III) [18].
Figure 6. Collapsing FSGS.
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The induction of albuminuria in this model is not related to any of the known systemic 
mediators of glomerular injury, such as complement, coagulation factors, monocytes, neu-
trophils, or platelets [15]. In subsequent studies we have shown that injection of the anti-APA 
mAbs increased glomerular Ang II levels [19]. However, in adult mice induction of albumin-
uria was independent from Ang II, as proven by our studies in angiotensinogen knock-out 
mice [17]. We questioned if the eﬀ ects of anti-APA administration may be dependent in 
the developmental stage of the glomeruli. It is well known that Ang II is important during 
nephrogenesis. Most components of the RAS are expressed in the developing kidney. The 
role of APA is unknown. We have studied the expression of APA during nephrogenesis and 
the eﬀ ect of APA inhibition in newborn mice (chapter 2). 
In the experiments described in chapter 3, we have examined the expression of several im-
portant podocytic proteins in relation to the time course of the albuminuria in our anti-APA 
mouse model. We have included cytoskeleton (-associated) proteins, adhesion molecules, 
slit-diaphragm proteins and heparan sulfate proteoglycans, all known to aﬀ ect podocyte 
integrity, associated with podocytic injury or proteinuria. In addition, we measured ultra-
structurally the number of foot processes per μm GBM and the width of the slit pore be-
tween the podocytes by morphometric methods. In subsequent studies we have improved 
the methodology of calibrating the morphometric measurements on electron microscopical 
images (chapter 4).
Pathogenesis of focal segmental glomerulosclerosis
 In recent years we have used the Thy-1.1 transgenic mouse model for the study of focal seg-
mental glomerulosclerosis [20;21]. Thy-1.1 transgenic mice carry a mouse-human transgene 
that causes ectopic expression of the mouse Thy-1.1 antigen on podocytes. Injection of mAbs 
directed against the Thy-1.1 antigen induces an acute albuminuria within 10 min and a dose 
dependent development of FSGS within 3 weeks. The early stages of FSGS in this model are 
characterised by prominent cell proliferation and the lesions clearly resemble human collaps-
ing FSGS. We noted that the proliferating cells were parietal epithelial cells (PECs), rather than 
podocytes. Moreover we showed that the extracellular matrix that formed the adhesion was 
produced by the PECs [22].
To evaluate the role of the PECs in human FSGS we have used a nephrectomy specimen of a 
patient with recurrent FSGS after transplantation (chapter 5). This enabled us to evaluate over 
400 serial sections. We could demonstrate that parietal epithelial cells also play an important 
role in the formation of the cellular lesions and the scar in human idiopathic FSGS. We subse-
quently have investigated the origin of the proliferating cells in collapsing FSGS associated 
with HIV and pamidronate (chapter 6). 
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Global glomerulosclerosis
Progressive glomerular injury is eventually characterized by global glomerulosclerosis. Two 
types of global glomerulosclerosis can be distinguished: the vascular type (also referred to as 
obsolescent type) and the glomerulopathic type (also referred to as solidiﬁ ed type). The latter 
type is often observed in patients with FSGS. In biopsies of children with a nephrotic syn-
drome we observed small glomeruli, which somewhat resembled global glomerulosclerosis. 
We have coined the term involuted glomeruli to describe them. The involuted glomeruli can 
be distinguished from the above mentioned forms of global glomerulosclerosis (chapter 7). 
We have evaluated biopsies of a cohort of children with frequently relapsing minimal change 
nephrotic syndrome for the presence of involuted glomeruli and have tried to relate their 
presence with clinical parameters (chapter 8). Finally, in chapter 9 we describe the long term 
follow-up of mice injected twice with the proteinuric anti-APA mAbs. We did not observe 
development of FSGS. Intriguing was the observation that these mice developed small dense 
glomeruli, clearly resembling the involuted glomeruli in humans.
We discuss and summarize our ﬁ ndings in chapters 10 and 11
Introduction 17
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ABSTRACT
Aminopeptidase-A (APA) is a metalloprotease that cleaves N-terminal aspartyl and glutamyl 
residues from peptides. Its best known substrate is angiotensin II (Ang II), the most active 
compound of the renin angiotensin system (RAS). The RAS is involved in renal development. 
Most components of the RAS system are expressed in the developing kidney. Thus far, APA 
has not been studied in detail.
In the present study we have evaluated the expression of APA at the protein-, mRNA-, and 
enzyme activity level in the kidney during nephrogenesis. Furthermore, we have studied the 
eﬀ ect of inhibiting APA enzyme activity by injection of anti-APA antibodies into 1-day-old 
newborn mice. APA expression was observed from the comma stage onwards, predominant-
ly in the developing podocytes and brush borders of proximal tubular cells. Notably, APA 
was absent in the medulla or the renal arterioles. Inhibition of APA enzyme activity caused 
temporary podocyte foot process eﬀ acement, suggesting a minimum role for APA during 
nephrogenesis.
Keywords: podocyte, nephrogenesis, aminopeptidase-A, albuminuria, monoclonal anti-
bodies, inhibition, enzyme activity, mouse
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INTRODUCTION
Angiotensin II (Ang II) is the most active component of the renin angiotensin system (RAS). 
The RAS is involved in the regulation of vascular tone and maintenance of blood pressure. 
Ang II is also involved in the regulation of cell growth. In adult life Ang II contributes to renal 
injury by increasing the blood pressure, initiating glomerular injury and inducing ﬁ brosis [1]. 
These eﬀ ects of Ang II are predominantly mediated by activation of the angiotensin type 
1a receptor (AT1a). Indeed, overexpression of the AT1a receptor in rat podocytes resulted in 
focal glomerulosclerosis [2]. Inhibitors of the RAS system thus have become important tools 
in the treatment of patients with renal diseases [3]. In contrast, in the fetal kidney an intact 
RAS system is essential for a normal development [4,5]. Treatment of newborn mice or rats 
with angiotensin converting enzyme (ACE) inhibition resulted in abnormal development of 
the kidney characterised by papillary atrophy and severe wall thickening of the cortical arter-
ies and arterioles. Similar abnormalities were observed in mice with a targeted disruption of 
genes involved in the RAS system such as angiotensinogen, ACE and the AT1 receptor (re-
viewed in Guron and Friberg, 2000). Most components of the RAS system are expressed in the 
developing kidney in a time and site speciﬁ c manner. Detailed studies have demonstrated 
expression of angiotensin, renin, ACE and the AT1 and AT2 receptor (reviewed in Guron and 
Friberg, 2000). Thus far little attention has been given to aminopeptidase-A (APA). 
APA (EC 3.4.11.7) is a membrane-bound metalloprotease that cleaves N-terminal aspartyl 
and glutamyl residues from peptides. Its best known substrate is angiotensin II [6]. APA has 
a wide-spread organ distribution suggesting that this enzyme has a role in many diverse 
biological processes [7].
Investigators have suggested that APA may be involved in blood pressure regulation 
and the pathogenesis of preeclampsia [8]. In the adult mouse kidney APA is expressed on 
podocytes and brush borders of proximal tubular epithelial cells, and to a lesser degree on 
juxtaglomerular (JC) cells, endothelial cells of peritubular capillaries (PTC) and in pars media 
of arteries. In our studies on membranous nephropathy we have developed a panel of an-
tibodies directed against APA [9]. Injection of a combination of antibodies that inhibit APA 
enzyme activity, increased renal AII levels and induced an acute and profound albuminuria 
[10]. The mAbs are highly speciﬁ c for APA since we observed no binding upon injection into 
APA-deﬁ cient mice [10]. These monoclonal antibodies have provided us with tools to study 
the tissue distribution of APA [7]. In the present study we have evaluated the expression of 
APA at the mRNA -, protein -, and enzyme activity level during nephrogenesis in mice. In ad-
dition we examined the eﬀ ect of APA inhibition during nephrogenesis.
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MATERIALS AND METHODS
Animals
Female BALB/c mice in late pregnancy, aged 2 to 3 months, were purchased from Charles 
River, Sulzfeld, Germany. E18 old BALB/c mouse embryos or newborns, day 1 (E18-19 days 
post coitum (d.p.c.)), were used to study the nephrogenesis of the mouse kidney. In mice 
nephrogenesis starts at E11-12 (forming metanephros) and continues for 7-10 days (P1-2) 
after birth. In mice, 80% of the glomeruli form after birth. Microscopic examination of kidneys 
from E18 old embryos allows studying glomeruli at various developmental stages, ranging 
from the earliest developmental stage (vesicle formation) in the outer cortex to mature 
glomeruli in the inner cortex. 1-day-old mice were used to study the eﬀ ect of inhibiting APA 
enzyme activity during nephrogenesis. All procedures involving mice were approved by the 
Animal Care Committee of the University of Nijmegen and conformed to the Dutch Council 
for Animal Care and National Institutes of Health guidelines. 
Animal experiments
For the distribution study kidneys from E18 old embryos were removed from BALB/c mice, 
snap frozen in liquid nitrogen for immunoﬂ uorescence, enzymehistochemistry and mRNA in 
situ hybridization, or immersion ﬁ xed for light microscopy (LM) and immunoelectron micros-
copy (IEM).
To study the eﬀ ect of APA inhibition during nephrogenesis we injected combinations of 
anti-APA antibodies in 1-day-old mice. The characteristics of the three rat mAbs used in this 
study (ASD-3, ASD-37 and ASD-41) have been described previously [9]. The anti-APA mAbs 
have been propagated in vitro by hollow ﬁ ber culture (Nematology Department, Agriculture 
University Wageningen, The Netherlands). Injection of the combination ASD-37/41 inhibited 
the APA enzyme activity completely and induced a massive acute albuminuria at day 1. In 
contrast, the combination ASD-3/41, which did partly inhibit APA activity on the podocyte 
and completely inhibited the enzyme activity of the brush border (BB), did not induce pro-
teinuria. We have used a single intravenous injection of a total dose of 0.8 mg of the nephri-
togenic combination ASD-37/41 or the non-nephritogenic combination ASD-3/41 (both with 
1:1 weight ratio). Groups of mice (n=5) were studied 9, 21 days and 3 months after injection. 
Urinesamples were collected via spontaneously voiding at day 1 and via bladder puncture 
at days 9, 21 and 3 months, after which mice were killed and the kidneys processed for light 
microscopy, immunoﬂ uorescence, enzymehistochemistry and electron microscopy.
Morphologic studies
To study the expression of APA by immunoﬂ uorescence (IF), we have used the mAbs ASD-3, 
an anti-APA mAbs of subclass IgG1. All the three rat mAbs used in this study (ASD-3, ASD-37 
and ASD-41) give the same staining pattern of APA. Kidneys from E18 old embryos were snap 
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frozen in liquid nitrogen. Two μm-thick, acetone ﬁ xed sections were incubated for 60 minutes 
at room temperature. Binding of the mAbs was visualized with FITC-labeled rabbit anti-rat IgG 
containing 4% normal mouse serum (Dako, Glostrup, Denmark) as described before [9,11].
The enzyme activity of APA was visualized by enzyme histochemistry according to Lojda and 
Gossrau, as described before [12], with the APA-speciﬁ c substrate L-glutamic acid-4-methoxy-
ß-naphtylamide (Bachem, Bubendorf, Switzerland). The intensity of the developed colour was 
recorded semi quantitatively on a scale from 0 to 4+ [13].
APA mRNA was detected by RNA in situ hybridization using both a sense and an antisense 
344 bp digoxigenin-labeled cRNA probe, as described before [9].
For light- and electronmicroscopy (LM / EM) the kidneys were immersion-ﬁ xed in 2.5% glutar-
aldehyde dissolved in 0.1 M sodium cacodylate buﬀ er, pH 7.4, overnight at 4°C and washed 
in the same buﬀ er. The tissue fragments were post ﬁ xed in palade buﬀ ered 2% OsO4 for 
1 hr, dehydrated, and embedded in Epon 812, Luft’s procedure (Merck, Darmstadt, Germany). 
Semithin (1µm) and ultrathin sections were cut on an ultratome, Reichert Ultracut S (Leica 
Microsystems). The semithin slices were stained with toluidine blue and examined using light 
microscopy. Ultrathin sections were stained with 4% uranyl acetate for 45 min and subse-
quently with lead citrate for 4 min at room temperature. Sections were examined in a JEOL 
1200 EX2 electron microscope (JEOL, Tokyo, Japan).
For IEM the kidneys were immersion-ﬁ xed in a mixture of 10 mM periodate, 75 mM lysine and 
2% paraformaldehyde, pH 6.2 (PLP) for 3 hr. After rinsing several times in PBS, the embryonic 
kidneys were cryoprotected by immersion in 2.3 M sucrose, pH 7.2, for 1 hr, and then frozen 
in liquid nitrogen. Twenty μm-thick sections were incubated with ASD-3, for 18 hr at 4ºC. 
Binding of the mAbs was visualized with peroxidase-labeled rabbit anti-rat IgG containing 
4% normal mouse serum (Seralab/Sanbio, Uden, The Netherlands), as described before. For 
IEM ultrathin sections were cut on an ultratome (Leica, Reichert Ultracuts, Wien, Austria). The 
sections were examined in a Jeol 1200 EX2 electron microscope (JEOL, Tokyo, Japan).
RESULTS
In mice nephrogenesis starts at E11-12 (metanephros formation) and continues for 7-10 days 
after birth. Formation of the kidney epithelium involves reciprocal inductive interactions be-
tween two mesoderm-derived structures, the uretic bud, an outgrowth of the Wolﬃ  an duct, 
and the adjacent metanephric mesenchyme. The bud branches into collecting ducts, and the 
mesenchyme diﬀ erentiates into nephrons [14,15]. In mice, 80% of the glomeruli form after 
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birth. Microscopic examination of kidneys from E18 old embryos reveals glomeruli at vari-
ous developmental stages ranging from the earliest developmental stage (vesicle formation) 
in the outer cortex to mature glomeruli in the inner cortex, a low magniﬁ cation overview 
shows several stages (Figure 1a). The various stages of glomerular development can be nicely 
distinguished by transmission electron microscopy. Figure 2 illustrates a typical example of a 
developing glomerulus in the comma stage (Figure 2a), the S-stage (Figure 2b) and the early 
capillary stage (Figure 2c). 
Histology and immunoﬂ uorescence
In the earliest histologically deﬁ nable glomerular stage, the comma stage, (Figure 3a) there 
was only trace staining for APA by immunoﬂ uorescence (Figure 3b). Controls for background 
were completely negative. Its morphological shape and the presence of the earliest ingrowth 
of capillaries, recognized by using our antibody ASD-13, which is speciﬁ c for glomerular en-
dothelium, identiﬁ ed the comma stage.
In the next stage, the S-stage (Figure 3c), there was staining for APA of the cells lining the 
vascular cleft destined to become podocytes and with lower intensity also of the epithelial 
cells destined to become parietal epithelial cells. In addition cells that will develop into the 
proximal tubule stained faintly positive for APA without a clear polarity (Figure 3d, arrow). In 
the more advanced early capillary stage (Figure 3e), the staining of cells destined to become 
podocytes is more intense (Figure 3f ). Staining is membranous and strongest nearest to the 
capillary tuft. At this stage there is luminal staining of the proximal tubules, restricted to 
the brush border (Figure 3f, arrow). In addition there is still weak staining of the developing 
parietal epithelial cells. Finally, in the mature glomerulus (Figure 3g), APA staining shows a 
homogeneous podocytic pattern. In addition the brush borders of the proximal tubules stain 
for APA (Figure 3h). In the mature kidney, faint APA expression can also be observed in the 
granular juxtaglomerular cells and on the endothelial cells of the peritubular capillaries (PTC) 
(Figure 1f ), whereas no expression is observed in the eﬀ erent and aﬀ erent arterioles, the 
distal tubules, the loops of Henle or the collecting ducts.
 Figure 1. Developmental stages: kidneys from E18 old embryos show glomeruli at various developmental stages ranging from the 
earliest developmental stage (vesicle formation) in the outer cortex to glomerular maturation in the inner cortex (A, overview toluidine blue 
staining). The APA mRNA expression during nephrogenesis could be demonstrated during all stages, especially in the S-stage (B) the developing 
podocytes could be nicely recognized, in massive amounts in some proximal tubules (B, insert) and in developing podocytes in the capillary 
stage (D). In addition, APA enzyme activity could already be demonstrated in these early stages (C), (arrow developing podocytes) and was 
continuously demonstrable and increased in the more advanced capillary stage (E). In the proximal tubules APA enzyme activity could also be 
demonstrated in the brush border membranes, arrow (E). In mature kidney the immunohistological presence of glomerular APA in the podocytes 
and brush borders of the proximal tubules stain for APA, faint APA expression can also be observed in the granular juxtaglomerular cells and on 
the endothelial cells of the peritubular capillaries (F). IEM (G) illustrates the membranous podocytic pattern (A x150, B-C x600, D x1000, E x600, 
F x300, G x5000).
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Figure 2. At the electronmicroscopical level the diﬀ ertent stages and the developing podocytes could be nicely distinguished, the comma-stage 
(A), the S-stage (B) and the more advanced early capillary stage (C) (A-B x900, C x2500).
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Figure 3. Expression of APA in the developing glomeruli studied by immunoﬂ uorescence: APA (demonstrated with the mAbs ASD-3) 
could already be detected in the earliest histological deﬁ nable glomerular stage, the comma stage and proximal tubular stages in the cortex but 
not in the medulla. In the comma stage the vascular cleft, arrowhead (A), could be nicely distinguished (also the capillaries could be recognized 
via ASD-13, a speciﬁ c antibody for glomerular endothelium, data not shown). APA staining could be seen in the developing podocytes and in a 
somewhat stronger degree in the center of the earliest developing proximal tubules, arrow (A,B). In the S-stage there was staining for APA of the 
cells lining the vascular cleft that are destined to become podocytes (arrowhead) (D). In addition cells that will develop into the proximal tubule 
stained faintly positive for APA without a clear polarity (arrow) (C,D). In the more advanced early capillary stage, several capillary loops start to 
develop within the glomerulus. These capillary loops are positively stained for APA (E,F). In the proximal tubules expression is now polarised, with 
predominant localization at the apical site in the brush border (arrow) (F). In the capillary stage APA was present in the glomerular capillary loops 
and in the brush borders of the proximal tubules (G,H) (A–H x600).
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To obtain more insight in the exact sub cellular localization of APA during nephrogenesis IEM 
on E18 old embryos was carried out (Figure 4). In the comma stage there was only a faint APA 
expression (Figure 4a). In the S-stage there was strong membrane staining of both develop-
ing podocytes and parietal epithelial cells. Staining was predominantly seen on surfaces 
lining Bowman’s space (Figure 4c). In the S-stage proximal tubular epithelial cells showed 
some expression of the apical/lateral membranes, arrows (Figure 4b) and strong staining of 
cytoplasmic vesicles close to the luminal surface of the epithelial cells (Figure 4d). In the early 
capillary stage membranes lining Bowman’s capsule were still strongly positive, probably api-
cal BB staining. In addition the early podocytes showed staining of apical, lateral and basal 
membranes and sometimes carried cytoplasmic vesicles (Figure 4e). At this later stage the 
epithelial cells of the proximal tubules showed merely brush border staining and no longer 
staining of cytoplasmic vesicles (Figure 4f ). In the mature kidney IEM conﬁ rmed the membra-
nous staining pattern of the podocytes (Figure 1g).
Enzyme histochemistry with a speciﬁ c APA substrate on frozen sections of E18 old embry-
onic kidneys showed that APA enzyme activity could already be demonstrated in early stages 
(Figure 1c) and further increased in glomeruli in a more advanced developmental stage, early 
capillary stage (Figure 1e). In the proximal tubules APA enzyme activity could be demon-
strated in the brush border (Figure 1e, arrows).
 
We also determined APA mRNA expression during nephrogenesis by non-radioactive RNA in 
situ hybridization. Glomerular APA mRNA could be demonstrated in all developmental stages. 
Nicely the expression is seen in cells destined to become podocytes (Figure 1b, S-stage). In 
addition we could demonstrate APA mRNA in developing proximal tubules (Figure 1b, inset). 
In the early capillary stage expression is restricted to the podocytes (Figure 1d). In the mature 
kidney APA mRNA expression was restricted to the perinuclear zone of podocytes, expression 
in other compartments could not be detected or was very low [9].
Table 1 summarizes our ﬁ ndings.
 Figure 4. Immunoelectron microscopy on day E18 old embryos: In the comma stage APA was faintly observed on the membranes of 
the early epithelial cells. APA was only seen on those epithelial cells that ﬁ rst came in contact with the ingrowing endothelial cells of the vascular 
cleft (A). In the more advanced S-stage the APA staining on the membranes of the epithelial cells was much more pronounced. Furthermore, APA 
on these epithelial cells was only stained on the membranes lining the earliest developing Bowman’s space (C). APA was present on the early 
apical membranes of the parietal epithelial cells lining Bowman’s capsule and on the top membranes and early foot processes of the developing 
podocytes. The occluding junctions were located between the visceral epithelial cells (C,E). In the developing proximal tubules APA was ﬁ rst 
observed on the apical/lateral membranes (B) and predominantly in the cytoplasm in distinct vesicles of these early proximal tubular epithelial 
cells (D). Later in development the formation of the proximal tubular brush borders becomes more pronounced and APA was found in massive 
amounts on the brush border membranes, then the strong cytoplasmic staining of APA was absent (F) (A x900, B x25000, C x3500, D x12000, 
E x5000, F x2500).
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Table 1: Expression of APA during kidney development.
Developmental phase
APA 
IF
APA
 IEM
 APA 
mRNA
APA 
E.A.
Comma phase (E18-P1)¹
Tubular ± ± ± ±
Epithelial ± ± ± ±
Endothelial  – – –
S-phase: (E18-P1)
Tubular (proximal); Cytoplasm
Apical (BB)
Bas. Lateral
+
±
–
+
±
–
++ +
Epithelial (podocyte) ++ ++ +++ +++
Endothelial – – – –
Pre - / Capillary phase: (E18-P1)
Tubular (proximal); Cytoplasm
Apical (BB)
Bas. Lateral
+
–
–
+
–
++
++
Epithelial (podocyte) +++ +++ ++ +++
Endothelial – – – –
Adult phase: P3²
Tubular (proximal); Cytoplasm
Apical (BB)
Bas. Lateral
++
–
–
++
±
±
+++
Epithelial (podocyte) ++ ++ + ++++
Endothelial ³ – – – –
1) Embryonic day 18-postnatal week 1.
2) Postnatal week 3.
3) APA expression was observed on endothelial cells of peritubular capillaries and in the pars media of arteries.
IF, immunoﬂ uorescence; IEM, immunoelectronmicroscopy; EA, enzyme activity; BB, brush border.
Injection of the nephritogenic APA antibody combination ASD-37/41 in 1 day-old mice com-
pletely blocked enzyme activity (Figure 5a) and cause albuminuria at day 1 (60,000 ± 4,000 
µg/ml) whereas the combination ASD-3/41 albuminuria only partly blocked enzyme activity 
(Figure 5b) and did not induce albuminuria (140 ± 21 µg/ml). APA enzyme activity was still 
absent at day 9 after injection of ASD-37/41 and was normalized at day 21 (Figure 5c). Partial 
foot process eﬀ acement was present at day 1 and persisted at day 9 and 21(Figure 5e). These 
abnormalities were not accompanied by albuminuria (day 9 ASD-37/41 (240 ± 47 µg/ml); 
ASD-3/41 (120 ± 20 µg/ml); day 21 ASD-37/41 (180 ± 25 µg/ml); ASD-3/41 (120 ± 20 µg/ml); 
mice were followed for 3 months after injection of antibodies. At 3 months there were no 
abnormalities either by light microscopy (Figure 5d), electronmicroscopy (Figure 5f ) or en-
zymehistochemistry.
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Figure 5. Blocking APA enzyme activity: Injection of the nephritogenic APA antibody combination ASD-37/41 in 1 day-old mice, blocked 
enzyme activity completely for 9 days (A). In mice treated with the combination ASD-3/41 enzyme activity was partly blocked in the glomeruly 
and completely in the proximal tubular brush borders (B). Total blocking of the renal APA activity did not led to abnormal development of the 
kidney. In kidneys removed at days 9 and 21 after injection of the combination ASD-37/41, we observed partial podocyte foot-process eﬀ acement 
(E). At day 21 enzyme activity was completely returned at normal levels (C). After 3 months foot-process eﬀ acement disappeared (F) and no 
morphological abnormalities were observed at either the light microscopical (D) or electron microscopical level (F) (A-D x300, E-F x5000).
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DISCUSSION
From our study it is evident that APA is expressed in the kidney during nephrogenesis. APA 
was detectable from the earliest stage of glomerular development, the comma stage, on-
wards. In later stages APA expression was conﬁ ned to the podocytes and the brush border 
membranes of the proximal tubular epithelial cells. The subcellular localisation of APA was 
conﬁ rmed by IEM [7]. We have conﬁ rmed the activity of APA by enzymhistochemistry. Of 
note, APA was not expressed in the medulla nor in the endothelium of the renal arteries or 
arterioles. Only in the mature glomerulus faint expression was observed in the juxtaglomeru-
lar cells (JC), the peritubular capillaries (PTC) and pars media of arteries.
We were interested in APA since this enzyme is involved in the degradation of Ang II, the 
most active compound of the RAS system. Ang II is a cytokine that participates in renal dam-
age and has vasoactive and proﬁ brotic properties and contributes to kidney injury by causing 
hypertension and glomerulosclerosis. Impairment of Ang II degradation may inﬂ uence Ang II 
action and indeed animal studies have suggested a role for APA in blood pressure regulation 
[8,16]. Ang ll components of the renin-angiotensin system (RAS) are highly expressed in the 
developing kidney. A role for angiotensin II in renal development has been suggested. The 
cellular distribution of angiotensin II type 1 (AT1) and type 2 (AT2) receptor mRNA in mouse 
kidneys at several embryonic stages and up to three weeks after birth by in situ hybridization 
is widespread. The expression is extra high at E18-P1 and is localised in tubular-, epithelial-, 
endothelial cells and in the papilla. In support of this notion, pharmacological interruption of 
angiotensin II type-1 (AT(1)) receptor signalling in animals with ongoing nephrogenesis pro-
duces speciﬁ c renal abnormalities characterized by papillary atrophy, abnormal wall thicken-
ing of intrarenal arterioles, tubular atrophy associated with expansion of the interstitium, and 
a marked impairment in urinary concentrating ability, suggesting a role for angiotensin II in 
renal development. Similar changes in renal morphology and function develop also in mice 
with targeted inactivation of genes encoding renin, angiotensinogen, angiotensin-convert-
ing enzyme, or both AT(1) receptor isoforms simultaneously. Taken together, these results 
clearly indicate that an intact signalling through AT(1) receptors is a prerequisite for normal 
renal development [5]. So an intact RAS system is important for a normal development of the 
kidney. However, in our experiments blockade of APA enzyme activity for 9 days only led to 
temporary eﬀ acement of foot processes, with no morphological abnormalities present after 
3 months. Our ﬁ ndings are in line with studies demonstrating normal renal development 
in APA-knockout mice [17] or in rats with an increased expression of the AT1a receptor on 
podocytes [2]. In view of the dependence of normal kidney development on Ang II, adverse 
eﬀ ects of impaired Ang II degradation by blockade of APA might not be expected. Of note, 
we observed no APA expression in the areas of the kidney which are most dependent on in-
tact Ang II for development i.e. the papilla, the collecting ducts and the intra renal arterioles. 
We observed APA expression in the podocytes and the brush borders of the proximal tubules. 
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The expression partly overlaps with the expression of the AT1 receptor. In the fetal kidney 
high circulating levels of AngII are present. It has been demonstrated that the expression 
of APA increases upon stimulation by AngII [8]. Upregulation of APA is directed by the AT1a 
receptor [18]. 
Therefore, it is possible that the expression of APA in the developing kidney follows and is de-
pendent on the local Ang II levels. We cannot exclude that APA is becoming more important 
after birth when Ang II exerts negative eﬀ ects. These negative eﬀ ects are shown via short-
term infusion of Ang II in rats which causes renal injury leading to the development of salt 
dependent hypertension in these rats in later life [19]. Furthermore, Ang II is involved in the 
development of hypertension in the spontaneously hypertensive rat, since ACE-inhibitors 
administered at young age prevented hypertension. The development of hypertension has 
been attributed to an increased expression of the AT1a receptor in the proximal tubules [20]. 
Thus, future studies should evaluate the eﬀ ects of APA inhibition in young mice on long-term 
blood pressure regulation.
CONCLUSION
APA is highly expressed in the developing kidney. Complete inhibition of APA enzyme activ-
ity during nephrogenesis for 9 days after birth, only led to podocyte eﬀ acement at day 9 and 
day 21 which disappeared after 3 months, suggesting a minimum role for APA in embryonal 
development.
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ABSTRACT
Administration of a speciﬁ c combination of anti-aminopeptidase-A (APA) mAbs (ASD-37/41) 
in mice induces an acute albuminuria, which is independent of angiotensin II, a well known 
substrate of APA. In the present experiments, we examined whether binding of the mAbs 
initiated changes in the podocytic expression of cytoskeleton (- associated), adhesion and slit 
diaphragm proteins in relation to the time-course of albuminuria. In addition, we measured 
ultrastructurally the extent of foot process retraction (the number of foot processes per μm 
GBM) and the width of the slit pore between the podocytes by morphometric methods. An 
injection of the mAbs combination ASD-37/41 induced a massive but transient albuminuria 
that started at 6 hr, and peaked at 8 hr after which it declined. However, even at day 7 after 
injection of the mAbs some albuminuria was present. Injection of the combination ASD-3/41 
or saline did not induce an albuminuria. Notably, we observed changes in the staining of 
CD2AP and podocin, two slit-pore associated proteins, that coincided with the start of the 
albuminuria. Nephrin staining was reduced and podocytic actin staining became more gran-
ular only at a time albuminuria was declining (24 hr). The number of foot processes per μm 
GBM was already decreased at 4 hr with a further reduction thereafter. The width of the slit 
pore was unchanged at the time of peak albuminuria and gradually decreased thereafter. At 
day 7 podocytic foot process eﬀ acement was even more prominent althought albuminuria 
was only slightly abnormal. Expression of CD2AP was still granular. We observed however a 
change toward normal in the expression of podocin. Injection of saline or ASD-3/41 had no 
eﬀ ect on the expression of podocytic proteins, the number of foot processes or width of the 
slit pore. Our data show that the onset of albuminuria in the anti-APA model is related to 
alterations in CD2AP and podocin, proteins that are important for maintaining slit diaphragm 
structure and podocytic function. Extended studies at day 7 demonstrated uncoupling of 
albuminuria, podocytic foot process eﬀ acement and CD2AP staining. Changes in podocin 
more closely parallelled changes in albuminuria.
Keywords: podocyte, slit-diaphragm, aminopeptidase-A, albuminuria, mouse
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INTRODUCTION
In recent years we have described a mouse model of podocytic activation or injury charac-
terized by a massive but transient acute albuminuria, and induced by a single intravenous 
injection of a combination of two mAbs directed against speciﬁ c epitopes of mouse ami-
nopeptidase-A (APA) [1]. Induction of the albuminuria is not dependent on systemic me-
diators, such as inﬂ ammatory cells, complement, or the coagulation system [1,2,7]. Recently 
we have demonstrated that the induction of albuminuria is not dependent on the presence 
of angiotensin II [2]. Thus it is unlikely that systemic factors or hemodynamic changes are 
involved in our anti-APA model and evidence for a local mechanism must be sought. APA 
has a widespread organ distribution, but in the mouse kidney it has a high expression on the 
cell membranes of podocytes and brush borders of proximal tubular epithelial cells [3,7]. It is 
therefore hypothesized that the enhanced glomerular permeability in this model is initiated 
by the binding of anti-APA mAbs to at least two pathogenic domains on glomerular APA 
resulting in an altered morphology and physiology of the podocyte and maybe the release of 
mediators that are involved in the albuminuria.
In the present experiments, we have examined the expression of several important podo-
cytic proteins, in relation to the time course of the albuminuria. We have included cytoskel-
eton (-associated) proteins, adhesion molecules, slit-diaphragm proteins and heparan sulfate 
proteoglycans, all known to aﬀ ect podocyte integrity, associated with podocytic injury or 
proteinuria in several experimental and human forms of glomerulonephritis [4]. In addition 
we have quantitated the degree of foot process retraction and the width of the slit pore. 
MATERIALS AND METHODS
Animals
BALB/c mice, aged 6 to 10 weeks and weighing 20-25 gr, were purchased from Charles River, 
Sulzfeld, Germany. All procedures involving mice were approved by the Animal Care Commit-
tee of the University of Nijmegen and conformed to the Dutch Council for Animal Care and 
National Institutes of Health guidelines. 
Animal experiments
The characteristics of the three rat mAbs against diﬀ erent epitopes of mouse APA used in this 
study (ASD-3, ASD-37 and ASD-41) have been described previously [5]. The anti-APA mAbs 
have been propagated in vitro by hollow ﬁ ber culture (Nematology Department, Agricul-
ture University Wageningen, The Netherlands). Injection of the combination ASD-37/41 into 
BALB/c mice induced a massive acute albuminuria at day 1, whereas the combination ASD-
3/41 had no eﬀ ect.The administration of ASD-37/41 almost completely inhibited the APA 
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enzyme activity in vivo, whereas ASD-3/41 did not alter the enzyme activity [5]. Mice received 
a single intravenous injection of a total dose of 4 mg of the nephritogenic combination ASD-
37/41 or the non-nephritogenic combination ASD-3/41 (both with 1:1 weight ratio). Groups 
of mice (n=3) were studied at deﬁ ned time-points after injection of mAbs (see results). Urine 
was collected via bladder puncture, after which mice were killed and the kidneys processed 
for light microscopy, immunoﬂ uorescence and electron microscopy. The amount of albumin 
in the urine samples was determined by radial immunodiﬀ usion [6].
MORPHOLOGIC STUDIES
Immunoﬂ uorescence
For immunoﬂ uorescence, kidney fragments were snap frozen in liquid nitrogen and two-μm 
acetone ﬁ xed cryostat sections were stained with Alexa 488-labeled goat anti-rat Ig (Molecu-
lar Probes, Eugene, OR) for 60 min at room temperature to investigate the presence of the 
injected anti-APA mAb. Glomerular APA expression was analyzed using the anti-APA mAbs 
ASD-38 followed by incubation with FITC-labeled sheep anti-rat IgG2b (Serotec, Oxford, UK) 
as described before [2]. The expression of important podocytic proteins and GBM was exam-
ined at 0, 1, 2, 4, 6, 8, 16, 24, 48 hr and 7 days using unlabeled primary mAbs and FITC-labeled 
secondary antibodies as listed in Table 1. The sections were analysed by a confocal system, 
the Leica TCS NT (Leica lasertechnik GmbH, Heidelberg, Germany).
Light microscopy and electron microscopy
For light microscopy pieces of kidneys were ﬁ xed in Bouin’s solution overnight at room tem-
perature, dehydrated and embedded in paraplast (Amstelstad Amsterdam The Netherlands). 
Two μm-thick sections were stained with periodic acid Schiﬀ  and methenamine silver [7]. 
For electron microscopy small pieces of kidneys were ﬁ xed in 2.5% glutaraldehyde dissolved 
in 0.1M sodium cacodylate buﬀ er, pH 7.4 overnight at 4° C and washed in the same buﬀ er. 
The tissue fragments were postﬁ xed in cacodylate-buﬀ ered 1% OsO
4
 for 2 hr, dehydrated, 
and embedded in Epon 812 (Merck, Darmstadt, Germany). Ultrathin sections were cut on an 
ultratome (Leica, Reichert Ultracuts, Wien, Austria), and contrasted with 4% uranyl acetate 
for 45 min and subsequently with lead citrate for 4 min at room temperature. Sections were 
examined in a Jeol 1200 EX2 electron microscope (JEOL, Tokyo, Japan).
Measurements of foot processes, slit pores and GBM
Negatives of electron micrographs (magniﬁ cation x6000) were scanned at 600 dpi resolution 
using a ﬂ atbed scanner (Epson Perfection 1200 Photo, Epson Europe, Amsterdam), resulting 
in a specimen-level pixel size of approximately 7x7nm2. Measurement of resulting images 
was performed using Leica QWin Pro V2.4 (Leica Imaging Systems Ltd, Cambridge, UK) under 
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Microsoft Windows NT 4.0. The system was calibrated using the marker bar on the electron 
micrographs. For ﬁ ve open random capillary loops in each of ﬁ ve randomly selected glom-
eruli per specimen, the GBM was indicated interactively using a graphic tablet. The image 
analysis software was used to measure the length of the GBM for each loop. Also, for each 
loop the number of podocytic foot processes was manually counted and expressed as the 
number of foot processes per µm GBM length; resulting in 25 measurement points for each 
specimen. Using QWin, the width of 100 individual slitpores was measured interactively for 
each specimen in the same set of digitized electron micrographs.
Statistical analysis
Group comparisons were performed using Anova with Tukey post-hoc testing. For the num-
ber of podocytes per µm GBM, glomeruli were taken as a random factor to study the eﬀ ect 
of heterogeneity within individual mice. P-values less than 0.05 were considered signiﬁ cant. 
All statistics were performed using SPSS statistical software (SPSS 9.0 for Windows, SPSS Inc., 
Chicago, IL)
RESULTS
Albuminuria
In mice injected with 4 mg of the nephritogenic combination ASD-37/41 albuminuria was 
ﬁ rst noted at 6 hr, and peaked at 8 hr at values of 58,667 ± 3,771 µg/ml. As shown in Figure 1, 
the albumin excretion decreased thereafter reaching a value of 8,056 ± 6,764 µg/ml at day 1, 
1,739 ± 1,061 µg/ml at day 2, and 2,249 ± 1,447 µg/ml at day 7. Mice injected with the non-ne-
phritogenic combination ASD-3/41 did not develop signiﬁ cant albuminuria (102 ± 24 µg/ml 
at 8 hr).
Expression of podocytic and GBM components
By immunoﬂ uorescence we investigated at 0,1,2,4,6,8,16,24,48 hr and 7 days the binding of 
the injected mAbs in the glomeruli and the presence of APA. In addition we examined at 
these timepoints the expression of several podocytic and GBM proteins that may be involved 
in the induction of albuminuria in this model. The proteins investigated are listed in Table 1.
After injection of ASD-37/41 we observed initial binding of the mAbs to capillary loops in a 
homogeneous pattern that changed into a ﬁ ne granular pattern at 6 hr, and a more granular 
pattern at 24 hours. We also noted a similar change in the glomerular APA expression from 
a homogeneous staining pattern into a ﬁ ne granular one (Figure 2). As described before, we 
observed binding of antibodies to the brush borders of the proximal epithelial cells as early 
as 2 hr after injection [8].
Interestingly we also observed changes in the expression pattern of the slit diaphragm 
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components podocin, CD2AP, and nephrin as well as the cytoskeleton protein actin. The 
normal homogeneous staining along the capillary loops of podocin became more granular 
at 6 hr with evidence of a recovery at day 7 (Figure 3). At the same time CD2AP expression 
changed from a normal ﬁ ne granular into a granular pattern at 6 hr that persisted unchanged 
until day 7 (Figure 3). At the early time point no changes in the expression of nephrin were 
noted. The staining for nephrin at 24 hr was slightly less than in previous hours (Figure 2). 
Glomerular actin aggregated into a more granular pattern at 24 hr when albumin excretion 
was already declining (Figure 2). The expression of the other components listed in Table 1 did 
not change during the ﬁ rst 24 hr after injection of the mAb.
ASD-3/41 mAbs bound homogeneously to the periphery of the glomerular loops and this 
binding pattern remained the same during the ﬁ rst 24 hr. Also the expression of APA and all 
the components listed in Table 1 did not change upon injection of ASD-3/41 mAb.
Light and electron microscopy
By light microscopy we did not see any changes in glomerular or tubular morphology in the 
BALB/c mice injected either with ASD-37/41 or ASD-3/41 during the time of the experiment. 
By electron microscopy we observed segmental fusion of podocytic foot processes during 
the experiment which was quantitated (see below).
Morphometric Measurements
In mice that received the non-nephritogenic combination ASD-3/41 or saline, morphometry 
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Figure 1. Albuminuria at diﬀ erent time points after injection of 4 mg of a combination of two mAbs against aminopeptidase-A (ASD-37/41; 
weight ratio 1:1) into BALB/c mice (mean ± SD).
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Figure 2. The immunohistologic presence of glomerular APA after injection of the mAbs into BALB/c mice. Panel A shows the normal 
homogeneous presence of APA at the periphery of the capillary tuft (corresponding to a podocytic pattern). After injection of the antibodies the 
expression pattern of APA changed from 6 hr onward into a ﬁ ne granular one that persisted until day 7(B; x700). The immunologic localization of 
the slit diaphragm associated protein nephrin and glomerular actin at 2 and 24 hr after injection of anti-APA mAb. The mild nephrin staining (C) 
at the periphery of the glomerular tuft was less intense at 24 hr (D). Glomerular actin as shown by TRITC-labeled phalloidin is present in mesangial 
cells and podocytes. The homogeneous staining for actin at 2 hr in podocytes (E, arrow) became more granular 16-24 hr after administration of 
the anti-APA mAbs (F, arrow) and persisted until day 7 (A-F x500).
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Figure 3. The immunologic localization of the slit diaphragm associated proteins podocin and CD2AP at 2 hr, 6 hr and 7 days after 
injection of anti-APA mAb. The prominent homogeneous staining for podocin along the capillary wall at 2 hr (A) became more granular and 
less intense from 6 hr onward (B). At day 7 the expression of podocin changed toward normal (C; x500). The immunologic localization of the slit 
diaphragm associated protein CD2AP changed from normal faint ﬁ ne granular staining along the capillary wall at 2 hr (D) into a more granular 
and more intense staining at 6 hr (E), that persisted until day 7 (A-F x500).
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was done on tissue samples obtained at 24 hr, and in mice that received the nephritogenic 
combination ASD-37/41 studies were done at 4, 8, 24 hr and 7 days. The slit pore width 
was unchanged at 4 hr and 8 hr after administration of ASD-37/41 (Table 2). We observed 
a decrease of the slit pore width only at 24 hr. In contrast, a reduction in the number of 
foot-processes occurred early and was already apparent at 4 hr after administration of ASD-
37/41, at a time point that albuminuria was not detectable (Table 2). Foot process eﬀ acement 
progressed from 4 hr onward. As evident from the data in Table 2 foot process eﬀ acement 
was even more prominent at day 7. 
Table 2: Slit pore width and number of foot processes as measured on electron microscopical sections.
saline ASD-3/41 ASD-37/41
Slit pore width (nm)
4 hr
8 hr
24 hr 39 ± 7 40 ± 8
41 ± 11
37 ± 10
28 ± 5a
Foot process (n / µm GBM)
4 hr
8 hr
24 hr
Day 7
1.7 ± 0.3 1.9 ± 0.4
1.4 ± 0.5a
1.2 ± 0.4a
0.9 ± 0.3a,1
0.5 ± 0.3a,2
BALB/c -mice were injected with saline, the non-nephritogenic combination of two anti-APA mAbs (ASD-3/41), or the nephritogenic 
combination ASD-37/41 (see Methods section). At the indicated time points small pieces of renal cortex were processed for electron microscopy. 
Mean ± SD
a)  p<0.001 vs saline and ASD3/41
1)  p<0.001 vs ASD-37/41 at 4 hr
2)  p<0.05 vs ASD-37/41 at 24 hr and p<0.001 vs others
DISCUSSION
Injection of the combination of the anti-APA mAbs ASD-37 and ASD-41, which act synergisti-
cally on two nephritogenic epitopes of APA, induced an early massive albuminuria which 
started at 6 hr, reached its maximum at 8 hr and declined thereafter. In previous studies we 
have excluded complement, coagulation factors, inﬂ ammatory cells, and angiotensin II as 
mediators of proteinuria [1,2]. Therefore, in the present study we have evaluated the potential 
role of podocytic alterations in the development of albuminuria. Our anti-APA model in mice 
has some resemblance to an antibody mediated model in rats, in which a single injection of 
antibodies against podoplanin, a 43-kD protein on the podocytic cell membrane, leads to a 
transient proteinuria and eﬀ acement of foot processes that is independent of complement 
and inﬂ ammatory cells [9].
The GBM was for long considered the main size and charge selective ﬁ lter. Recent studies 
have provided evidence that the podocyte and especially the slit diaphragms are important 
in maintaining the glomerular ﬁ ltration barrier [4,10,11]. The slit diaphragm may function 
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as the size-selective barrier, while the negative charges of the GBM are responsible for the 
charge-selective barrier [12,13,14].
Theoretically proteinuria may be the result of loss of GBM negative charge, detachment 
of the podocyte from the GBM, cytoskeleton rearrangements of the podocyte that inﬂ uence 
podocyte and slit diaphragm geometry, or functional abnormalities of the slit diaphragm 
complex or the GBM secondary to podocytic injury. Our study provided no arguments for 
one of the ﬁ rst three possibilities. The expression of JM403, an antibody against heparan 
sulfate used to characterize GBM negative charge [15,16], remained normal, thus suggesting 
that the acute albuminuria is not related to a defect or reduction of GBM negative charge. 
We also did not observe reduced expression of α3-integrin or dystroglycan, arguing against 
changes in podocyte-GBM adhesion. Of note, detachment was never observed by electron 
microscopy. An important role for primary cytoskeletal rearrangements is also unlikely. We 
only noted aggregation of podocytic actin at 24 hr, at a time point albuminuria was declining. 
Therefore, these changes are probably a consequence of podocytic foot process eﬀ acement 
or related to preceding changes in podocin and CD2AP.
Our data point to the slit diaphragm complex as the culprit of the increased permeability 
in our model. We observed changes in the expression pattern of CD2AP and podocin as early 
as 6 hr after administration of the antibodies, the earliest time point that albuminuria was 
noted. At this time point foot process density had decreased.
CD2AP and podocin are proteins that are involved in maintenance of the slit diaphragm. 
The important role of the slit diaphragm constituents in the functioning of the glomerular 
ﬁ ltration barrier has been demonstrated by the proven relation between abnormalities of 
the slit diaphragm and podocytic speciﬁ c proteins and the development of proteinuric renal 
diseases [4]. Nephrin was the ﬁ rst protein to be discovered as an essential component of 
the slit diaphragm. Nephrin, a protein product of the gene NPHS1, is a 1241 amino acid long 
plasma membrane protein that is exclusively expressed in the podocytes [17,18]. Mutations 
in nephrin are the cause of congenital nephrotic syndrome of the Finnish type [19]. Nephrin 
knock-out mice do not develop foot processes and are proteinuric [20]. Intravenous injection 
of the mAbs 5-1-6, which was recently discovered speciﬁ c for rat nephrin, induces an acute, 
transient proteinuria in rats with eﬀ acement of foot processes and displacement of nephrin 
and slit diaphragm along the capillary loops [21,22]. Nephrin may function as a structural 
component of the slit diaphragm, although recent studies also have disclosed signalling 
properties [23]. Podocin, a product of the NPHS2 gene, is a member of the stomatin family of 
proteins and forms hairloop structures with both the C and N terminal of the protein situated 
in the cytoplasm of the podocytes [24]. Mutations in podocin are associated with familial 
autosomal recessive forms of focal glomerulosclerosis in humans [25]. CD2AP (CD2-associ-
ated protein) was originally discovered in lymphocytes as an SH3 domain containing adaptor 
protein of the CD2 receptor. CD2AP is also present in podocytes, and CD2AP knock-out mice 
showed identical clinical and morphological features as nephrin knock-out mice [26]. Recent 
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studies have provided evidence that nephrin, CD2AP and podocin are closely linked; podocin 
interacts with nephrin and CD2AP [27,28], a cytoplasmic binding partner of nephrin. Neph-
rin and CD2AP are being linked to the actin cytoskeleton [29] and podocin augmenting the 
signalling properties of nephrin [23]. Normal functioning of each component is necessary for 
maintaining normal glomerular permeability.
Our data suggest that binding of the anti-APA mAbs cause alterations in the CD2AP-podo-
cin-nephrin complex with resulting changes in the permeability. We did not observe early 
changes in the expression of nephrin. This might be explained by the relatively low speciﬁ city 
of our anti-nephrin antibody. Alternatively, we must conclude that the changes in podocin 
and CD2AP are most important. In this respect the recent studies in the Lmx1b knockout 
mouse seem relevant [30,31]. Lmx1b knock-out mice show phenotypic abnormalities in the 
glomeruli, with immature podocytes, a reduced number of foot processes and absent slit-
diaphragms. In these mice mRNA and protein levels of podocin are greatly reduced. Also, 
changes in CD2AP expression were noted in one study [30]. Of note, expression of nephrin 
was normal in these knock-out mice [30,31].
We have extended our studies in order to ﬁ nd more convincing evidence for the relation-
ship between albuminuria and alterations of the slit-pore complex. At day 7 albuminuria 
had decreased more than 20 fold, although values were still abnormal. The expression of 
CD2AP was unaltered, whereas the expression of podocin had slightly changed toward nor-
mal. These observations indicate an uncoupling between albuminuria and the expression 
of CD2AP and podocin, and question the role of alterations in these slit-pore proteins in the 
pathogenesis of albuminuria. The initial changes in expression of CD2AP and podocin may be 
an epiphenomenon, possibly related to alterations in foot process morphology i.e. foot pro-
cess eﬀ acement. However, our morphometric analyses point to clear discrepancies between 
podocin and CD2AP staining and foot process morphology. Despite the enormous reduction 
in albuminuria foot process eﬀ acement was more prominent at day 7. If the observed altera-
tions in podocin and CD2AP were merely epiphenomena, one would have expected an even 
more granular expression pattern. In contrast, the expression of CD2AP remained unchanged 
and the expression of podocin changed toward normal. How can we reconcile the above 
mentioned ﬁ ndings? We suggest the following sequence of events: binding of anti APA mAbs 
to podocytic APA results in injury or activation of the podocyte, with ensuing changes in 
slit-pore structure. As a consequence albuminuria occurs. Antibody binding is present for 7 
days and more. The slit-pore structure remains altered, which explains ongoing albuminuria. 
However, progressive eﬀ acement of the podocytic foot process leads to a reduction in the 
number of slit-pores and thus attenuates albuminuria.
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CONCLUSION 
We have found that albuminuria in the anti-APA model started 6 hr after injection of the 
nephritogenic combination of mAb, ASD-37/41. Albuminuria reached its peak at 8 hr, and 
decreased rapidly thereafter. Foot process eﬀ acement occurred before the onset of albumin-
uria and increased until day 7. We also noted early changes in the staining pattern of two slit 
diaphragm associated components, i.e. podocin and CD2AP. The data suggest that injection 
of anti-APA mAbs results in albuminuria by causing podocytic alterations at the level of the 
slit-pore.
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ABSTRACT
The magniﬁ cation factor in transmission electron microscopy is not very precise, hampering 
for instance quantitative analysis of specimens. Calibration of the magniﬁ cation is usually 
performed interactively using replica specimens, containing line or grating patterns with 
known spacing. In the present study, a procedure is described for automated magniﬁ cation 
calibration using digital images of a line replica. This procedure is based on analysis of the 
power spectrum of Fourier transformed replica images, and is compared to interactive mea-
surement in the same images. Images were used with magniﬁ cation ranging from 1,000x to 
200,000x. The automated procedure deviated on average 0.10% from interactive measure-
ments. Especially for catalase replicas, the coeﬃ  cient of variation of automated measurement 
was considerably smaller (average 0.28%) compared to that of interactive measurement 
(average 3.5%). In conclusion, calibration of the magniﬁ cation in digital images from transmis-
sion electron microscopy may be performed automatically, using the procedure presented 
here, with high precision and accuracy.
Keywords: Transmission electron microscopy, calibration, digital image analysis, pattern rec-
ognition, geometry.
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INTRODUCTION
Transmission electron microscopy (TEM) is widely used for the ultrastructural study of cells 
and tissues. At present, traditional photography of EM images is increasingly replaced by 
digital techniques, capturing a digital image directly from the microscope. Digital image 
acquisition also facilitates stereological techniques, which enable reliable measurement 
of microscopic features such as length, area and diameter of particles. To perform stereol-
ogy in an accurate and reproducible way, geometrical calibration of the imaging device is 
critical. Unfortunately, TEM magniﬁ cation is not very precise. Even when adjustments have 
been made using standardized procedures [1], magniﬁ cation aberration may be as high as 
5% with modern TEMs, increasing with equipment age [2,3]. The calibration options found 
on modern TEMs are aimed at calibration of the viewing console, of which the magniﬁ ca-
tion may deviate from digitally acquired images. Internal (inside the specimen of interest) or 
external (using a separate calibration specimen) reference standards are required to calibrate 
the magniﬁ cation of digitally acquired images with each recording session. For this purpose, 
replica specimens may be used, which show a line or grating pattern with a known number 
of lines per unit area. For moderate magniﬁ cations up to 25,000x (25K), an external shadow-
cast carbon replica may be used, typically containing 2160 lines/mm (line spacing 463 nm). 
Higher magniﬁ cations may be calibrated with an internal line replica, e.g. a replica based 
on catalase crystals (line spacing 8.75 nm) [1,2]. Alternatively, the MAG*I*CALTM calibration 
specimen may be used [4]. This specimen consists of an ion milled cross section of a silicon 
single crystal consisting of a series of atomically ﬂ at layers of Si and SiGe, resulting in diﬀ erent 
layer spacings which may be used to calibrate the entire TEM magniﬁ cation range (1,000x to 
1,000,000x). Next to these replica specimens, colloidal particles [5] and for higher magniﬁ ca-
tions spherical virus diameters may be used as internal calibration standards [3].
Using the line or grating pattern of a replica for magniﬁ cation calibration in digitally ac-
quired images is usually performed manually, by interactively indicating the distance be-
tween a manually counted number of lines. If the average distance between replica lines 
in pixels is known, the specimen level pixel size (in nm) can easily be calculated using the 
replica speciﬁ cations. Interactive calibration is laborious and may lack precision. The aim of 
the present study was development of an automated procedure for calibration of digital TEM 
images, using a line replica image. The automated method was evaluated against interactive 
calibration using the same replica images.
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MATERIALS AND METHODS
Electron microscopy
All images were produced using a JEM-1200EX II (Jeol Europe B.V., The Netherlands). The TEM 
was aligned and adjusted (column alignment, depolarization of magniﬁ cation forming lens-
es, tilt axis alignment [6]) according to manufacturer’s instructions. Image acquisition was 
performed using digital imaging plate technology for TEM via the Dibis Micron Vario (Ditabis, 
Pforzheim, Germany). This system uses reusable image plates which are exposed in the TEM 
identical to classical photo negatives. Plates were read out digitally in a separate system (read 
out pixel size 17.5x17.5μm2). Resulting images (size 4910x4340 pixels) were stored as uncom-
pressed tiﬀ  ﬁ les. In this study, a carbon replica of 2160 lines/mm (line replica; EMS, Hatﬁ eld, 
UK) and a catalase replica (inter line distance 8.75 nm; EMS, Hatﬁ eld, UK) were used.
Digital image analysis
Image analysis was performed using custom written macros for KS400 software (Carl Zeiss 
GMBH, Germany). Calculation of the average distance between replica lines was based on the 
fact that the repetition of replica lines is represented by local maxima in the power spectrum 
of the Fourier transformed replica image (Fourier image). Figure 1A shows an example of 
a digitally acquired replica image at magniﬁ cation 1200x. A subimage of this image (white 
frame in Figure 1A) was Fourier transformed (power spectrum of the result is shown in Figure 
1B).The local maxima in the Fourier image correspond to the base frequency of the replica 
lines and multiples of this frequency (higher order moments; Figure 1B). Because the input 
image is real valued (as opposed to complex valued), the Fourier transformed image is fully 
symmetric. To simplify the analysis, the left half of the Fourier image is cleared.
Segmentation of local maxima in the power spectrum of the Fourier transformed image 
was performed using a dynamic segmentation: the Fourier image was ﬁ ltered using a low 
pass ﬁ lter (mean ﬁ lter, size 45x45 pixels) and the result was subtracted from the Fourier im-
age. Pixels with diﬀ erence >25 were considered to be part of a local maximum and were 
labeled “object” pixels. If the distance d between replica lines (in pixels) is small (e.g. when a 
low magniﬁ cation is used, relative to the replica line spacing), the local maxima in the Fourier 
image are relatively far apart. In these cases, segmentation of a single local maximum in the 
Fourier image sometimes resulted in multiple small objects, located very close together. In 
these cases, a binary closing was performed on the resulting binary image (structuring ele-
ment 8-connected neighborhood). The number of iterations for the binary closing (1 or 2) 
depended on the combination of magniﬁ cation and replica line spacing. Object pixels result-
ing after the binary closing were grouped together to form (8 connected) binary objects. The 
binary object at the Fourier image origin (centre of the image) was removed. In cases with 
local maxima very close to each other, this resulted in removal of the ﬁ rst one or two maxima 
as well.
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The local maximum in the Fourier image closest to the origin corresponds to the base fre-
quency of replica lines in the original image (Figure 1C). The distance between Fourier origin 
and ﬁ rst local maximum (fx, fy) is the reciprocal of the distance between replica lines (dx, dy) 
in the original image (Figures 1C, D). From the measured (fx, fy) the distance d between rep-
lica lines can be calculated [7] (Appendix A). To decrease the error caused by the imprecision 
of locating the local Fourier maxima, and because in some cases the ﬁ rst local maximum has 
erroneously been erased together with the centre of origin, the two detected local maxima 
fx
fy
C
A
B
ED
dx
dy
d
Į
replica lines
Fourier image
f’f”
Figure 1. Example of a TEM image of a carbon line replica (A) at 1200x magniﬁ cation. The sub image indicated by a white frame was Fourier 
transformed, of which the power spectrum was calculated (B). The location of the local maxima in the Fourier power spectrum (C) may be used 
to calculate the distance between replica lines in the original replica image (D). To increase precision, the two most distant maxima were used in 
the present study (E).
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most distant from the origin were used instead of the ﬁ rst local maximum (Appendix B). The 
centre of mass was determined for each detected binary object. Polar coordinates were cal-
culated describing the distance of the object centre of mass to the Fourier image origin and 
the angle with the positive x-axis. In some cases, local maxima were present in the Fourier 
image which were not a representation of the replica pattern. To distinguish between these 
maxima and the maxima representing the replica line pattern, a histogram was calculated 
of the angles of all objects to the positive x-axis (bin size 0.025 radians). All higher order 
moments of the maxima representing the replica pattern are located on a line through the 
Fourier image origin. Therefore, the histogram bin with the highest number of maxima (his-
togram mode) was considered to contain the maxima representing the replica line pattern. 
Of all local maxima within this histogram bin, the two maxima with the largest distance to the 
image origin were selected (Figure 1E). The distance between replica lines was calculated us-
ing the equations in Appendix A and B. The KS400 macro developed in this study is available 
on request, please contact the corresponding author.
Interactive calibration
Interactive calibration was performed using standard KS400 functions. The digitally acquired 
replica image was shown on a computer screen and the user interactively indicated one rep-
lica line near the edge of the image by drawing a straight line segment along the (left or 
right) side of the replica line in the image overlay. Next, a second replica line, as far distant 
from the ﬁ rst as possible, was interactively deﬁ ned by clicking on the side (identical side 
as for the ﬁ rst replica line) of this line with the computer cursor. The system automatically 
calculated the shortest distance between the indicated line and point (Appendix C). The user 
manually counted the number of lines in between the two indicated lines. From these, the 
average distance between replica lines in pixels was calculated.
Experiments
Digital TEM images of the carbon line replica (inter line spacing 463 nm) were acquired at 1K, 
2K, 3K, 4K, 6K, 7.5K, 10K, 12K, 15K, 20K and 25K magniﬁ cation. Digital TEM images of the cata-
lase replica (inter line spacing 8.75 nm) were acquired at 50K, 100K, 150K and 200K magniﬁ ca-
tion. Digital images were produced with 4910x4340 pixels resolution. Inter line spacing was 
manually measured in all carbon line replica images by two observers (JAWMvdL / HBPMD), 
using the procedure described above. Measurements were made in the centre of the images, 
with a software zoom factor (on the computer screen) which was determined by the observer 
for each individual case. To study intraobserver variability, one observer also performed the 
interactive measurement in 5 manually selected sub-images of diﬀ erent parts of all (carbon 
and catalase) replica images.
The automated procedure was used to measure the inter line spacing in all replica images. 
To ensure that the entire analyzed images were ﬁ lled with the replica line pattern, and to 
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speed up the Fourier transform, subimages were taken from the originally acquired images. 
Subimage size was chosen such that enough replica lines were present in the image for accu-
rate analysis: 1024x1024 pixels for the image acquired at 1K magniﬁ cation, 2048x2048 pixels 
for magniﬁ cations 2K to 15K and 50K, and 4096x4096 pixels for magniﬁ cations 25K and 100K 
to 200K. The number of iterations for the binary closing was related to the distance between 
local maxima in the Fourier image. Two iterations were used for magniﬁ cations 10K and 50K 
to 200K, 1 iteration for magniﬁ cation 15K and no binary closing at all for magniﬁ cations 20K 
and 25K. To study the variability of the automated procedure, the same analysis was per-
formed 5 times for sub-images taken from diﬀ erent parts of each replica image.
Statistics
For statistics and production of graphs, SPSS for Windows was used (version 11.0.1; SPSS Inc, 
Chicago, IL). The interobserver eﬀ ect for manual measurements was studied using a one-
sample t-test for the relative diﬀ erence between observers. The diﬀ erence between manual 
and automated measurements was evaluated using Wilcoxon signed ranks test. Strength of 
the relationship between variables was tested using Spearman rank correlations. P-values 
below 0.05 were considered to be statistically signiﬁ cant.
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Figure 2. The relative diﬀ erence between automated and manual measurement of the inter line distance in replica images of diﬀ erent 
magniﬁ cations. Magniﬁ cations are shown on a logarithmic axis.
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RESULTS
The interobserver eﬀ ect for manual measurement of the replica inter line distance was found 
to be small (mean 0.20%, range 0.028% – 0.47%) but signiﬁ cant (p<0.005). Results from the 
automated procedure were on average 0.10% (range -1.46 to 2.97%) below manual mea-
surements (Figure 2). This diﬀ erence was not statistically signiﬁ cant. The largest diﬀ erences 
between manual and automated measurement were seen for the two highest magniﬁ ca-
tions. No signiﬁ cant correlation was found between magniﬁ cation and diﬀ erence between 
automated and manual measurement.
For each magniﬁ cation the expected inter line distance in pixels can be calculated from 
the imaging and replica parameters. Figure 3 shows measured distances as compared to this 
calculated distance. Intraobserver variability and the variability in the automated procedure 
were small for the carbon replica (Figure 3A), with average coeﬃ  cient of variation (CV) 0.45% 
(maximum 0.7%) for manual and 0.56% (maximum 1.0%) for automated measurements. The 
largest deviation from the calculated inter line distance was seen for 1K magniﬁ cation, which 
TEM setting is known to be less precise. For the catalase replica (Figure 3B) the intraobserver 
CV was on average 3.5% (maximum 5.3%), for the automated measurements the average CV 
was 0.28% (maximum 0.43%). For this replica, manual assessment of the inter line spacing is 
hampered by low image contrast and the presence of noise (Figure 4). No signiﬁ cant correla-
tion was found between CV and magniﬁ cation.
DISCUSSION
Digital image acquisition has become the standard in transmission electron microscopy. It 
is well known that the magniﬁ cation factor given by the microscope is in general not very 
precise. If precision of the magniﬁ cation in digitally acquired TEM images is of importance, 
e.g. when performing measurements, image calibration is required. Traditionally, interactive 
manual calibration is performed to determine the specimen level pixel size, using replica 
images with known inter line spacing. In the present study, a fully automated procedure is 
described for use with replica images to perform magniﬁ cation calibration in digital TEM im-
ages. This procedure, which is based on analysis of the power spectrum of the Fourier trans-
form, was found to give results comparable to those obtained by manual calibration. When 
using a catalase replica, the automated procedure was superior to manual calibration in 
terms of measurement precision. The catalase replica images show considerably less contrast 
and more noise than the carbon replica images, making manual calibration less reliable.
In general, accuracy is considered to be of higher importance than precision in stereology 
[8]. Measurement lacking precision may be improved by increasing the number of samples, 
whereas poor accuracy leads to biased data. However, imprecise calibration of an entire set 
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automated measurement. (A) shows results for the carbon replica, (B) for the catalase replica.
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of images (e.g. comprising a patient data set) may lead to biased measurement results on 
patient level. Therefore, precision and accuracy are equally important for magniﬁ cation cali-
bration.
The automated procedure is widely applicable, as it is insensitive to local image artifacts, 
and to image contrast and brightness to a large extent. Also, the procedure is insensitive to 
mechanical rotation of the replica image, as rotation of an image causes rotation of the corre-
sponding Fourier transform over the same angle, resulting in the same distances between lo-
cal maxima. In this study a commonly used carbon line replica with 2160 lines/mm was used, 
as well as a catalase replica with inter line spacing of 8.75 nm. The procedure, however, will 
work with any replica containing a ﬁ xed number of repeating lines with constant spacing. For 
example, the general purpose MAG*I*CALTM specimen [4] can be used with the automated 
procedure, enabling magniﬁ cation calibration over a large range of magniﬁ cations. Also, this 
procedure may be applied to a grating replica, for which minor adaptations will be required 
to handle the diﬀ erent pattern of local maxima in the Fourier image. Use of jpeg compression 
should be avoided, as this compression causes multiple false maxima in the power spectrum 
of the Fourier transform.
TEM image of catalase replica
100K magnification 200K magnification
Figure 4. TEM image of the catalase replica at 100K and 200K magniﬁ cation. Clearly, the line patterns in these images suﬀ er from low contrast 
and noise, resulting in imprecise manual magniﬁ cation calibration. The automated calibration procedure was capable of measuring the inter 
line spacing with high precision.
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The size of the subwindow and the number of iterations for the binary closing step have 
to be selected to match the images used. Subimages should be selected which are ﬁ lled as 
much as possible with the replica line pattern. Optimal parameters for taking subimages and 
binary closings have to be determined for each setup, as these depend on the used replica, 
magniﬁ cation and also on the parameters of the digital imaging procedure.
CONCLUSION
This paper describes a procedure for accurate automated calibration of TEM magniﬁ cation in 
digital replica images. Next to be less labor intensive, the procedure is also more reproducible 
than manual calibration using a replica specimen.
Appendix A
The distance d between replica lines (Figure 1D) can be expressed as:
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In case of a rectangular Fourier image ( ss xy = ) [7]:
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Appendix B
Instead of using the ﬁ rst local maximum in the Fourier image, higher order moments may be 
used, decreasing the imprecision caused by determination of the location of local maxima. 
Higher order moments are found at multiples of (ƒ
x
, ƒy). In the present study, all local maxima 
with similar orientation (in relation to the Fourier image origin) were detected (see Materials 
and Methods). The two local maxima most distant from the origin were used for calculation 
of (ƒ
x
, ƒy). The most distant local maximum detected by the automated segmentation will 
be called (ƒ’
x
, ƒ’y) and the second most distant local maximum (ƒ”x, ƒ”y) (Figure 1E). The most 
precise estimation of (ƒ
x
, ƒy) is:
n
f
n
fff yxyx
'
,
'
, =
with n the number of maxima detected.
Because the segmentation procedure is not always capable of discriminating between 
the Fourier origin and the ﬁ rst few local maxima, n can not reliably be determined directly. 
Instead, the number of maxima detected can be calculated by:
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The value of n has to be rounded to the nearest integer.
Appendix C
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ABSTRACT
Focal segmental glomerulosclerosis (FSGS) is one of the most common patterns of glomeru-
lar injury encountered in human renal biopsies. Epithelial hyperplasia, which can be promi-
nent in FSGS has been attributed to dediﬀ erentiation and proliferation of podocytes. Based 
on observations in a mouse model of FSGS, we pointed to the role of parietal epithelial cells 
(PECs). In the present study we investigated the relative role of PECs and podocytes in human 
idiopathic FSGS.
We performed a detailed study of lesions from a patient with recurrent idiopathic FSGS by 
serial sectioning, marker analysis and 3D reconstruction of glomeruli. We have studied the 
expression of markers for podocytes, PECs, mesangial cells, endothelium and myoﬁ broblasts. 
We also looked at proliferation and composition of the deposited extracellular matrix. 
We found that proliferating epithelial cells in FSGS lesions are negative for podocyte and 
macrophage markers, but stain for PEC markers. The composition of the matrix deposited by 
these cells is identical to Bowman’s capsule. 
Conclusion; Our study demonstrates that PECs are crucially involved in the pathogenesis 
of FSGS lesions. 
Keywords: parietal epithelial cell, podocyte, epithelial cell proliferation and glomerulosclerosis.
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INTRODUCTION
Focal segmental glomerulosclerosis (FSGS) has become one of the most common glomeru-
lar diseases [1]. FSGS is characterized by focal and segmental occurrence of lesions with 
mesangial sclerosis, obliteration of glomerular capillaries with hyalinosis and intracapillary 
foam cells, formation of adhesions between the glomerular tuft and Bowman’s capsule, and 
podocyte hypertrophy [2]. FSGS is not a disease entity, but rather a pattern of injury with 
quite diverse clinical behaviour, morphology, and possibly also pathogenesis [3]. Recently, 
various morphological variants have been deﬁ ned and a classiﬁ cation has been proposed to 
better address the diversity of FSGS [4]. Five light microscopic variants of FSGS were deﬁ ned: 
the perihilar variant (lesions predominantly located at the vascular pole), the tip variant (the 
presence of lesions located at the urinary pole), the cellular variant (characterized by endo-
capillary hypercellularity), the collapsing variant (collapse of the glomerular tuft associated 
with epithelial cell hypertrophy and hyperplasia), and ﬁ nally FSGS not otherwise speciﬁ ed 
(NOS) if lesions do not ﬁ t into one of the above mentioned categories. All morphological vari-
ants are accompanied by some degree of epithelial proliferation, being minimal or absent in 
the perihilar variant and sometimes very prominent in the cellular and collapsing variant. 
The pathogenesis of FSGS has been the subject of recent studies. Many investigators have 
focussed on the visceral epithelial cell, the so-called podocyte. Normal podocytes are con-
sidered terminally diﬀ erentiated, post-mitotic cells, which are unable to proliferate and to 
compensate for damaged neighbouring podocytes. Studies by Kriz et al [5;6] in various rat 
models of FSGS indicated loss of podocytes and adherence of the parietal epithelial cell (PEC) 
to the naked GBM as the critical event in the formation of FSGS lesions. Studies on the patho-
genesis of the more cellular FSGS lesions have focused on the collapsing variant of FSGS [7]. 
From these studies the concept of the dediﬀ erentiated and dysregulated podocyte emerged 
[8-12]. Dysregulated podocytes are characterized by loss of podocyte markers, and are no 
longer growth restricted and have regained the ability to proliferate. Based on these ﬁ ndings 
epithelial hyperplasia, which is also commonly observed in ‘active’ FSGS lesions other than 
collapsing lesions, is generally considered to be the result of proliferation of dediﬀ erenti-
ated podocytes. Recently, we have reported on FSGS in Thy-1.1 transgenic mice (a model of 
collapsing FSGS) and have provided evidence that proliferating epithelial cells in lesions are 
of PEC origin and that these cells deposit the extracellular matrix that eventually forms the 
scars [13].
We now investigated the role of PECs in human idiopathic FSGS by detailed analysis of 
FSGS lesions in a nephrectomy specimen of a patient with recurrence of idiopathic FSGS in 
his renal allograft.
68
C
ha
p
te
r 5
METHODS
Patient and methods
Our patient developed a steroid-resistant nephrotic syndrome in 1994, at the age of 8 years. In 
1995 bilateral nephrectomy was performed because of untreatable nephrotic syndrome and 
deteriorating renal function. He was treated by peritoneal dialysis. In October 1996 patient 
received a renal transplant. The postoperative course was characterized by an early recur-
rence of proteinuria, which persisted despite plasma ﬁ ltration. Approximately 6 months after 
transplantation the allograft was removed and peritoneal dialysis was resumed. In August 
2002 a second transplant was performed, with a 3-mismatched kidney from a cadaveric do-
nor. In view of the previous experience pre-emptive plasma ﬁ ltration was performed. The ini-
tial immunosuppressive regimen consisted of the anti-CD25 antibody daclizumab, mycophe-
nolate mofetil, prednisone and cyclosporine. The kidney functioned immediately, and serum 
creatinine decreased to values of 1.4 mg/dl. The patient was treated with plasma ﬁ ltration 
three times weekly, and only mild proteinuria was noted (0,2 – 1,0 g/day). In October 2002, 
while reducing the number of plasmpheresis sessions and lowering the immunosuppressive 
dose, proteinuria gradually increased reaching values between 3-4 g/day in November 2002. 
Switching form cyclosporine to tacrolimus was ineﬀ ective. A renal biopsy was performed in 
December. Light microscopically we found 13 glomeruli. One glomerulus showed advanced 
sclerosis, the others had a normal aspect. Ultrastructural analysis showed particular podocyte 
eﬀ acement and microvillous transformation, compatible with a recurrence FSGS.
In view of the reported eﬃ  cacy in a French study, the patient was treated with added cy-
clophosphamide for 8 weeks and more intensive plasmapheresis [14]. There was no major 
eﬀ ect, although after ending this treatment a deﬁ nite increase of proteinuria was observed. 
Over the next months, proteinuria remained severe, patient was frankly nephrotic and ﬁ nally 
developed moderate renal insuﬃ  ciency, which did not respond to replacement of tacrolimus 
by rapamycin. After lengthy discussions, and in view of the clinical and psychological condi-
tion of the patient, it was decided to perform a nephrectomy, and resume renal replace-
ment therapy with haemodialysis. Nephrectomy was performed October 2003, one year after 
transplantation.
Preparation of the kidney specimen for Light microscopy, Immunohistochemistry and Electron Microscopy
The nephrectomized kidney measured 13 x 7 x 6 cm and weighed 290 grams. The outer as-
pect of the kidney was normal, the vessels contained no thrombi nor were there any macro-
scopical abnormalities when dissecting the kidney. Some pyramid-shaped segments were 
dissected and separately ﬁ xed in bouin, buﬀ ered formalin and snap frozen in liquid nitrogen. 
For electron microscopy we divided the cortex in ﬁ ve equal parts.
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Light microscopy
For light microscopy, kidney fragments were ﬁ xed in Bouin’s solution and formaldehyde, 
dehydrated, and embedded in paraplast (Amstelstad, Amsterdam The Netherlands). 2 µm 
sections were stained with periodic acid-Schiﬀ , and with silver methenamine [15]. 
Immunohistochemistry
Immunohistochemical staining was performed on kidney sections ﬁ xed in 4% buﬀ ered form-
aldehyde for 24 hr and embedded in paraﬃ  n. 4 µm sections were incubated with monoclonal 
antibodies (mAb) and polyclonal antibodies (pAb) directed at various markers for podocytes, 
PECs, macrophages and myoﬁ broblasts as detailed in table 1. As secondary antibody we 
used powervision Poly-HRP-anti Mouse/Rabbit/Rat IgG (Immunologic, Klinipath, Duiven, The 
Netherlands). Detection was carried out with the use of peroxidase as label and diaminoben-
zidine as substrate. For the doublestaining, ﬁ rst the polyclonal antibody (pAb) was detected 
and completed. As detecting antibody we used Envision AF-anti Rabbit IgG (Immunologic, 
Klinipath, Duiven, The Netherlands), detection was carried out with the use of alkaline phos-
fatase as label and FastBlue as substrate. Thereafter samples were incubated with the second 
antibody, as detecting antibody we used powervision Poly-HRP-anti Mouse/Rabbit/Rat IgG 
(Immunologic, Klinipath, Duiven, The Netherlands). Detection was carried out with the use of 
peroxidase as label and AEC/red as substrate.
Immunoﬂ uorescence microscopy
Kidney fragments were snap-frozen in liquid nitrogen, and 2 µm acetone ﬁ xed cryostat sec-
tions were used. Kidney sections were incubated with antibodies directed against synaptopo-
din, collagen IV chains, and heparan sulfate species (Table 1). Detection of the anti-collagen 
antibodies was done using goat anti-mouse AlexaTM 488 antibodies (Molecular probes Inc, 
Leiden, The Netherlands). We have performed double staining for synaptopodin (a marker of 
diﬀ erentiated podocytes) and heparan sulfate species with exclusive presence in either Bow-
man’s capsule or the GBM. Synaptopodin was detected using an anti-synaptopodin mAbs 
(Progen Biotechnik, Heidelberg, Germany), followed by a FITC labelled sheep anti-mouse 
IgG1 (Nordic Immunologicals, Tilburg, The Netherlands). The single chain antibodies used 
for staining of heparan sulfate species [16;17] were detected via a rabbit antibody directed 
against the VSV-g epitope tag (ICL, Oregon, USA) and ﬁ nally detected with a goat anti-rabbit 
AlexaTM 568 antibodies (Molecular probes Inc, Leiden, The Netherlands). The sections were 
examined with a confocal laser scanning microscope (CLSM) (Leica lasertechnik GmbH, Hei-
delberg, Germany).
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Table 1: Antibodies used for the detection of glomerular antigens
Antigen Primary antibody Dil. Supplier / Reference
Podocyte components
Synaptopodin 
CD 10
Vimentin
VEGF
PEC components
PAX-2
Cytokeratin
Pan cadherine
Proliferation
KI 67
Miscellaneous
Macrophage
α smooth muscle actin
Bouwman’s Capsule
Collagen IV α1
Heparan sulfate Single chain
GBM
Collagen IV α3
Heparan sulfate Single chain
Mouse anti-synaptopodin
Mouse anti human CD10 
Mouse anti human Vimentin
ISH m-RNA Probe (*ng/ml)
Rabbit anti human PAX-2 
Mouse anti human CAM 5.2 (CK8)
Mouse anti human Pan cadherin
Mouse anti human MIB-1
Mouse anti human CD68 
Mouse anti human SMA
Mouse anti-α 1 collagen
Single chain antibody HS4E4
Mouse anti-α 3 collagen
Single chain antibody HS4C3
1
50
800
100*
50
50
500
200
2000
15000
10
1
10
1
Progen, Heidelberg, Germany
Monosan, Caltag lab.,Burlinggame
Biogenex, Ramon, CA
 [18]
Zymed laboratories Inc. San Francisco, USA
BD Biosciences, San Diego, CA
Sigma, St. Louis, USA
Dako, Glostrup, Denmark
Dako, Glostrup, Denmark
Sigma, St. Louis, USA
Wieslab, Lund, Sweden
 [16]
Wieslab, Lund, Sweden
 [17]
In situ hybridisation
Kidney sections were ﬁ xed in 4% buﬀ ered formaldehyde for 24 hr and embedded in paraf-
ﬁ n. 4 µm sections were incubated and subjected to VEGF in situ hybridization (ISH) using a 
digoxigenin-labeled VEGF-A antisense RNA probe [18]. The corresponding sense probe was 
used as a control. This ISH was followed by Immunohistochemical staining with the monoclo-
nal antibody (mAb) CK8. As secondary antibody we used powervision Poly-HRP-anti Mouse/
Rabbit/Rat IgG (Immunologic, Klinipath, Duiven, The Netherlands). Detection was carried out 
with the use of AF as label and AEC as substrate.
Three-dimensional reconstruction of inﬁ ltrating PECs
The nephrectomy specimen gave us the opportunity to cut serial sections of a relatively large 
area segment (containing more then 250 glomeruli). At least 400 serial sections were cut and 
incubated for CK8 as described under Immunohistochemistry of the Patient and Methods 
section. In a selected set of sections covering 300 microns we digitized 40-50 serial images 
of each glomerulus. These section Images visualized by DAB staining were directly digitized 
from a light microscope into the KS400 Universal Image Processing and Analysis software via 
a CCD color camera; binary images of the structures were created and the binary images were 
exported into 3D reconstruction software ‘3D doctor’ (Able software corperation, Lexington, 
USA) to reconstruct and to view still and rotating 3D images on a computer monitor, enabling 
us to produce a 3D model of the glomerulus. 3D reconstruction was performed to reconstruct 
3D models of 14 glomeruli showing early to more advanced lesions. 
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Transmission Electron Microscopy
For electron microscopy, we used immersion ﬁ xation, small fragments of cortex were ﬁ xed 
in 2.5% glutaraldehyde dissolved in 0.1 M sodium cacodylate buﬀ er, pH 7.4, overnight at 4°C 
and washed in the same buﬀ er. The tissue fragments were postﬁ xed in palade-buﬀ ered 2% 
OsO4 for 1 hr, dehydrated, and embedded in Epon 812, Luft’s procedure (Merck, Darmstadt, 
Germany). Ultrathin sections were contrasted with 4% uranyl acetate for 45 min and subse-
quently with lead citrate for 5 min at room temperature. Sections were examined in a Jeol 
1200 EX2 electron microscope (JEOL, Tokyo, Japan).
Analysis of glomeruli in consecutive tissue sections
A pyramid-shaped segment in paraﬃ  n was cut and provided over 400 serial sections. Exami-
nation glomerular proﬁ le: Assessment of glomeruli for FSGS lesions was performed using a 
stack of 145 micron. Seven PAS-stained tissue sections equal divided over this stack were 
completely scanned. Of each glomerulus 3 - 5 PAS-stained cross sections were evaluated. 
In total 137 whole glomeruli were evaluated. Images were acquired using an AxioCam MRc 
(Carl Zeiss, Germany) connected to an AxioPlan 2 Imaging microscope (Carl Zeiss, Germany). 
The microscope was equipped with a computer controlled scanning stage (8 specimen stage, 
Märzhäuser GmbH, Wetzlar, Germany controlled by a Ludl MAC5000 controller, Ludl Elec-
tronic Products Ltd., Hawthorne, NY). Images were acquired using a 20x objective (Plan Apo-
chromat, NA=0.6), resulting in a specimen level pixel size of 53x.53μm2. Image acquisition 
was performed using custom written macros in KS400 image analysis software (version 3.0, 
Carl Zeiss, Germany). For each tissue section, a user-deﬁ ned region of interest was automati-
cally scanned and consecutive individual microscopic ﬁ elds were stitched together into large 
24 bit RGB TIFF images. Each individual microscopic ﬁ eld was autofocussed, and grabbed 
images were shading corrected. 
Pairs of images of consecutive tissue sections were opened in Aperio ImageScope (v.4.14; 
Aperio Technologies, Vista, CA) and ‘synchronized’, i.e. both tissue sections could be viewed 
simultaneously and a change of the view position (location or magniﬁ cation) in one ‘virtual’ 
section automatically caused an identical movement in the view of the second section. All 
glomeruli were numerically labeled in the image overlay, so that a single glomerulus could 
be followed in each section in which it was present. Each glomerular proﬁ le was examined. 
For the scoring of FSGS lesions each glomerular cross-section was subdivided into four quad-
rants. The position of the vascular pole was deﬁ ned in this way; data were obtained with 
respect to the location and extent of lesions in each of 137 whole glomeruli contained in the 
kidney segment. For each glomerulus 3 to 5 PAS-stained sections could be studied. Lesions 
were categorized in four diﬀ erent groups. The ﬁ rst group contained only normal or ischemic 
quadrants sometimes associated with wrinkling or even collapse of the capillaries of the glo-
merular tuft, without cellular hypertrophy or hyperplasia. Second group showed early lesions 
deﬁ ned by collapse of the capillaries, accompanied by hypertrophy and epithelial prolifera-
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tion (hyperplasia) of glomerular epithelial cells and early adhesions between the glomerular 
tuft and Bowman’s capsule. The third contained more advanced lesions, characterized by 
collapse of the capillaries of the glomerular tuft, with foam cells, ECM accumulation, sclerotic 
segments and various degrees of hypercellularity. The last group consisted of quadrants of 
glomeruli with advanced sclerosis. 
To analyze the distribution of the various marker proteins and to determine the cellular 
origin, consecutive sections were used for incubations with the various antibodies as de-
scribed in Table 1. Using our system, two consecutive proﬁ les of the same glomerulus could 
be viewed simultaneously. In addition, we have performed doublestaining using diﬀ erent 
sets of marker proteins to strengthen our ﬁ ndings.
RESULTS
Histopathology 
We have evaluated 137 whole glomeruli. Of each glomerulus 3 - 5 PAS-stained cross sec-
tions were scored. A total of 2232 glomerular quadrants were each assigned to one of the 4 
categories normal, collapsing lesion, ‘typical’ FSGS and advanced sclerosis (Figure 1). In 1541 
quadrants we saw a normal glomerular tuft (69%), 30 quadrants showed pure collapse with 
epithelial cell proliferation (hyperplasia) (1.5%), 588 quadrants showed ‘typical’ FSGS lesions 
with segmental collapse, adhesions, foam cells, ECM accumulation and variable epithelial 
cell swelling and hyperplasia (26%), and 73 quadrants were aﬀ ected by advanced sclerosis 
(3.5%). Lesions of all categories could be located anywhere in the glomerulus (perihilar, at the 
tubular pole, or elsewhere). Within a single glomerulus aﬀ ected quadrants were sometimes 
assigned to diﬀ erent categories. In these cases it often turned out that in such a glomerulus 
there was one conﬂ uent lesion with diﬀ erent morphology depending on the plain of section-
ing. Glomeruli in the juxtamedullary half of the cortex were more frequently aﬀ ected (38.4% 
of quadrants demonstrating FSGS lesions) than the more peripherally located glomerli 
(23.9% involved). Overall, lesions showed a wide morphological spectrum with at the one 
end collapse and prominent epithelial cell proliferation and at the other end sclerosis with-
out prominent hypercelularity. Morphological appearance of lesions was presumibly related 
to the age/developmental stage of the lesions. We focussed on the lesions with prominent 
epithelial cell proliferation to study the relative role of podocytes and PECs.
We studied the phenotype of epithelial cells in Bowman’s space using consecutive sections 
and double stainings. We investigated the expression of markers speciﬁ c for podocytes; (syn-
aptopodin, CD10, vimentin and VEGF), PECs; (CK8, Pan-cadherin and PAX-2) macrophages; 
(CD68) and myoﬁ broblasts; (α smooth muscle actin). In both normal and aﬀ ected glomeruli 
we observed a uniform staining of the PECs lining Bowman’s capsule for PAX-2 and Pan-cad-
Parietal epithelial cells are involved in FSGS 73
herin. In glomeruli of normal control kidney tissue and in non-aﬀ ected glomeruli of our pa-
tient CK8 staining was generally faint or absent (not shown). In our patient, in all glomeruli 
with FSGS lesions cells lining Bowman’s capsule were segmentlly CK8 positive. Notably, in 
our patient also in some glomeruli without FSGS lesions (serial sections were examined) we 
observed strong CK8 positivity of PEC’s with a segmental and pachy distribution. Thus, CK8 
staining appears to be a marker of early PEC activation. In collapsing lesions synaptopodin 
expressing podocytes were seen covering the collapsed tuft (Figure 2A, synaptopodin). 
These synaptopodin expressing podocytes were covered by synaptopodin negative but CK8 
and PAX-2 positive epithelial cells (Figure 2A, CK8). This ﬁ nding was conﬁ rmed via double 
staining for synaptopodin and PAX-2 (Figure 2B, C). We did an additional double staining for 
VEGF mRNA and CK8. VEGF mRNA is speciﬁ cally expressed by podocytes [19]. Again we ob-
served VGEF positive cells and CK 8 positive cells but never double positive cells (Figure 2D, 
E, VEGF/CK8). In FSGS lesions with signiﬁ cant ECM accumulation (the ‘typical’ FSGS category), 
A
DC
B
Figure 1. Glomerular histology: The morphology of the FSGS lesions was highly variable, ranging from segmental collapse of a few capillaries 
to advanced global sclerosis. Panel A shows an early lesion with segmental capillary collapse and epithelial hyperplasia (arrows). Some of 
the epithelial cells have prominent resorpsion droplets. The upper part of the glomerulus appears unremarkable. Glomeruli in panels B and 
C show more extensive abnormalities with on top of collapsed capillaries with epithelial hyperplasia more advanced (‘typical’) FSGS lesions 
(arrowheads) with sclerosis, adhesions, epithelial hyperplasia and mild endocapillary hypercellularity with endocapillary foam cells. Panel D 
shows a hypocellular globally sclerotic glomerulus covered with a single layer of epithelial cells, which do not appear, activated (x450).
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Figure 2. Phenotype of proliferating epithelial cells: Panel A shows serial sections of a glomerulus with a collapsing lesion. The epithelial 
cells (asterisk) that cover the collapsed segment are strongly CK8 positive. Also most of the PECs lining Bowman’s capsule are CK8 positive. Some 
PECs are CK8 negative (arrowheads). Podocytes covering the collapsed segment stain positive for synaptopodin. Panel B,C show a double staining 
for synaptopodin (red) and PAX-2 (blue). Sometimes PAX-2 positive cells were located on top of synaptopodin expressing podocytes (panel B), 
whereas in lesions with more sclerosis synaptopodin expression in aﬀ ected segments was lost. Double positive cells were not present. Panel D,E 
shows a double staining for VEGF mRNA and CK8. Podocytes are VEGF positive and PECs and epithelial cells that are part of an FSGS lesion are CK8 
positive. Double positive cells were not present (A x200, detail x800, B,C x600, D x400, E x600).
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Figure 3. Phenotype of epithelial cells in Bowman’s space in lesions with sclerosis (‘typical’ FSGS lesions): Two sections through the 
same glomerulus are shown in panel A and B. For each plain of sectioning consecutive sections were stained for CK8, synaptopodin and PAX-2. 
Epithelial cells in Bowman’s space are positive for CK8 and PAX-2, but negative for synaptopodin. In aﬀ ected segments synaptopodin positivity 
is lost (x375).
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Figure 4. Parietal epithelial cells ‘invade’ the glomerular tuft: 3D reconstruction of glomeruli demonstrated that CK8 positive cells (red) 
are always in continuity with CK8 positive cells lining Bowman’s capsule (green). The glomerular tuft is shown in blue and was deleted from panel 
B to better visualize the deep penetration of CK8 positive cells. Panel B and C show the same glomerulus as panel A but from a diﬀ erent angle. For 
clarity 6 of the sections used for the 3D reconstruction are also shown. CK positive cells, whether positioned at the outer aspect of the collapsed 
segment or even within the central areas, are always connected to the CK8 positive layer of PECs lining Bowman’s capsule. The 3D images can best 
be appreciated in the Supplementary Material (Compact Disc).
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we observed a decreased expression or even a total loss of expression of podocyte markers, 
while the non-aﬀ ected-segments still did expres podocyte markers (Figure 3, synaptopodin). 
Epithelial cells in Bowman’s space were negative for synaptopodin (Figure 3, synaptopodin) 
and all other tested podocyte markers (not shown) but stained positive for PAN-cadherin, 
CK8 (Figure 3, CK8) and PAX-2 (Figure 3, PAX-2). We also observed PAN-cadherin, CK8 and 
PAX-2 positive cells in the central areas of the glomerular tuft (Figure 3 and 4). The 3D images 
demonstrated that these CK8 positive cells were always in continuity with the CK8 positive 
layer of PECs lining Bowman’s capsule (Figure 4). MIB-1 staining showed positive cells along 
Bowman’s capsule near aﬀ ected segments of the glomerulus (Figure 5), whereas MIB-1 stain-
ing was only sporadically observed in normal kidney tissue. Notably, we did not observe cells 
that stained positive for either vimentin or CD68 in Bowman’s space or the lumens of the 
proximal or distal tubules.
We analysed the composition of the extracellular matrix deposited in lesions by staining se-
rial sections with antibodies directed against the α1 (Figure 6A), and α3 (Figure 6B) chains of 
collagen IV. In addition, we have used an anti-HS single chain antibody (HS4E4) that in normal 
kidney tissue predominantly stains Bowman’s capsule and not the GBM, and HS4C3, which 
stains the GBM and mesangial matrix. The ECM in adhesions stained for collagen α1 (IV) (Fig-
ure 6C) and HS4E4 (Figure 6D), and was negative for collagen α3 (IV) and HS4C3. Thus, the 
staining properties of the newly formed ECM were identical to those of Bowman’s capsule, 
indicating that the deposited matrix was produced by PECs rather than podocytes. 
This conclusion was strengthened by double immunostaining of kidney sections using 
anti-synaptopodin antibodies and the single chain antibody HS4E4 (Figure 7A, control). In 
glomeruli with collapsing lesions we observed expression of synaptopodin underneath a 
layer of newly formed, HS4E4 positive ECM (Figure 7B, arrow white). In lesions with more 
sclerosis there was loss of the synaptopodin expression (Figure 7C, white asterisks). 
Collageen (IV) α1
A B
Figure 5. KI-67 staining: Most proliferating cells are seen along Bowman’s capsule in segmental lesions or elswhere in the glomerulus. A 
minority of positive cells is located more centrally in the glomerulus (x375).
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Ultrastructural analysis by transmission electron microscopy showed that in hypercellular le-
sions without prominent ECM deposition podocytes appeared activated with foot process ef-
facement and microvillous transformation. In these non-sclerotic lesions we never observed 
podocyte detachment nor areas of denuded GBM. In contrast, denuded segments of Bow-
man’s capsule were frequently observed and podocytes were sometimes positioned against 
these naked segments of Bowman’s capsule (Figure 8A) or against activated appearing cells 
lining Bowman’s capsule, presumably PECs (Figure 8C). These latter cells resembled parietal 
epithelial cells as deﬁ ned by Gaﬀ ney et al [20] i.e. enlarged cells with a somewhat cubical 
appearance with round and enlarged nuclei. In most cells the cytoplasm was vacuolated and 
more appreciable than in normal PECs. Some of these cells had swollen mitochondria and 
disrupted cell membranes consistent with injury. Sometimes the number of nuclei along 
Collagen (IV) α1 Collagen (IV) α3
HS4E4Collagen (IV) α1
A B
C D
Figure 6. The ECM deposited by proliferating epithelial cells has the same staining characteristics as Bowman’s capsule: Serial 
sections were stained with collagen IV α 1 (panel A, C) and collagen IV α 3 (panel B). Collagen IV α 1 strongly stains Bowman’s capsule, the newly 
deposited matrix forming the adhesions (arrows panel A, C) and the mesangial matrix. There is weak GBM staining for Collagen IV α 1 (panel A), 
Collagen IV α 3 (panel B) stains the GBM and not Bowman’s capsule. Panel D shows positive staining of an adhesion for the single chain antibody 
HS4E4 (arrowhead). In control kidney, this antibody directed against a heparan sulphate species only stains Bowman’s capsule and not the GBM 
(A,B x450, C,D x900).
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Bowman’s capsule was increased and occasionally mitotic ﬁ gures were observed, indicating 
proliferative activity. Deposition of ECM-like material between the tuft and epithelial cells in 
Bowman’s space was sometimes observed (ﬁ gure 8B-asterisk). In lesions with more advanced 
sclerosis we did see areas of denuded GBM, indicating loss of podocytes at this stage. In 
such denuded areas we sometimes saw deposition of newly formed ECM directly on top of 
the GBM (Figure 7D-E, black asterisks). We have looked for evidence of podocyte apoptosis. 
However, we did not see apoptotic bodies in aﬀ ected glomerular segments (there was also 
no caspase-3 positivity, data not shown).
*
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Figure 7. Newly formed extracellular matrix is deposited on top of the GBM and sometimes on top of synaptopodin expressing 
podocytes: Double staining for HS4E4 (red) and synaptopodin (green) is shown for a normal glomerulus (panel A), a segmental lesion (panel 
B) and a glomerulus with advanced global sclerosis (panel C). In control glomeruli HS4E4 stains Bowman’s capsule and not the GBM. Adhesions 
stain for HS4E4 and sometimes HS4E4 positive ECM is deposited on top of synaptopodin positive podocytes (arrow panel B). In glomeruli with 
advanced sclerosis synaptopodin expression is lost (asterisk panel C). In panels D and E transmission electron micrographs show that in a segment 
with prominent sclerosis podocytes are absent and newly formed ECM (asterisk panel E) is deposited on top of the GBM (arrowhead panel E). 
Hyperplastic cells lining Bowman’s capsule cover this matrix (asterisk panel D) (A,C x300, B x700, D x1200, E x7000).
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Figure 8. Transmission electron microscopy: Panels A to C show glomerular segments with an increase of epithelial cells in Bowman’s space 
without prominent sclerosis (early lesions). Podocytes appear activated with extensive foot process eﬀ acement, microvillous transformation and 
enlarged nuclei (panel A). Locally, the parietal epithelium appeared damaged and denuded segments Bowman’s capsule were present (arrow 
panel A). Segmentally, there appeared to be an increased number of nuclei along Bowman’s capsule (panel B). We sometimes observed bridging 
epithelial cells between activated podocytes and Bowman’s capsule (panel C). The insert shows the cell contact between the podocyte and the 
bridging cell with apparent fusion of cell membranes. Amorphous extracellular matrix was sometimes present surrounding the epithelial cells 
in Bowman’s space (asterisk panel B). In lesions with more advanced sclerosis (panel D) we did see denuded GBM segments and sometimes 
remnants of podocytes (arrowhead) appeared to be present. Amorphous extracellular matrix was sometimes deposited on top of the naked GBM 
(asterisk) (A,B x7000, C,D x5000). 
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DISCUSSION
Our patient suﬀ ered from recurrent FSGS after transplantation, and the etiology of the glo-
merular lesion in this condition is considered identical with that of primary FSGS. The FSGS 
lesions in our patient were morphologically diverse, ranging from recent collapse with promi-
nent epithelial hyperplasia to advanced sclerosis. Based on the classiﬁ cation of FSGS variants 
proposed by D’Agati and co-workers [4], FSGS in our patient would have to be classiﬁ ed as 
collapsing type FSGS, although only a small proportion of glomerular segments showed pure 
collapse. Within a single glomerulus, we often observed large conﬂ uent lesions which in one 
plane of sectioning could appear hypercellular and in another plane of sectioning could ap-
pear mostly sclerotic. We therefore postulate that the diﬀ erent morphology of the lesions 
reﬂ ects diﬀ erences in the developmental stage of the FSGS lesions. In the present manuscript 
we focussed on the origin of the proliferating epithelial cells in early hypercellular lesions. 
Our study indicates that parietal epithelial cells are critically involved in the development 
of FSGS lesions in humans. We have demonstrated that the epithelial cells that for a large 
part constitute the early hypercellular lesions stained positively for PAX-2, CK8 and PAN-cad-
herin, were connected to cells lining Bowman’s capsule and did not express podocyte mark-
ers synaptopodin or VEGF. Obviously, the validity of markers to determine a cell type can be 
questioned in view of the prospect of (de-)diﬀ erentiation. For instance It has been shown that 
in developing kidney immature podocytes are PAX-2 positive, making it hardly possible to 
diﬀ erentiate between mature PECs and dediﬀ erentiated podocytes. Therefore we have used 
many other markers (CK8, PAN-cadherin, synaptopodin,VEGF) and performed double staining 
experiments (PAX-2/synaptopodin, VGEF/CK8) and results were always in perfect agreement: 
proliferating cells were positive for all PEC markers and negative for the podocyte markers. 
It is worth mentioning that a recent study showed that PAN-cadherin is not expressed on 
activated podocytes after injection of puromycin [22]. In our study CK8 proved a marker of 
activated PECs. In normal kidney PECs are negative or stained only faintly positive for CK8. In 
some of the normal appearing glomeruli in our patient there was strong CK8 staining of cells 
lining Bowman’s capsule in a segmental distribution. By serial sectioning we could show that 
in these glomeruli adhesions between the glomerular tuft and Bowman’s capsule were absent, 
thus providing a strong argument that PECs acquire the CK8 positive phenotype upon activa-
tion. Additional evidence supporting the PEC origin of the proliferating epithelial cells comes 
from the ﬁ nding that the staining characteristics of the extracellular matrix that is produced 
by these cells are identical to those of Bowman’s capsule. Finally, 3D analysis conﬁ rmed that 
all CK8 positive cells within a glomerulus are in continuity with cells lining Bowman’s capsule. 
Taken together, these data argue that proliferating epithelial cells in early FSGS lesions are 
PECs and question the contribution of the so called dediﬀ erentiated podocyte. 
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The ﬁ ndings in our patient are very similar to our previous observations in the Thy-1.1 trans-
genic mouse. In this mouse model of collapsing FSGS we observed that the proliferating 
epithelial cells strongly expressed CD10 (a speciﬁ c PEC marker in mouse). In addition we 
noted that the composition of the newly formed ECM resembled Bowman’s capsule and thus 
was produced by PECs [13]. Double staining for the podocytic transgene Thy-1.1 and the 
proliferation marker Ki-67 proved that there was no proliferation of the podocytes during the 
development of early FSGS lesions. 
How do our ﬁ ndings relate to those of other authors? The early hypercellular lesions we 
studied are classiﬁ ed by many authors as collapsing FSGS lesions although in the earliest 
description by Valeri, it was suggested that the term collapsing FSGS should be restricted to 
biopsies in which any glomerulus contained global collapse or at least 20% of the glomeruli 
showed segmental collapse [22]. Nonetheless, the histology observed in our patient is very 
similar to the glomerular proﬁ les shown in papers by Schwartz [23], Bariety [9], and Othaka 
[11;12], and were deﬁ ned as cellular or collapsing lesions. The latter authors have used im-
munostaining to identify the cell types and concluded that the proliferating epithelial cells 
were dediﬀ erentiated podocytes, since these cells showed no expression of mature podo-
cyte markers. In contrast, these cells stained for PEC markers such as PAX-2, hence the idea 
of dediﬀ erentiation. It is evident that immunostaining of unknown cells has limitations in 
judging their cellular origin, since in fact during nephrogenesis in the S-shaped body stage, 
podocytes have features comparable to mature PECs [24]. Therefore, the authors have used 
the localization of the cells to deﬁ ne their origin and since the hyperplastic epithelial cells 
covered the glomerular tuft and often lacked an apparent connection to Bowman’s capsule, 
these cells were identiﬁ ed as podocytes. However in a recent review it was clearly pointed 
out that the absence of a connection between the epithelial cells and Bowman’s capsule is 
not a very good criterion without proper three dimensional (3D) analysis [25]. 
In seminal studies of Nagata et al [26;27] and Kihara et al [28] it has already been suggested 
that PECs do contribute to the cellular lesions. These authors however proposed that PECs 
proliferate and cover the capillary tuft as a consequence of denudation of the GBM due to 
detachment and loss of podocytes. In our patient we never observed podocyte detachment 
in early lesions, nor did we note podocytes in the urinary space. Rather, we observed pro-
liferating PECs directly on top of podocytes. We can only speculate about the stimulus for 
PEC proliferation. Possibly, the interaction between activated/injured podocytes and acti-
vated/injured PECs or between activated/injured podocytes and denuded areas of Bowman’s 
capsule plays a role. 
It is important to empasize that our data do not dispute the fact that in the chain of events 
that leads to full blown FSGS lesions it is the podocyte that is initially injured, causing pro-
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teinuria. However, we do challenge the concept that ensuing epithelial cell proliferation, 
which is important for progression of the FSGS lesions, is due to proliferation of dediﬀ erenti-
ated podocytes. An exception may be HIV-induced collapsing FSGS which is characterized 
by global collapse in many glomeruli and by the absence of adhesions. It is therefore likely 
that podocyte proliferation does occur in this condition, probably related to incorporation of 
viral genome in podocytic DNA [29;30]. In some forms of FSGS there is little or no prolifera-
tion of epithelial cells and the mechanism of FSGS development may be diﬀ erent in these 
conditions. For example studies by Kriz et al have pointed to the role of podocyte loss in the 
development of FSGS in various rat models. These models are all characterized by glomerular 
hypertension and capillary ballooning and may therefore be more relevant for secondary 
FSGS than for idiopathic FSGS. Most patients with secundary FSGS have rather inactive, hypo-
cellular lesions, with lesions predominantly involving the perihilar region of the glomerulus.
CONCLUSION
Parietal epithelial cells are crucially involved in the pathogenesis of idiopathic FSGS.
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ABSTRACT
Collapsing focal segmental glomerulosclerosis (cFSGS) is characterized by hyperplasia of glo-
merular epithelial cells. In a mouse model of FSGS and in a patient with recurrent idiopathic 
FSGS we identiﬁ ed the proliferating cells as parietal epithelial cells (PECs). In the present 
study we have evaluated the origin of the proliferating cells in cFSGS associated with HIV 
and pamidronate. We performed a detailed study of glomerular lesions in biopsies of two 
patients with HIV associated cFSGS and a nephrectomy specimen of a patient with pamidro-
nate associated cFSGS. Glomeruli were studied by serial sectioning using light and electron 
microscopy and immunohistochemistry to determine the epithelial cell phenotype. We used 
synaptopodin, VEGF and CD10 as podocyte markers, CK8 and PAX2 as PEC markers and Ki-67 
as marker of cell proliferation. The newly deposited extracellular matrix was characterized 
using anti-heparan sulphate single chain antibodies.
The proliferating cells were negative for the podocyte markers, but stained positive for the 
PEC markers and the cell proliferation marker Ki-67. The proliferating PAX-2 and CK8 positive 
cells that covered the capillary tuft were always in continuity with PAX-2/CK8 positive cells 
lining Bowman’s capsule. The matrix deposited by these proliferating cells stained identically 
to Bowman’s capsule. 
Our study demonstrates that PECs proliferate in HIV and pamidronate associated cFSGS. 
Our data do not support the concept of the proliferating, dediﬀ erentiated podocyte.
Keywords: HIV, pamidronate, parietal epithelial cell, podocyte, epithelial cell proliferation, 
collapsing lesions and glomerulosclerosis.
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INTRODUCTION
Focal segmental glomerulosclerosis (FSGS) is one of the most common patterns of glomerular 
injury [1]. Recently, various morphological variants have been described and a new classiﬁ ca-
tion was proposed [2]. The traditional forms of FSGS now classiﬁ ed as perihilar and FSGS-not 
otherwise speciﬁ ed, lack epithelial cell proliferation and are characterized by mesangial scle-
rosis, obliteration of glomerular capillaries, formation of adhesions between the glomerular 
tuft and Bowman’s capsule, podocyte hypertrophy, hyalinosis and intracapillary foam cells. 
In contrast, epithelial cell proliferation is prominent in the other variants, in particular in col-
lapsing FSGS, deﬁ ned by segmental or global collapse of the glomerular tuft associated with 
epithelial cell hypertrophy and hyperplasia. 
In recent studies on the pathogenesis of FSGS a central role was assigned to the visceral 
epithelial cell, the so-called podocyte. The podocyte is considered to be a highly specialized 
and diﬀ erentiated cell, unable to replicate. Kriz and co-workers have studied the develop-
ment of FSGS in various rat models [3-5]. Based on these studies Kriz and Mundel (reviewed 
in [6]), proposed that podocyte loss (podocytopenia) was the critical starting event in FSGS. 
Neighbouring podocytes cannot compensate for this loss, resulting in denudation of the GBM 
and formation of an adhesion between the capillary tuft and the parietal epithelial cells. 
The concept of the terminally diﬀ erentiated, not-replicating podocyte seemed incompat-
ible with the development of the proliferative lesions observed in collapsing FSGS. Since the 
proliferating cells cover the glomerular tuft they are considered by several investigators to 
be of podocytic origin [7;8], although they do not express podocyte markers such as syn-
aptopodin, VEGF and WT1. These and similar observations have fostered the concept that 
proliferating, dediﬀ erentiated podocytes are the main cell type involved in the formation of 
cellular lesions in collapsing FSGS [9-11]. Few studies have questioned this concept, appar-
ently because of the localisation of the cells, despite the observation that the proliferating 
cells express cytokeratins, a marker expressed by parietal epithelial cells and not by podo-
cytes [12-14].
We previously studied the origin of the proliferating epithelial cells in FSGS in more detail 
in the Thy-1.1 transgenic mouse (a model of collapsing FSGS), providing evidence that in this 
model the proliferating epithelial cells are of PEC origin [15]. Recently our conclusions were 
conﬁ rmed and strengthened by Asano et al, who found PEC proliferation in their transgenic 
mouse with LacZ expressing podocytes [16]. Subsequently, we performed detailed studies of 
glomerular lesions in a patient with recurrent idiopathic FSGS [17]. Using 3D analysis we were 
able to ﬁ rmly establish that the proliferating cells were of PEC origin. 
Thus our previous studies questioned a major contribution of proliferating podocytes to 
the formation of cellular lesions in FSGS in general and we discussed the possibility that in 
this respect HIV associated cFSGS may be an exception [17]. In the present study we have 
investigated the characteristics of the proliferating epithelial cells in glomerular lesions of 
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patients with HIV and pamidronate associated cFSGS. Our study indicates that also in these 
conditions, most proliferating cells are PECs.
MATERIALS AND METHODS
Patients
We studied biopsies from 2 HIV patients with collapsing FSGS and a nephrectomy specimen 
from a patient with pamidronate associated collapsing FSGS. The latter patient was treated 
with aminohydroxypropylidene bisphosphonate (APD: ’pamidronate’) because of persistent 
hypercalcaemia after renal transplantation, she received oral APD in dayly dosage of 300 mg 
for 20 months, 450 mg for 6 months and 600 mg for 2 months. Subsequently I.V. APD was 
administered in a dose of 60 mg at two-weekly intervals. Severe proteinuria was noted after 
the third infusion. The HIV biopsies contained 11 and 17 diﬀ erent glomeruli respectively, and 
the paraﬃ  n block from the nephrectomy specimen contained over 77 glomeruli. The material 
was serially sectioned and from each specimen more than 100 sections were examined. One 
of every 5 sections was PAS stained for LM evaluation and intervening sections were retained 
for immunostainings.
Light microscopy
For light microscopy, kidney fragments were ﬁ xed in formaldehyde, dehydrated, and embed-
ded in paraplast (Amstelstad, Amsterdam The Netherlands). 2 µm sections were stained with 
periodic acid Schiﬀ , and with silver methenamine [18].
Immunohistochemistry
Immunohistochemical staining was performed on kidney sections ﬁ xed in 4% buﬀ ered form-
aldehyde for 24 hr and embedded in paraﬃ  n. 4 µm sections were incubated with monoclonal 
antibodies (mAb) and polyclonal antibodies (pAb) directed at various markers for podocytes, 
PECs, as detailed in table 1. As secondary antibody we used power vision Poly-HRP –anti 
mouse/rabbit/rat IgG (Immunologic, Klinipath, Duiven, The Netherlands). Detection was car-
ried out with the use of peroxidase as label and diaminobenzidine as substrate. 
For the doublestaining CD10/CK8, ﬁ rst the polyclonal antibody (pAb) CD10 was detected 
and completed. As detecting antibody we used Envision AF-anti Rabbit IgG (Immunologic, 
Klinipath, Duiven, The Netherlands), detection was carried out with the use of alkaline phos-
phatase as label and FastBlue as substrate. Thereafter samples were incubated with the 
monoclonal antibody (mAb) CK8, as detecting antibody we used powervision Poly-HRP-anti 
Mouse/Rabbit/Rat IgG (Immunologic, Klinipath, Duiven, The Netherlands). Detection was 
carried out with the use of peroxidase as label and AEC/red as substrate.
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For the doublestaining synaptopodin/CK8, ﬁ rst the monoclonal antibody (mAb) synapto-
podin was incubated and as detecting antibody we used powervision Poly-HRP-anti Mouse/
Rabbit/Rat IgG (Immunologic, Klinipath, Duiven, The Netherlands). Detection was carried out 
with the use of peroxidase as label and DAB as substrate. Thereafter samples were incubated 
with the monoclonal antibody (mAb) CK8, as detecting antibody we used powervision Poly-
AP-anti-Mouse IgG (Immunologic, Klinipath, Duiven, The Netherlands). Detection was carried 
out with the use of alkaline phosphatase as label and AEC/red as substrate.
Immunoﬂ uorescence microscopy
Kidney fragments were snap-frozen in liquid nitrogen, and 2 µm acetone ﬁ xed cryostat sec-
tions were used. Kidney sections were incubated with antibodies directed against heparan 
sulfate species (Table 1). The single chain antibodies used for staining of heparan sulfate spe-
cies [19;20] were detected via a rabbit antibody directed against the VSV-g epitope tag (ICL, 
Oregon, USA) and ﬁ nally detected with a goat anti-rabbit AlexaTM 488 antibody (Molecular 
probes Inc, Leiden, The Netherlands). The sections were examined with a ﬂ uorescence micro-
scope (Leica microsystems GmbH, Heidelberg, Germany).
Table 1: Antibodies used for the detection of glomerular antigens
Antigen Primary antibody Dil. Supplier / Reference
Podocyte components
Synaptopodin 
CD 10
VEGF
PEC components
PAX-2
Cytokeratin 8
Proliferation
KI 67
Bouwman’s capsule
Heparan sulfate single chain
GBM
Heparan sulfate single chain
Mouse anti-synaptopodin
Rabbit anti-human CD10 
ISH m-RNA Probe (*ng/ml)
Rabbit anti-human PAX-2 
Mouse anti-human CAM 5.2 (CK8)
Mouse anti-human MIB-1
Single chain antibody HS4E4
Single chain antibody HS4C3
1
50
100*
50
50
200
1
1
Progen, Heidelberg, Germany
Monosan, Caltag lab.,Burlinggame
 [21]
Zymed laboratories Inc. San Francisco, USA
BD Biosciences, San Diego, CA
Dako, Glostrup, Denmark
 [20]
 [19]
In situ hybridization
Kidney sections were ﬁ xed in 4% buﬀ ered formaldehyde for 24 hr and embedded in paraf-
ﬁ n. 4 µm sections were incubated and subjected to VEGF in situ hybridization (ISH) using a 
digoxigenin-labeled VEGF-A antisense RNA probe [21], as secondary antibody we used sheep 
anti-digoxigenin alkaline phosphatase. Detection was carried out with NBT/BCIP, the corre-
sponding sense probe was used as a control. This ISH was followed by immunohistochemical 
staining with the monoclonal antibody (mAb) CK8. As secondary antibody we used biotin-
labeled rabbit anti-mouse (Immunologic, Klinipath, Duiven, The Netherlands). Detection was 
carried out with the use of ABC Vectastain, peroxidase as label and AEC/red as substrate. 
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Transmission Electron Microscopy
For electron microscopy, we used immersion ﬁ xation, small fragments of cortex were ﬁ xed 
in 2.5% glutaraldehyde dissolved in 0.1 M sodium cacodylate buﬀ er, pH 7.4, overnight at 4°C 
and washed in the same buﬀ er. The tissue fragments were postﬁ xed in palade-buﬀ ered 2% 
OsO4 for 1 hr, dehydrated, and embedded in Epon 812, Luft’s procedure (Merck, Darmstadt, 
Germany). Ultrathin sections were contrasted with 4% uranyl acetate for 45 min and subse-
quently with lead citrate for 5 min at room temperature. Sections were examined in a Jeol 
1200 EX2 electron microscope (JEOL, Tokyo, Japan). 
RESULTS
We studied biopsies from 2 HIV patients with collapsing FSGS and a nephrectomy specimen 
from a patient with pamidronate associated collapsing FSGS. The latter patient was treated 
with aminohydroxypropylidene bisphosphonate (APD:’pamidronate’) because of persistent 
hypercalcaemia after renal transplantation; she received oral APD in dayly dosage of 300 mg 
for 20 months, 450 mg for 6 months and 600 mg for 2 months. Subsequently I.V. APD was 
administered in a dose of 60 mg at two-weekly intervals. Severe proteinuria was noted after 
the third infusion.
The HIV biopsies contained 11 and 17 diﬀ erent glomeruli respectively, and the paraﬃ  n 
block from the nephrectomy specimen contained over 77 glomeruli. The material was serially 
sectioned and from each specimen more than 100 sections were examined. One of every 5 
sections was PAS stained for LM evaluation and intervening sections were retained for im-
munostainings.
 
In the biopsies with HIV associated nephropathy (HIVAN) we observed a wide spectrum of 
glomerular lesions by light microscopy. At the one end of the spectrum there were normal 
appearing glomeruli and at the other end glomeruli with advanced sclerosis. For our analy-
ses we focussed on glomeruli with ‘early’ collapsing lesions, as deﬁ ned by collapse of the 
glomerular tuft without, or with only minimal, sclerosis (deposition of new matrix). In these 
glomeruli the collapsed tuft was either still covered with a single layer of epithelial cells 
with only limited segmental proliferation (2 out of 28) or collapse was accompanied by a 
prominent increase of epithelial cells, ﬁ lling Bowman’s space (18 out of 28). These epithelial 
cells appeared activated, with enlarged nuclei with prominent nucleoli and vacuolation of the 
cytoplasm with the presence of reabsorption droplets (Figure 1A). Some glomeruli showed 
advanced sclerosis (7 out of 28) and one glomerulus appeared normal. True adhesions of the 
tuft to Bowman’s capsule were not found when analysing serial sections. Ultrastructural anal-
ysis by transmission electron microscopy showed the presence of tubuloreticular inclusions 
(TRIs) in the glomerular endothelial cells of both HIV biopsies. Podocytes appeared activated 
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and showed foot process eﬀ acement and microvillous transformation. The podocytes in 
pamidronate nephropathy were enlarged and highly vacuolated. The morpholocial appear-
ance of collapsing lesions in pamidronate associated cFSGS diﬀ ered from those in HIVAN, as 
in this condition we usually observed only a single layer of epithelial cells in Bowman’s space, 
covering the glomerular tuft (34 out of 77). In 5 of 77 glomeruli we observed segmental mul-
tilayering of epithelial cells in Bowman’s space. It was noted that these cells on top of the tuft 
appeared severely injured with extreme vacuolation and ballooning, more so than in HIVAN 
(Figure 1B). Also in pamidronate associated cFSGS adhesions were not found. 
For phenotypic analysis of the epithelial cells in Bowman’s space serial sections were stained 
with podocyte markers (synaptopodin, CD10, and VEGF), PEC markers (CK8 and PAX-2) and 
proliferation marker Ki-67. To characterise the ECM we stained with an anti-HS single chain 
antibody that in normal glomeruli predominantly stains Bowman’s capsule and not the GBM 
(HS4E4) and one that stains only the GBM and the mesangial matrix (HS4C3) (markers are 
described in Table 1). To strengthen our ﬁ ndings, we additionally performed VEGF/CK8, syn-
aptopodin/CK8 and CD10/CK8 double stainings.
In normal control kidney tissue the cells lining Bowman’s capsule (PECs) uniformly stained 
for PAX-2 and were negative (occasional weak positivity was observed) for CK8 (not shown). 
Podocytes uniformly stain for synaptopodin and CD10. CD10/CALLA is not a podocyte spe-
ciﬁ c marker but in humans strongly stains podocytes in addition to brush border and vascu-
lar smooth muscle cells [22]. In HIVAN normal looking glomeruli also demonstrated uniform 
A B
Figure 1. Glomerular histology (PAS staining) in HIV associated cFSGS (panel A) and pamidronate associated cFSGS (panel B): Panel 
A HIV associated cFSGS (HIVAN) shows a glomerulus with collapse of the capillary tuft and prominent epithelial cell proliferation in Bowman’s 
space. Most of the glomeruli in our HIV biopsies had this appearance (18 out of 28). The epithelial cells appeared activated, with enlarged nuclei 
with prominent nucleoli and vacuolation of the cytoplasm with the presence of reabsorption droplets. Podocyte injury with enlargement, 
vacuolation and ballooning was more evident in pamidronate associated cFSGS (panel B) and multilayering of epithelial cells in Bowman’s space 
was only sporadically and segmentally observed (A, B x450).
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PAX-2 staining and additionally showed strong CK8 staining in a segmental pattern, compat-
ible with activation of PECs (Figure 2A). In glomeruli with collapse and limited cell prolifera-
tion, CK8 positive cells segmentally covered the capillary tuft (Figure 2C,D). These cells were 
always in contact with CK8 positive cells lining Bowman’s capsule. The remainder of the tuft 
was covered with a single layer of cells that were negative for all PEC and podocyte markers 
except for CD10, which was strongly and uniformly positive. In glomeruli with prominent 
hypercellularity epithelial proliferation was conﬁ med by positive staining for Ki-67 (Figure 
3B). Most cells in Bowman’s space were CK8 and PAX 2 positive (Figure 3A). In these glomeruli 
there was often no or only faint expression of synaptopodin (Figure 3C). Notably, most cells 
in the periphery of the glomerular tuft were positive for CD10 (Figure 3D), thus conﬁ rming 
that podocytes were still present. To strengthen these ﬁ ndings, we additionally performed 
CK 8
CK 8 HS4E4A
C D
B
PAS
Figure 2. Phenotype of proliferating epithelial cells in HIV associated nephropathy in segmental lesions: Panel A shows a section 
of a normal looking glomerulus (no lesions) with segmental CK8 positive cells lining Bowman’s capsule. The anti HS single chain antibody HS4E4 
showed that newly deposited matrix in areas of epithelial proliferation stained as Bowman’s capsule, shown for a glomerulus with more advanced 
sclerosis (Figure 2B). In glomeruli with collapse, podocyte hypertrophy and limited cell proliferation, CK8 positive cells segmentally covered the 
capillary tuft. These cells were always in contact with CK8 positive cells lining Bowman’s capsule, as demonstrated in serial sections (Figure 2C,D) 
(A-D x450).
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Figure 3. Phenotype of proliferating epithelial cells in HIV associated nephropathy in glomeruli with extensive proliferation: 
In A-D serial sections are shown. The proliferating cells were mostly CK8 positive (E, F-red staining) and almost all were PAX 2 positive (panel 
A). Proliferation was conﬁ med by Ki-67 (panel B). Dediﬀ erentiated podocytes lost expression of synaptopodin (panel C), but were still positive 
for CD10 (panel D). Doublestainings synaptopodin/CK8 (panel E) and CD10/CK8 (panel F) conﬁ rmed that the proliferating cells (asterisk) were 
positive for CK8 and are found adjacent / on top of synaptopodin or CD 10 positive residual podocytes. No cells were found doubly positive 
for synaptopodin/CD10 and CK8. In more advanced lesions podocytes lost all there markers. In panel F (arrow) a single podocyte has kept its 
expression for CD10 (A-D x450, E,F x700).
96
C
ha
p
te
r 6
CK 8CD 10
B C
A BVEGF/CK8
D Syn/CK8Ki-67 E
*
Figure 4. Phenotype of epithelial cells in pamidronate nephropathy: We observed a focal and segmental CK8 expression by PECs lining 
Bowman’s capsule, in normal appearing glomeruli (Figure 4A-left, red staining). In more advanced glomerular lesions CK8 positive cells were also 
found overlying the capillary tuft (panel A-right). VEGF expression is present in podocytes of a normal appearing glomerulus (panel A-left, blue 
staining) and is absent in an aﬀ ected glomerulus (panel A-right). In serial sections segmental CD10 positivity was observed (panel B, arrow), 
underneath CK8 positive cells (panel D, arrowhead), indicating the presence of some residual podocytes. Sometimes CK8 positive cells covering 
the tuft were interspersed with CK8 negative but CD10 positive cells. These CD10 positive cells showed already vacuolisation and ballooning (panel 
B, C, asterisk). This latter ﬁ nding was also conﬁ rmed by a synaptopodin/CK8 double staining (panel E). We never observed VEGF/CK8 co-expression 
or synaptopodin/CK8 co-expression. Epithelial cells lining Bowman’s capsule and the glomerular tuft were mitotically active (panel D) althought 
proliferation in HIVAN was more extensive (A,D x450, B,C,E x900).
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synaptopodin/CK8 (Figure 3E) and CD10/CK8 (Figure 3F) double stainings. No cells were 
found doubly positive for synaptopodin/CD10 or CK8. In more advanced lesions eventually 
the podocytes lost all there markers.
Also in pamidronate nephropathy we observed focal and segmental CK8 expression in nor-
mal appearing glomeruli (Figure 4A-left). In glomeruli with collapse CK8 positive cells were 
found overlying the capillary tuft (Figure 4A-right) and occasionally continuity of CK8 posi-
tive cells covering the tuft and CK8 positive cells covering Bowman’s capsule was seen away 
from the vascular pole. VEGF expression is present in a normal appearing glomerulus (Figure 
4A-left) and is absent in an aﬀ ected glomerulus (Figure 4A-right). The expression pattern 
observed in the normal appearing glomerulus is identical to the expression observed in nor-
mal glomeruli in humans or mice (see Figure S1, as supplemental material). Ki-67 positivity 
was noted in PEC’s covering Bowman’s capsule (Figure 4D). Segmentally CD10 positivity was 
observed underneath CK8 positive cells (Figure 4B,C). Of note, CK8 positive cells covering 
the tuft were interspersed with CK8 negative CD10 positive cells, indicating the presence of 
residual podocytes (Figure 4C, asterisk). This latter ﬁ nding was also conﬁ rmed by a synapto-
podin/CK8 (Figure 4E) double staining. We never observed co-expression of CK8/PAX2 with 
podocytemarkers! 
In both HIV and Pamidronate associated cFSGS staining with the anti HS single chain 
antibody HS4E4 showed that new matrix that stained as Bowman’s capsule was sometimes 
deposited in areas of epithelial proliferation. More extensive deposition of HS4E4 positive 
ECM was seen in glomeruli with more advanced sclerosis (Figure 2B).
DISCUSSION
Our study demonstrates that most of the proliferating cells in HIV and pamidronate associ-
ated collapsing FSGS are parietal epithelial cells. This conclusion is based on the ﬁ nding that 
the proliferating cells are often positive for CK8, always positive for the PEC marker PAX2 and 
negative for the podocyte markers synaptopodin, CD10 and VEGF. In addition, the staining 
characteristics of the extracellular matrix that is produced by the proliferating cells are identi-
cal to those of Bowman’s capsule. Admittedly, the use of cellular markers to deﬁ ne the origin 
of proliferating cells can be questioned, since it can be argued that cellular activation may 
induce phenotypic changes and could cause a switch from an activated podocyte pheno-
type to a parietal cell phenotype. However, the CK8 and PAX-2 positivity strongly supports 
the PEC origin of these cells as shown in our previous study [17]. In normal kidney PECs are 
negative or stain only faintly positive for CK8. In some of the normal appearing glomeruli in 
our patients there was strong CK8 staining of cells lining Bowman’s capsule in a segmental 
distribution. By serial sectioning we could show that in these glomeruli adhesions between 
98
C
ha
p
te
r 6
the glomerular tuft and Bowman’s capsule were absent, thus providing a strong argument 
that these PECs acquire the CK8 positive phenotype upon activation, prior to proliferation. 
Perhaps the most striking argument for our conclusion is the demonstration of CK8 positive 
cells on top of residual CD10 and even synaptopodin positive podocytes by double staining. 
Our present ﬁ ndings in HIV and pamidronate associated cFSGS conﬁ rm and extend the con-
clusions of our previous studies. In the Thy-1.1 transgenic mouse, a model of collapsing FSGS, 
we observed that the proliferating epithelial cells strongly express PEC markers. In addition 
we noted that the staining characteristics of the newly formed ECM are identical to Bowman’s 
capsule arguing that this matrix is produced by PECs [15]. Double staining for the podocytic 
transgene Thy-1.1 and the proliferation marker Ki-67 proved that there is no proliferation of 
podocytes during the development of FSGS lesions. Asano et al conﬁ rmed these ﬁ ndings 
in a recent study [16]. These authors have generated a transgenic mouse with podocytes 
that express LacZ. Injection of LMB2, an immunotoxin against the podocytic CD25 antigen, 
into these Nphs1-Cre/ ROSA26-loxP/NEP25 mice, causes podocyte injury characterized by 
vacuolar degeneration eventually leading to glomerular sclerosis. In this model proliferat-
ing epithelial cells accumulated in Bowman’s space, as seen in cFSGS. These authors found 
no evidence for proliferation or transdiﬀ erentiation of podocyte-derived cells but did ﬁ nd 
proliferating PECs migrating onto the visceral site. 
A detailed study of FSGS lesions in the kidney of a patient with recurrent idiopathic FSGS 
[17] revealed that also in humans the proliferating cells in collapsing lesions are parietal epi-
thelial cells (PECs). 
Although these studies ﬁ rmly established a role for PECs in the cellular lesion of cFSGS in 
mice as well as in a patient with idiopathic FSGS, we questioned if similar events would occur 
in HIV associated cFSGS. HIV associated cFSGS is the prototypical example of cFSGS, charac-
terized by a very high proliferation rate. Proliferating cells are by some authors considered 
to be dysregulated podocytes, but data from the literature are conﬂ icting. Evidence from in 
vitro studies showed that incorporation of HIV–1 Nef induces proliferation of podocytes [23]. 
However, in mice podocyte speciﬁ c expression of HIV-1 Nef does cause podocytes to enter 
the cell cycle, but does not lead to completion of mitosis [24]. A recent study in a mouse 
model of HIV-nephropathy (the HIV13FBV mouse) has provided additional support for our 
conclusions [25]. These mice express HIV-1 genes in podocytes and avid cell proliferation is 
observed within Bowman’s space. The extracapillary proliferating cells adjacent to the pari-
etal epithelial cells lining Bowman’s capsule were often positive for Ki-67 and cytokeratin, 
whereas the cells adjacent to the GBM were rarely positive for Ki-67. No cells were found 
doubly positive for synaptopodin and Ki-67. From their observations the authors conclude 
that most proliferating cells in Bowman’s space are derived from parietal epithelial cells [25].
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Barisoni and Bariety et al proposed that the loss of speciﬁ c podocyte markers deﬁ nes a novel 
dysregulated and proliferating podocyte phenotype and suggests a common pathogenetic 
mechanism in collapsing FSGS [7;9]. In our studies we found that in collapsing idiopathic FSGS 
and HIV-associated nephropathy, there was disappearance of podocyte markers, consistent 
with dediﬀ erentiation. Synaptopodin disappeared very early but remarkably CD10/CALLA 
[26] remained positive longer, to disappear in advanced lesions. Other investigators also ob-
served a variable degree of expression reduction for diﬀ erent podocyte markers, especially in 
unaﬀ ected portions of the tuft in segmentally injured glomeruli, or in glomeruli without any 
visible collapse or other histologic abnormalities [7]. Our ﬁ ndings are therefore consistent 
with dysregulation of podocytes but do not support proliferation of podocytes. 
To summarize our date, in HIV and pamidronate associated cFSGS we do ﬁ nd dediﬀ erentia-
tion of podocytes but most of the epithelial cells in Bowman ‘s space are derived from the 
parietal epithelium. These ﬁ ndings are similar to what we previously observed in a patient 
with recurrent idiopathic FSGS in both the segmental collapsing lesions and non-collaps-
ing FSGS lesions with prominent epithelial hyperplasia. Therefore, it can be argued that in 
all forms of FSGS with prominent epithelial hyperplasia there is proliferation of PECs and 
that in this respect collapsing FSGS can be included in the spectrum of FSGS and need not 
be regarded as a distinct entity caused by a dysregulated podocyte phenotype. It can be 
hypothesized that a common pathogenetic mechanism applies to all variants of FSGS and 
that the type of lesion that is seen depends on the extent of podocyte activation. In FSGS 
secondary to hyperﬁ ltration (often peri-hilar variant), podocyte activation may be focal and 
mere loss of podocytes with subsequent adherence of PECs to the glomerular tuft results in 
sclerosis [5]. If podocyte activation is more widespread and acute, as we belief is the case in 
primary (idiopathic) FSGS, PEC proliferation is more prominent. Presumably, PEC proliferation 
is the direct result of interactions between activated podocytes and PECs and growth fac-
tors produced by podocytes may play an important role. In HIV associated collapsing FSGS 
prominent epithelial proliferation follows massive podocyte activation upon integration of 
the viral genome. In pamidronate collapsing FSGS rapid widespread toxic loss of podocytes 
may lead to the collapsing phenotype with less PEC proliferation as compared to HIV associ-
ated collapsing FSGS.
CONCLUSION
Most of the proliferating cells in collapsing glomerulopathy are derived from the parietal 
epithelium. This conclusion holds for all forms of cFSGS i.e. idiopathic, Pamidronate and HIV 
associated FSGS. 
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SUPPLEMENTARY MATERIAL
Figure S1. In situ hybridisation of mRNA VEGF in (A,B) normal human and (C) mice glomeruli.
A
B
C
VEGF; Normal human kidney
Detail (arrow) VEGF
VEGF; Normal mouse kidney Figure S1. In situ hybridisation of mRNA VEGF in 
(A,B) normal human and (C) mice glomeruli.
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ABSTRACT
Global glomerulosclerosis can be divided in the vascular (obsolescent) type and the glo-
merulopathic (solidiﬁ ed) type. In biopsies from children with recurrent nephrotic syndrome 
we noticed small, globally sclerosed glomeruli that appeared to be distinct from global glo-
merulosclerosis. These small sclerosed glomeruli, best described as involuted glomeruli, are 
characterised by a marked reduction in size and a lack of accompanying tubular atrophy and 
interstitial ﬁ brosis.
We have characterised these involuted glomeruli in detail by light microscopy and electron 
microscopy. Via immunostainings we have studied the expression of markers for podocytes 
(synaptopodin, CD10), parietal epithelial cells (PAX-2), miscellaneous matrix components (Col 
I, III & IV), endothelium (CD 34), myoﬁ broblasts (SMA) and made a comparison with the clas-
sical vascular type and glomerulopathic type.
The involuted glomeruli contain discontinuous matrix components which form an inter-
connecting network with matrix continuity (adhesions) between the glomerular tuft and 
Bowman’s capsule. They can be diﬀ erentiated from the other types of global glomeruloscle-
rosis. Most notable is the presence of vital podocytes and parietal epithelial cells, which have 
retained their staining characteristics, in between the matrix, and the absence of periglo-
merular and peritubular inﬂ ammation.
Our study demonstrates that glomerular involution is a special form of global glomerulo-
sclerosis. The absence of periglomerular and tubulo-interstitial ﬁ brosis suggests a diﬀ erent 
pathogenesis.
Keywords: global glomerulosclerosis, parietal epithelial cell, podocyte, periglomerular ﬁ bro-
sis, glomerulopathic glomerulosclerosis, vascular glomerulosclerosis, involution.
Involution of glomeruli in children 105
INTRODUCTION
With advancing age the number of globally sclerosed glomeruli in the human kidney in-
creases. This is a more or less physiological phenomenon that is related to arteriosclerosis. 
More than 10% globally sclerosed glomeruli is considered as pathological for persons over 
the age of 40 years [1;2]. Two types of global glomerulosclerosis can be distinguished: the 
vascular type (also refererred to as obsolescent type) and the glomerulopathic type (also 
refererred to as solidiﬁ ed type) [3]. Vascular glomerulosclerosis is characterised by a retracted 
glomerular tuft without tuft adhesions, surrounded by a hypocellular homogeneous col-
lagenous matrix in the former Bowman’s space (only recognizable in a silver or PAS stain). 
Glomerulopathic sclerosis is characterized by a solidiﬁ ed non-retracted glomerular tuft with 
often recognizable tuft adhesions and without the homogeneous collagenous matrix in 
Bowman’s space. The former is mostly associated with decreased perfusion resulting from 
arterial intimal ﬁ brosis in aging or hypertension, whereas the latter form is the result of on-
going damage in glomerular diseases. It has been suggested that global sclerosis may also 
occur without renal disease as part of a normal damage and repair process. In fact, globally 
sclerosed glomeruli have been found in children below the age of 2 years [4]. Notably, global 
glomerulosclerosis is always accompanied by tubulo-interstitial ﬁ brosis. In recent years Kriz 
and co-workers have proposed the concept of misdirected ﬁ ltration as a mechanism by which 
glomerulosclerosis leads to periglomerular and tubulointerstitial ﬁ brosis [5].
We recently noticed globally sclerosed glomeruli that appeared to be distinct from either 
vascular or glomerulopathic glomerulosclerosis in biopsies from children with recurrent ne-
phrotic syndrome. These sclerosed glomeruli are characterised by a marked reduction in size 
and apparent lack of accompanying tubular atrophy and interstitial ﬁ brosis. Small globally 
sclerosed glomeruli in the setting of congenital or childhood nephrotic syndrome in children 
< 1 year have been previously noticed by others and were referred to as ‘microglomeruli’ in 
the old literature [6]. However, it has not been investigated whether these glomeruli truly 
represent a distinct type of sclerosis. It was reported that their presence does not predict 
prognosis in the setting of congenital nephrotic syndrome, but other than that their poten-
tial meaning has not been addressed. In the present study we have characterised these glom-
eruli in detail by light microscopy, immunostainings and electron microscopy, and made a 
comparison with the classical vascular type of glomerulosclerosis and the glomerulopathic 
type of glomerulosclerosis in the setting of focal and segmental glomerulosclerosis. Our ﬁ nd-
ings indicate that the small globally sclerosed glomeruli in the setting of childhood nephrotic 
syndrome represent a unique type of glomerular injury, best described by the term glomeru-
lar involution. We hypothesize that this is a special form of glomerulosclerosis with a diﬀ erent 
pathogenesis.
106
C
ha
p
te
r 7
METHODS
Patients
Small glomeruli are often recognized in renal biopsies of children with minimal change 
disease. We have counted the number of small globally sclerosed glomeruli in the biopsies 
of 8 children (age 3-9 years) with minimal change nephropathy. All patients had presented 
with a nephrotic syndrome and were biopsied because of a frequent relapsing or steroid 
dependent course. For comparison we studied 5 biopsies from children without proteinuria. 
Their primary diagnosis was hyperoxaluria and thin basement membrane nephropathy. To 
investigate the involuted glomeruli in more detail we used biopsies of three patients with 
minimal change disease. For comparison we used nephrectomy specimens with evidence 
of the other types of global glomerulosclerosis. Vascular sclerosis was investigated in the 
normal cortex of a male, 74 years old patient, nephrectomized because of a renal clear cell 
carcinoma. We studied the solidiﬁ ed type of global sclerosis in a nephrectomized kidney from 
a patient with end stage FSGS.
Light microscopy, Immunohistochemistry and Electron Microscopy 
Light microscopy
For light microscopy, kidney fragments were ﬁ xed in Bouin’s solution or formaldehyde, dehy-
drated, and embedded in paraplast (Amstelstad, Amsterdam The Netherlands). 2 µm sections 
were stained with periodic acid-Schiﬀ , and with silver methenamine.
Immunohistochemistry
Immunohistochemical staining was performed on kidney sections ﬁ xed in 4% buﬀ ered form-
aldehyde for 24 hr ﬁ xation and embedded in paraﬃ  n. 4 µm sections were incubated with 
monoclonal antibodies (mAb) and polyclonal antibodies (pAb) directed at various markers 
for podocytes, parietal epithelial cells (PECs), macrophages, endothelium, myoﬁ broblasts 
and matrix components such as collagen as detailed in table 1. As secondary antibody we 
used powervision Poly-HRP-anti Mouse/Rabbit/Rat IgG (Immunologic, Klinipath, Duiven, The 
Netherlands). Detection was carried out with the use of peroxidase as label and diaminoben-
zidine as substrate. 
Transmission Electron Microscopy
For electron microscopy, we used immersion ﬁ xation. Small fragments of cortex were ﬁ xed 
in 2.5% glutaraldehyde dissolved in 0.1 M sodium cacodylate buﬀ er, pH 7.4, overnight at 4°C 
and washed in the same buﬀ er. The tissue fragments were postﬁ xed in palade-buﬀ ered 2% 
OsO4 for 1 hr, dehydrated, and embedded in Epon 812, Luft’s procedure (Merck, Darmstadt, 
Germany). Ultrathin sections were contrasted with 4% uranyl acetate for 45 min and subse-
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quently with lead citrate for 5 min at room temperature. Sections were examined in a Jeol 
1200 EX2 electron microscope (JEOL, Tokyo, Japan).
Table 1: Antibodies used for the detection of glomerular antigens
Antigen Primary antibody Dil. Supplier / Reference
Podocyte components
Synaptopodin 
CD 10
PEC components
PAX-2
Cytokeratin
Miscellaneous
α smooth muscle actin
Endothelium
Vimentin
Collagen IV
Collagen IV α 1
Collagen IV α 5
Collagen I 
Collagen III
Macrophage
Mouse anti-synaptopodin
Mouse anti human CD10 
Rabbit anti human PAX-2 
Mouse anti human CAM 5.2 (CK8)
Mouse anti human SMA
Mouse anti human CD34
Mouse anti human Vimentin
Mouse anti human Collagen IV
Mouse anti-α 1 collagen
Mouse anti-α 5 collagen
Rabbit anti human Collagen I
Mouse anti human Collagen III
Mouse anti human CD68
1
50
50
50
15000
40
800
1250
40
10
40
10
2000
Progen, Heidelberg, Germany
Monosan, Caltag lab.,Burlinggame
Zymed laboratories Inc. San Francisco, USA
BD Biosciences, San Diego, CA
Sigma, St. Louis, USA
Monosan, Caltag lab.,Burlinggame
Biogenex, Ramon, CA
Sigma, St. Louis, USA
Wieslab, Lund, Sweden
Wieslab, Lund, Sweden
Monosan, Caltag lab.,Burlinggame
Monosan, Caltag lab.,Burlinggame
Dako, Glostrup, Denmark
RESULTS
We noticed the presence of small globally sclerosed glomeruli without accompanying inter-
stitial changes in children with recurrent nephrotic syndrome. An initial survey of 8 biopsies 
from children (age 3-9 years) with recurrent nephrotic syndrome and diagnosed as having 
minimal change nephropathy, showed that this type of sclerosed glomeruli was present in 21 
out of 177 glomeruli (12%). In comparison, these small sclerosed glomeruli were never seen 
(0 out of 70 glomeruli) in 5 biopsies from children (age 2-10 years) with non nephrotic kidney 
disease. We have characterized these small sclerosed glomeruli, which will be referred to as 
glomerular involution, in detail and made comparison with globally sclerosed glomeruli of 
the glomerulopathic type and vascular type.
Morphology
As compared to the classical forms of global sclerosis, in involution there is a marked re-
duction in diameter (approximately a quarter of the diameter of an open glomerulus). In 
the silverstainings with low power magniﬁ cation involuted glomeruli appear as small black 
nodules without apparent accompanying interstitial changes (Figure 1A). For comparison see 
Figure 2A and 2B for globally sclerosed glomeruli of the glomerulopathic and vascular type 
respectively. In fact, if present in low numbers involuted glomeruli can easily be overlooked. 
They are mostly evenly distributed throughout the cortex, althought sometimes there is a 
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predominant subcapsular localisation. On closer examination involuted glomeruli are made 
up of strong staining (non hyalinized) extracellular matrix, comparable to the matrix ob-
served in glomerulopathic sclerosis. This matrix, likely composed of remnants of the GBM 
and Bowman’s capsule, has the appearance of an interconnecting network in continuity (ad-
hesions) with the former glomerular tuft and Bowman’s capsule (Figure 1B,C). In addition, a 
small number of vital appearing cells are usually seen unlike in vascular sclerosis, where the 
contracted tuft does usually not contain any cells (see below). Remarkably, there is no split-
ting or duplication of Bowman’s capsule, as is usually observed in glomerulopathic sclerosis. 
A
CB
Figure 1. Histology, silver methenamine staining: With low magniﬁ cation involuted glomeruli appear as small black nodules (panel A). 
They are distributed throughout the cortex, without the presence of accompanying interstitial changes. In detail; the extracellular matrix strongly 
staines a network composed of remnants of the GBM and Bowman’s capsule (panel B,C). Embedded in the matrix there is a certain number of vital 
appearing cells. Sporadically atrophic tubules can be seen close to involuted glomeruli (panel B, arrow) (A x150, B,C x750).
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Also, there is no stromal reaction or hypercellularity of the surrounding interstitium, which is 
usually markedly present in glomerulopathic sclerosis and to a lesser extent also in vascular 
sclerosis. A few atrophic tubular structures, probably remnants of the tubular apparatus, can 
often be identiﬁ ed in proximity of involuted glomeruli (Figure 1B, arrow). Electron micros-
copy conﬁ rmed the presence of vital appearing cells that cover either the GBM or Bowman’s 
capsule in the involuted glomeruli, whereas these are absent in the other types of global 
glomerulosclerosis (data not shown). Identiﬁ able interrupted stretches of glomerular base-
ment membrane are seen and both the GBM and Bowman’s capsule are in part thickened 
(Figure 3, arrows). 
Immunohistochemistry
We characterized the three types of global glomerulosclerosis, glomerular involution (Figure 
4-6, A-D), glomerulopathic glomerulosclerosis (Figure 4-6, E-H), and vascular glomeruloscle-
rosis (Figure 4-6, I-L)), by immunostainings for synaptopodin and CD10 (podocytes), CK8 and 
PAX2 (parietal cells), CD68 (macrophages), α smooth muscle actin, (myoﬁ broblasts, mesan-
gial cells), CD34 (endothelium), vimentin and extracellular matrix components collagen I, III 
and IV and the α1 and α5 chain of collagen IV (Table 1). 
Remarkably, in involuted glomeruli some of the remaining cells stained for podocyte mark-
ers synaptopodin (Figure 4 B) and CD10 (Figure 4 C) and for PEC marker PAX-2 (Figure 4 D), 
whereas cells positive for these markers were neither seen in glomerulopathic sclerosis nor 
in vascular sclerosis (Parallel panels). 
A B
Figure 2. Types of global glomerulosclerosis: An example of glomerulopathic glomerulosclerosis also refererred to as solidiﬁ ed type as 
shown in panel A. Glomerulopathic glomerulosclerosis is characterized by a solidiﬁ ed non-retracted glomerular tuft with often recognizable 
tuft adhesions, splitting of Bowman’s capsule and prominent periglomerular ﬁ brosis. An example of vascular glomerulosclerosis is shown in 
panel B. This type is characterised by the retracted glomerular tuft, surrounded by a hypocellular homogeneous collagenous matrix in the former 
Bowman’s space, without tuft adhesions. There usually is moderate periglomerular ﬁ brosis (A, B x500).
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The extracellular matrix characteristics of the diﬀ erent types are depicted in ﬁ gure 5. Col-
lagen III was negative in all types of sclerosis (not shown). The hyalinized extracellular matrix 
ﬁ lling Bowman’s space in vascular sclerosis was strongly positive for collagen I (Figure 5J), 
whereas collagen I was not detected in involuted glomeruli (Figure 5B) or glomerulopathic 
sclerosis (Figure 5F). Collagen IV stains all of the matrix in involution and glomerulopathic 
sclerosis and only the contracted glomerular tuft in vascular sclerosis (Figure 5A,E,I). There 
was staining for both the α-1 and α-5 chain of collagen IV in involuted glomeruli (Figure 
5C,D), and glomerulopathic sclerosis (Figure 5G,H), whereas in vascular sclerosis the Bow-
man’s capsule was stained for the α-1 chain (Figure 5K) and the contracted tuft stained only 
for α-5 (Figure 5L).
CK8 positivity, a marker for activated parietal epithelial cells, was not seen (Figure 6A). CK8 
is not normally expressed in glomeruli, but can become expressed on parietal cells in fo-
cal and segmental glomerulosclerosis (FSGS) [7]. We observed residual staining in involuted 
glomeruli for smooth muscle actin (Figure 6B) and CD34 (Figure 6C), possibly representing 
Figure 3. Transmission electron microscopy of an involuted glomerulus: The observations by light microscopy (Figure1) are conﬁ rmed 
at high magniﬁ cation by EM. Involtuted glomeruli show an interconnecting network of GBM and Bowman’s capsule. Vital appearing cells are 
present. Cells which cover the GBM show foot process eﬀ acement and sometimes a single cell forms bridges between Bowman’s capsule and the 
GBM (arrows). The former GBM and Bowman’s capsule are thickened by irregular duplication and matrix deposition (x7000).
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Figure 4. Phenotype of glomerular cells: Cells in glomerular involution (panel A-D), glomerulopathic glomerulosclerosis (panel E-H) and 
vascular glomerulosclerosis (panel I-L). Light microscopy (PAS staining) is shown in panel A,E and I. Podocytemarkers synaptopodin (panel B), CD 
10 (panel C) and the parietal epithelial cells marker (PAX-2, panel D) are still expressed in involuted glomeruli and not in the other two types of 
glomerulosclerosis (A-D x400, E-L x250).
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Figure 5. Extracellular matrix characteristics: Cells in glomerular involution (panel A-D), glomerulopathic glomerulosclerosis (panel E-H) 
and vascular glomerulosclerosis (panel I-L). Collagen IV stains all of the matrix in glomerular involution (panel A), glomerulopathic sclerosis 
(panel E) and only the contracted glomerular tuft in vascular glomerulosclerosis (panel I). Collagen I only staines the hyalinized extracellular 
matrix ﬁ lling Bowman’s space in vascular glomerulosclerosis (panel J). The interconnecting network in involuted glomeruli stains for both the α-1 
and α-5 chain of collagen IV (panel C,D). Staining of the α-1 and α-5 chain of collagen IV was also seen in glomerulopathic glomerulosclerosis 
(panel G,H), whereas in vascular glomerulosclerosis Bowman’s capsule stains for the α-1 chain (panel K) and the contracted tuft stains for the 
α-5 chain of collagen IV (panel L) (A-D x400, E-L x250).
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Figure 6. Staining characteristics of the periglomerular region: Cells in glomerular involution (panel A-D), glomerulopathic 
glomerulosclerosis (panel E-H) and vascular glomerulosclerosis (panel I-L). CK8 is an activation marker of PECs in FSGS, is not expressed 
within the diﬀ erent types of sclerosed glomeruli but only staines tubular epithelium (panel A,E,I). In glomerulopathic and vascular sclerosis 
the periglomerular ﬁ brosis is highlighted by staining for vimentin and α SMA (myoﬁ broblasts) and CD34 (periglomerular capillaries). Note the 
absence of interstitial reaction in glomerular involution (panel B,D) (A-D x400, E-L x250).
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residual endothelial cells and mesangial cells. Intriguingly SMA staining was almost absent 
in the periglomerular region of the involuted glomeruli (Figure 6B), this in contrast to the 
staining which was very pronounced in glomerulopathic sclerosis and in vascular sclerosis 
(Figure 6F,J). Staining of capillary remnants for CD34 was observed in vascular sclerosis and 
involuted glomeruli, but not in glomerulopathic sclerosis (Figure 6C,G,K). 
The remarkable absence of interstitial changes accompanying glomerular involution was 
further highlighted by vimentin (Figure 6D,H,L), staining which showed prominent periglo-
merular expression in glomerulopathic sclerosis but not in involuted glomeruli.
All typical glomerular characteristics of the three forms of glomerulosclerosis are listed in 
table 2.
Table 2: Typical characteristics of the diﬀ erent types 
Glomerular Components Normal involution Glomerulopathic
sclerosis
Vascular sclerosis
Podocyte components
Synaptopodin 
CD 10
PEC components
PAX-2
Cytokeratin 8
Proliferation
KI 67
Miscellaneous
Macrophage (CD68)
α-smooth muscle actin
- intra glomerular
- peri glomerular
Endothelium (CD34)
Collagen IV
Collagen I
Collagen III
Glomerular volume
+++
++++
+++
=
=
=
+
=
+++
+
=
=
Normal
150-250 um
++
++
++
=
=
=
+
=
++
++
=
=
Very small
30-70 um
=
=
=
= 
=
=
+
+++
=
+++
=/+
=
Normal
150-250 um
=
=
=
= 
=
=
+
+++
++
=(BS) / ++(T)
++++(BS)
=
Normal
150-250 um
Abbreviations: BS-Bowman’s space, T-Glomerular tuft
DISCUSSION
Our ﬁ ndings justify the conclusion that glomerular involution is a type of glomerulosclerosis 
distinct from glomerulopathic and vascular glomerulosclerosis. The most evident distin-
guishing features are reduced size, remaining vital cells that stain for podocyte and parietal 
markers and a remarkable absence of interstitial damage. 
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It is likely that glomerular involution has been noted by other investigators although a clear 
description is lacking. Emery et al described glomerular involution and scarring in children, a 
process unlikely to be the result of vascular injury [4]. They observed these scarred glomeruli 
in children, occurring predominantly in children aged < 2 years, with preferential localisation 
in the subcapsular region and in approximity to the arcuate vessels. In the paper glomerular 
involution is described as the presence of small solid masses of connective tissue like mate-
rial lacking epithelial cells. Similar ﬁ ndings have been reported by Herxheimer, who noted 
hyalinised glomeruli in children < 1 year [8]. Both reports do not mention the tubulo-inter-
stitium. However, based on the description (lacking epithelial cells) and the predominant 
occurrence at very young age it is unlikely that these glomeruli may match our ﬁ ndings. 
Sibley et al described the occurrence of microglomeruli in children with a congenital ne-
phrotic syndrome. The microglomeruli averaged 20-40 µm in diameter and contained capil-
laries. The description of the glomeruli ﬁ ts our ﬁ ndings, although no mention is made of 
tubulo-interstitial injury [6].
Many studies have addressed global glomerulosclerosis [9]. It was shown that the number of 
obsolescent glomeruli increased with age, and correlated with interstitial ﬁ brosis and arterio-
lar intimal hyperplasia [9]. Glomerular involution appears to be very diﬀ erent from vascular 
glomerulosclerosis as there is no contraction of the glomerular tuft and no deposition of 
collagen I but rather production of collagen IV. Moreover, we did not detect any vascular 
changes in the renal tissue of patients with involuted glomeruli. The random distribution of 
the involuted glomeruli also argues against a vascular cause. Thus, whereas vascular sclerosis 
is thought to occur secondary to hypoperfusion, such a pathogenesis is unlikely in glomeru-
lar involution. 
It is intruiging that glomerular involution occurs in the setting of minimal change nephropa-
thy in patients with relapses (recurrent nephrotic syndrome) and therefore like FSGS is seen 
in the context of proteinuria. Therefore, one could ask if glomerular involution and glomeru-
lopathic sclerosis in FSGS are related processes. From a histological point of view the most 
apparent similarity is that in both types of glomerulosclerosis solidiﬁ cation is the result of 
matrix deposition by residual glomerular cells, which results in an ‘inﬂ ated’ glomerulus and 
tuft adhesions. In the last years the pathogenesis of glomerulosclerosis in FSGS has become 
much clearer [10-13]. It is generally accepted that in FSGS the podocyte is the cell that is 
initially injured, causing proteinuria. Studies in animal models have elucidated the following 
sequence of events which contribute to the characteristic lesions of FSGS: podocytes loose 
there diﬀ erentiation markers and disappear, there is activation and proliferation of parietal 
epithelial cells (PECs) or dediﬀ erentiated podocytes, and deposition of matrix with the for-
mation of the characteristic scar. The adhesions between the glomerular tuft and Bowman’s 
capsule are responsible for misdirected ﬁ ltration, moving ultraﬁ ltrate in the periglomerular 
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space, stimulating myoﬁ broblast proliferation. This periglomerular ultraﬁ ltrate typically 
spreads to the peritubular space. We have conﬁ rmed these abnormalities in human FSGS, 
and proposed that injury to PECs is important in this process [7].
In glomerular involution there is also deposition of extracellular matrix by cells of glomeru-
lar origin, causing consolidation and tuft adhesions. However, in involuted glomeruli there is 
no evidence of cell proliferation, podocyte markers remain present, there is no activation of 
PECs and no periglomerular ﬁ brosis or interstitial ﬁ brosis.
Based on these ﬁ ndings we hypothesize that misdirected ﬁ ltration does not occur in the 
process of glomerular involution. Apparently, glomerular involution occurs in the setting of 
podocyte injury with proteinuria, insuﬃ  cient to cause parietal epithelial cell injury and the 
associated formation of a bridging adhesion allowing misdirected ﬁ ltration. The injury stimu-
lates glomerular matrix production by glomerular epithelial cells and eventually the epithelial 
cells disappear. We have noticed these involuted glomeruli in children with minimal change 
disease, who were biopsied because of a relapsing cause of the disease. Thus, most patients 
have suﬀ ered from many episodes of proteinuria. Future studies are needed to further clarify 
the relation between proteinuria, treatment and the development of glomerular involution.
CONCLUSION
We describe a distinct type of global sclerosis that is observed in the setting of children with 
recurrences of minimal change nephrotic syndrome. This type of glomerulosclerosis without 
periglomerular and interstitial ﬁ brosis is best described as glomerular involution.
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ABSTRACT
We recently described the presence of small, globally sclerosed glomeruli in kidney biopsies 
of children with minimal change nephrotic syndrome. This abnormality, called glomerular 
involution, could be distinguished from the obsolescent and solidiﬁ ed forms of global glo-
merulosclerosis. These involuted glomeruli were characterised by a marked reduction in size, 
the persistence of vital cells within the matrix, and most notably, the absence of accompany-
ing tubular atrophy and interstitial ﬁ brosis.
In the present study we extend our observations on the presence of glomerular involu-
tion in biopsies of children with a frequently relapsing nephrotic syndrome due to minimal 
change nephropathy. Speciﬁ cally, we have evaluated possible explanatory variables.
We have studied biopsies of 18 children (11 M, 7 F) with frequently relapsing minimal 
change nephrotic syndrome. We observed involuted glomeruli in 12 biopsies, median per-
centage of involuted glomeruli was 6% (range 0-33%). The percentage of involuted glomeruli 
correlated with age at renal biopsy and the interval between onset of disease and time of 
renal biopsy. The percentage of involuted glomeruli was not dependent on gender, age at 
onset of disease or prednisone dose. Multivariate analysis revealed that the interval between 
onset of disease and time of renal biopsy was the only independent predictor.
In conclusion: small, globally sclerosed involuted glomeruli are regularly observed in chil-
dren with frequently relapsing minimal change nephrotic syndrome. The data suggest that 
glomerular involution is a slow process, related to the duration of the disease process.
Keywords: minimal change nephropathy, relapsing nephrotic syndrome, involution
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INTRODUCTION
We recently described glomerular involution as a special type of glomerular injury [1]. Glo-
merular involution is deﬁ ned by the presence of small glomeruli, which are characterized 
by disorganized matrix, the presence of vital cells in between the matrix, and the striking 
absence of periglomerular and interstitial ﬁ brosis. We have shown that glomerular involution 
can be distinguished from the other two types of global glomerulosclerosis i.e. the vascular 
type (also referred to as obsolescent type) and the glomerulopathic type (also referred to as 
solidiﬁ ed type).
We observed these involuted glomeruli in biopsies of children, notably of children with a 
nephrotic syndrome. In the present study we extend our observations. Speciﬁ cally, we have 
evaluated possible explanatory variables.
PATIENTS AND METHODS 
Patients
We have evaluated renal biopsies of children with a frequently relapsing nephrotic syndrome. 
These children were biopsied in the process of preparation for cyclophosphamide therapy. 
We only included biopsies classiﬁ ed as minimal change nephropathy by appropriate histo-
logical techniques (light microscopy, immunoﬂ uorescence and electronmicroscopy).
The clinical data of the patients were studied with particular emphasis on age of onset 
of disease, number of relapses, type and duration of immunosuppressive treatment and re-
lapse-free interval.
Light microscopy
Renal biopsies were processed according standard techniques. For light microscopy, kid-
ney fragments were ﬁ xed in Bouin’s solution or formaldehyde, dehydrated, and embedded 
in paraplast (Amstelstad, Amsterdam The Netherlands). 2 µm sections were stained with 
periodic acid-Schiﬀ  and with silver methenamine. Involuted glomeruli were identiﬁ ed by 
high-power magniﬁ cation. Glomeruli were scored and counted by one of us (HD), who was 
unaware of the clinical data of the patients.
RESULTS
We have studied the biopsies of 18 children with a steroid-dependent or frequently relapsing 
minimal change nephrotic syndrome. 
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Clinical characteristics of the patients are given in Table 1. There were 11 boys and 7 girls. 
Median age at disease onset was 2.8 years (1.6-10.6 years) and at biopsy 5.2 years (2.3-10.9 
years). Most patients expressed a frequently relapsing course of the nephrotic syndrome. 
All patients had received prednisone. Other immunosuppressive agents had not been used 
before the renal biopsy. All patients were initially treated according guidelines of the ISKDC. 
Some patients with steroid-dependent nephrotic syndrome were treated with low dose pred-
B C
A
Figure 1. Histology, silver methenamine staining: With low magniﬁ cation involuted glomeruli appear as small black nodules (panel A). 
They are distributed throughout the cortex and in this view the absence of tubular atrophy and periglomerular and tubulo-interstitial ﬁ brosis is 
noted. At high magniﬁ cation the involuted glomeruli consist of matrix, with persistence of cells within the matrix (A x 150, B-C x350).
Glomerular involution in children with minimal change nephrotic syndrome 123
nisone for prolonged time periods with titration of the prednisone dose against proteinuria 
assessed by urinary dipstick. The biopsies contained 19 (5-35) glomeruli. Many biopsies con-
tained small, globally sclerosed glomeruli with the characteristics of involuted glomeruli.
Typical examples are depicted in Figure 1 B,C. Most notable is the absence of periglomerular 
and tubular interstitial ﬁ brosis. The median percentage of involuted glomeruli was 6% (range 
0-33%). Biopsies of six patients did not show involuted glomeruli. When comparing patients 
without and with involuted glomeruli we observed a signiﬁ cant diﬀ erence in the age at renal 
biopsy (without involution: 3.9 ± 1.1 year, with involution 6.5 ± 2.6 years; p<0.05) and the 
interval between onset of disease and the renal biopsy (0.44 ± 0.43 years vs 3.8 ± 3.3 years; 
p<0.01). There were no signiﬁ cant diﬀ erences in gender distribution, maximal proteinuria 
at onset, serum albumin, number of recurrences or selectivity index. There was a signiﬁ cant 
correlation between the percentage of involuted glomeruli and the interval between onset 
of disease and renal biopsy (Figure 2, Spearman R=0.64; p<0.01), and a trend between age at 
biopsy and percentage involution (r=0.41; p=0.09). By logistic regression analysis the interval 
between disease onset and the renal biopsy was the only independent signiﬁ cant predictor.
Table 1: Clinical characteristics of the patients
Patients (N) 18
Sex (M/F) 11 / 7
Age at onset (yr) 2.8 (1.6 - 10.6)
Age at biopsy (yr) 5.2 (2.3 - 10.9)
Interval onset-biopsy (yr) 1.5 (0.2 - 6.7)
Number of relapses 2 (1 - 16)
Number of glomeruli 19 (5 - 35)
Involuted glomeruli (%) 6 (0 - 33)
Values are given as medians (range)
Figure 2. Correlation between the percentage of 
involuted glomeruli and the interval between disease 
onset and renal biopsy (Spearman R=0.64; p<0.01).
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DISCUSSION
Our study indicates that small, seemingly sclerosed glomeruli are regularly found in patients 
with frequently relapsing or steroid dependent minimal change nephrotic syndrome. In our 
series these glomeruli were observed in the majority (two thirds) of the renal biopsies. We 
previously have suggested to use the term glomerular involution to describe these small 
glomeruli [1]. Glomerular involution can be distinguished from the obsolescent and the so-
lidiﬁ ed form of global glomerulosclerosis.
We observed a signiﬁ cant relation between the percentage of glomerular involution and 
the interval between onset of disease and time of renal biopsy. Thus, involuted glomeruli are 
predominately observed in children who are biopsied several years after onset of the disease. 
We did not ﬁ nd a relation with number of recurrences, proteinuric selectivity index, maximal 
proteinuria at onset or serum albumin. Obviously, our study has the limitations of a retro-
spective study. In particular, it was impossible to obtain accurate and meaningful data on 
time-averaged proteinuria. Especially patients with a more protracted course were advised to 
check their urine by dipstick and adjust the dose and duration of prednisone therapy accord-
ingly. Detailed information obviously cannot be retrieved from the patient records. Therefore, 
we cannot draw conclusions on possible mechanisms of glomerular involution. Glomerular 
involution may be the consequence of initial glomerular injury, slowly developing afterward. 
Alternatively, it is quite possible that glomerular involution is the consequence of ongoing 
subtle injury, reﬂ ected by continued recurrence of proteinuria. The continued use of pred-
nisone may oﬀ er a third explanation. In an animal model of minimal change nephropathy, 
the so-called puromycin aminonucleoside model, chronic administration of methylpredniso-
lone caused glomerulosclerosis [2], an eﬀ ect attributed to hyperﬁ ltration. Chronic steroid 
treatment has also been implicated as cause of glomerulosclerosis. Prospective studies are 
needed to determine the best explanation.
The term glomerular involution has been used before to describe abnormal glomeruli in 
biopsies of children. Emery et al described glomerular involution and scarring in children, 
and considered that it was unlikely that this was the result of vascular injury [3]. They demon-
strated that these scarred glomeruli occurred predominantly in children aged < 2 years, with 
preferential localisation in the subcapsular region or in approximity to the arcuate vessels. 
In Emery’s paper glomerular involution is described as the presence of small solid masses of 
connective tissue like material lacking epithelial cells. Similar ﬁ ndings have been reported 
by Herxheimer, who noted hyalinised glomeruli in children < 1 year [4]. Both reports do not 
mention the tubulo-interstitium. However, based on the description of the glomeruli, the lack 
of epithelial cells and the clinical characteristics (predominant occurrence at very young age), 
it is unlikely that the glomeruli described by Emery or Herxheimer match our ﬁ ndings. Sibley 
et al described the occurrence of microglomeruli in children with a congenital nephrotic syn-
drome [5]. The microglomeruli averaged 20-40 µm in diameter and contained capillaries. The 
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description of these glomeruli bears resemblance with our ﬁ ndings, although no mention is 
made of the presence or absence of tubulo-interstitial injury [5].
Obviously, involuted glomeruli have lost their function. The observation that up to 30% 
of glomeruli are involuted in biopsies of children with minimal change nephrotic syndrome 
thus suggest that minmal change nephropathy is not so benign as suggested. Although renal 
function abnormalities were not detected in these children by standard creatinine assays, 
loss of functional nephrons may cause problems in the future. Therefore, more information is 
needed in the pathogenesis of this process.
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ABSTRACT 
We recently described the presence of small, seemingly sclerosed glomeruli in kidney bi-
opsies of children with recurrent minimal change nephrotic syndrome. This abnormality, 
called glomerular involution, can be distinguished from the vascular (obsolescent) type and 
glomerulopathic (solidiﬁ ed) type of global glomerulosclerosis. We now present a mouse 
model of glomerular involution. Six week old Balb/c mice received two weekly intravenous 
injections, on day 1 and again on day 7, of 4 mg of the combination of two monoclonal an-
tibodies directed at aminopeptidase-A (ASD-37/41). Mice injected with the non-proteinuric 
combination ASD-3/41 were used as controls. We followed the groups over 12 months and 
tested the urine samples for albuminuria every 4 weeks by placing mice in metabolic cages. 
Mice were sacriﬁ ced at months 7, 10 and 12 and kidneys processed for light microscopy, im-
munoﬂ uorescence, immunohistochemistry and electron microscopy.
Injection of ASD-37/41 caused an acute albuminuria after each injection. Thereafter albu-
minuria decreased to values slightly above normal within 21 days. During follow up albumin-
uria averaged 703 ± 626 µg/18 hrs in mice injected with ASD-37/41 as compared to 273 ± 225 
µg/18 hrs in controls. Involuted glomeruli were ﬁ rst observed in mice sacriﬁ ced 7 months 
after injection and the percentage of involuted glomeruli increased to 17% at 12 months. 
Abnormal glomeruli were not observed in control mice.
We have studied these involuted glomeruli in detail by light microscopy, electron micros-
copy and immunostaining and have investigated the expression of markers for podocytes 
(synaptopodin, WT-1, nephrin & VEGF), parietal epithelial cells (PAX-2), miscellaneous matrix 
components (coll I, III & IV, ASD-20), endothelium (CD 34), myoﬁ broblasts (SMA) and made a 
comparison with the involuted glomeruli observed in humans.
The involuted glomeruli in mice closely resembled the abnormal glomeruli described in 
humans. These glomeruli were characterised by small size, increased matrix and the presence 
of vital cells that stained with podocyte markers (synaptopodin, WT1, nephrin and VEGF) and 
PEC marker (PAX-2). Most notable was the absence of periglomerular and tubulo-interstitial 
inﬂ ammation and ﬁ brosis.
In conclusion; we present a mouse model of glomerular involution. This mouse model will 
enable studies to reveal the pathogenic pathways involved in this type of glomerular injury.
Keywords: APA, global glomerulosclerosis, parietal epithelial cell, podocyte, periglomerular 
ﬁ brosis, involution.
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INTRODUCTION
We recently described the presence of small, seemingly sclerosed glomeruli in kidney bi-
opsies of children with recurrent minimal change nephrotic syndrome [1]. This abnormality, 
called glomerular involution, could be distinguished from the vascular (obsolescent) form 
and glomerulopathic (solidiﬁ ed) form of global glomerulosclerosis. Glomerular involution 
was characterised by a marked reduction in size of the glomerulus, an apparent increase of 
matrix, the continued presence of vital glomerular epithelial cells and, most remarkably, the 
absence of periglomerular and tubulo-interstitial ﬁ brosis. These characteristics suggested a 
diﬀ erent pathogenic pathway. 
In recent years we have described a mouse model of podocytic activation and injury which 
resembles minimal change nephropathy. Administration of a speciﬁ c combination of anti-
aminopeptidase-A (APA) mAbs in mice induces an acute albuminuria which is independent 
of complement, inﬂ ammatory cells or angiotensin II [2;3]. Albuminuria is massive, starts at 6 
hr, reaches its maximum at 8 hr and declines to near-normal values thereafter. We have tried 
to induce FSGS in this model by repeating the injection of the mAbs. During follow-up we 
observed the development of glomerular abnormalities that resembled glomerular involu-
tion. This report details our ﬁ ndings. Our study indicates that the small glomeruli in our anti-
APA mouse model have similar characteristics than the involuted glomeruli in humans. Our 
mouse model can be used to study the pathogenesis of glomerular involution.
METHODS
Animals
BALB/c mice, aged 6 weeks and weighing 20–25 g, were purchased from Charles River, 
Sulzfeld, Germany. All procedures involving mice were approved by the Animal Care Commit-
tee of the University of Nijmegen and conformed to the Dutch Council for Animal Care and 
National Institutes of Health guidelines.
Antibodies used for intravenous injection
The characteristics of the three rat mAbs against diﬀ erent epitopes of mouse APA used in 
this study (ASD-3, ASD-37 and ASD-41) have been described previously [2]. The combination 
ASD-37/41 is nephritogenic and induces albuminuria, whereas the combination ASD-3/41 is 
non-nephritogenic and used as control. The anti-APA mAbs have been propagated in vitro 
by hollow-ﬁ ber culture (Nematology Department, Agriculture University Wageningen, The 
Netherlands).
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Animal Experiments
We have studied mice that received two intravenous injections 6 and 7 weeks after birth of 
4 mg of the nephritogenic combination ASD-37/41 or the non-nephritogenic combination 
ASD-3/41 (both with 1:1 weight ratio). The long term eﬀ ects were studied in mice which were 
followed for at least 6 months. Urinesamples (18 hr) were collected every 4 weeks by placing 
mice in metabolic cages. At each speciﬁ ed time point thereafter (7,10 and 12 months) mice 
were killed and kidneys processed for light microscopy, immunoﬂ uorescence and electron 
microscopy. The time-course of the acute albuminuria was studied in a separate set of experi-
ments. Urine samples were collected by bladder puncture within 24 hours and at day 2 and 
7 after the ﬁ rst injection and within 24 hours after the second injection. Albuminuria was 
measured by radial immunodiﬀ usion as described [4]. 
Light microscopy
For light microscopy, kidney fragments were ﬁ xed in Bouin’s solution and formaldehyde, 
dehydrated, and embedded in paraplast (Amstelstad, Amsterdam The Netherlands). 2 µm 
sections were stained with periodic acid-Schiﬀ , and with silver methenamine.
Immunohistochemistry
The expression of glomerular antigens was studied by immunohistochemistry and immuno-
ﬂ uorescence. Immunohistochemical staining was performed on kidney sections ﬁ xed in 4% 
buﬀ ered formaldehyde for 24 hr and embedded in paraﬃ  n. 4 µm sections were incubated 
with primary and secondary antibodies as listed in Table 1. Detection was carried out with 
the use of peroxidase as label and diaminobenzidine as substrate or via alkaline phosphatase 
(AF). For immunoﬂ uorescence (IF) kidneys were snap frozen in liquid nitrogen. Two μm-thick, 
acetone ﬁ xed sections were incubated with speciﬁ c antibodies for 60 minutes at room tem-
perature. The expression of important proteins was examined using unlabeled primary Ab 
and FITC-labeled secondary antibodies as listed in Table 1. The sections were analysed by a 
microscopical system, the Leica Discovery (Leica GmbH, Heidelberg, Germany).
In situ hybridisation
Kidney sections were ﬁ xed in 4% buﬀ ered formaldehyde for 24 hr and embedded in paraf-
ﬁ n. 4 µm sections were incubated and subjected to VEGF in situ hybridization (ISH) using a 
digoxigenin-labeled VEGF-A antisense RNA probe [5]. The corresponding sense probe was 
used as a control. 
Transmission Electron Microscopy
For electron microscopy, we used immersion ﬁ xation. Small fragments of cortex were ﬁ xed 
in 2.5% glutaraldehyde dissolved in 0.1 M sodium cacodylate buﬀ er, pH 7.4, overnight at 4°C 
and washed in the same buﬀ er. The tissue fragments were postﬁ xed in Palade-buﬀ ered 2% 
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OsO4 for 1 hr, dehydrated, and embedded in Epon 812, Luft’s procedure (Merck, Darmstadt, 
Germany). Ultrathin sections were contrasted with 4% uranyl acetate for 45 min and subse-
quently with lead citrate for 5 min at room temperature. Sections were examined in a Jeol 
1200 EX2 electron microscope (JEOL, Tokyo, Japan).
RESULTS
Proteinuria
Injection of the nephritogenic APA antibody combination ASD-37/41 in 6 weeks old mice in-
duced an acute albuminuria which was ﬁ rst noted at 6 hr, peaked at 8 hr after antibody injec-
Figure 1. The course of albuminuria in the 
experimental group (injection of ASD-37/41; 
straight line) and the control group (injection 
of ASD-3/41; interrupted line). N=6 mice per 
group till month 6. Albuminuria is higher in the 
experimental group (p<0.01).
Figure 2. Percentage of involuted glomeruli in the 
experimental group (injection of ASD-37/41; ) 
or the control group (injection of ASD-3/41; Δ) in 
relation to time of follow-up.
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tion and decreased thereafter. Albumin in urine was 58,046 ± 6,084 µg/ml at 8 hr, 3,247 ± 1,076 
µg/ml at 24 hr, 1148 ± 688 µg/ml at 48 hr, and 724 ± 334 µg/ml at day 7. Mice injected with the 
non-nephritogenic combination ASD-3/41 did not develop albuminuria (102 ± 24 µg/ml). The 
second injection of ASD-37/41 at day 7 also resulted in an acute albuminuria (13,412 ± 16,905 
µg/18 hrs) and decreased thereafter (1,989 ± 811 µg/18 hrs at 4 weeks). Albuminuria measured 
during long-term follow-up is presented in Figure 1. Albuminuria was consistently higher in 
mice that received ASD-37/41, although levels were only mildly increased.
A
CB
Figure 3. Histology, silvermethenamine staining: Involuted glomeruli appear as small black nodules (panel A). In an overview the involuted 
glomeruli are distributed throughout the cortex, without the presence of accompanying interstitial changes. The aspect of the extracellular 
matrix becomes evident in detail (panel B). Remnants of the glomerular basement membrane and Bowman’s capsule can be seen and form an 
interconnecting network. There is continuity between the former glomerular tuft and Bowman’s capsule and a small number of vital appearing 
cells can be seen (panel B). These glomeruli are characterised by the small size, seemingly increased matrix and the persistent presence of vital 
cells and resembled the involuted glomeruli in humans. For comparison an involuted glomerulus in a child with relapsing minimal change 
nephrotic syndrome is shown (panel C) (A x150, B,C x750).
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Glomerular morphology 
In mice sacriﬁ ced after 7 months we noted the presence of small, seemingly sclerosed glom-
eruli. The percentage of these involuted glomeruli increased with time of follow-up (Figure 
2). Abnormal glomeruli were not observed in control mice.
With low power magniﬁ cation the involuted glomeruli appear as small black nodules with-
out apparent accompanying interstitial changes (Figure 3A). With higher magniﬁ cation the 
relative increase of extracellular matrix becomes evident. Remnants of the glomerular base-
ment membrane and Bowman’s capsule can be seen and form an interconnecting network. 
There is continuity between the former glomerular tuft and Bowman’s capsule and a small 
number of vital appearing cells can be seen. Morphologically the small glomeruli found in 
our mouse model are very similar to the involuted glomeruli that can be observed in humans 
(Figure 3B and 3C). Notable is the absence of periglomerular ﬁ brosis or inﬂ ammation of the 
surrounding interstitium (Figure 4A). This ﬁ nding is in clear contrast with the marked periglo-
merular ﬁ brosis that is always present in our mouse model of FSGS (Figure 4B). 
We have analysed the cells that remain present in the involuted glomeruli by immunohis-
tochemistry and immunoﬂ uorescence. Cells were positive for either the podocyte markers 
nephrin, synaptopodin, WT1, ASD-38 and VEGF or the parietal epithelial cell marker PAX-2 
(Figure 5 A-J). We have performed additional stainings using ASD-20, an antibody that pre-
dominately stains the matrix of Bowman’s capsule in normal mouse glomeruli (Figure 5 D). 
Staining is more prominent and more diﬀ use in the involuted glomeruli (Figure 5 D and 5 I). 
Electron microscopy is depicted in Figure 6. There is thickening of the GBM and Bowman’s 
capsule. Podocytes show foot process eﬀ acement. There is an increase of matrix, which con-
nects the tuft and Bowman’s capsule. Notably, cells are uniformly present between this newly 
BA
α
S
M
A
Figure 4. Immunostaining with α SMA to characterize the periglomerular and interstitial inﬂ ammation / ﬁ brosis (panel A,B). 
Notable is the absence of periglomerular ﬁ brosis or inﬂ ammation of the surrounding interstitium in glomerular involution (panel A). For 
comparison, marked periglomerular ﬁ brosis is always present in a mouse model of FSGS (Thy-1.1 transgenic mouse: panel B) (A,B x400).
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Figure 5. Phenotype of glomerular cells and extracellular matrix characteristics in glomerular involution. The vital cells in the 
involuted glomeruli (marked via white or black arrow) still express podocytemarkers such as nephrin (panel A), synaptopodin (panel B), ASD-38 
(panel C), WT-1 (panel E), mRNA VEGF (panel F,G). The parietal epithelial cell marker (PAX-2, panel J) is also still present in involuted glomeruli. 
We have used staining with ASD-20, an antibody that predominately stains the matrix of Bowman’s capsule in normal mouse glomeruli (panel 
D). Involuted glomeruli show more diﬀ use staining (panel D-arrow), in more detail adhesions can be recognized (panel I-arrow). For comparison 
light microscopy (silvermethenamine) is shown in panel H (A-G x350, H-J x500). 
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formed matrix. We have also analysed normal appearing glomeruli of ASD-37/41 injected 
mice and age-related control mice by electron microscopy. GBM thickness was increased in 
ASD-37/41 injected mice (Figure 6 B) whereas GBM thickness was normal in ASD-3/41 injected 
mice (Figure 6 C). Also, foot processes were partially eﬀ aced in ASD-37/41 injected mice.
We were intrigued by the notable absence of periglomerular and tubulo-interstitial ﬁ brosis 
and the absence of atrophic tubuli. To further evaluate the relationship between the invo-
luted glomeruli and the tubular system we have cut serial sections and analyzed several small 
globally sclerosed glomeruli in diﬀ erent stages. Figure 7 presents serial sections of such an 
involuted glomerulus. We did not observe atrophic tubuli and did not ﬁ nd a connection be-
tween the glomerulus and a proximal tubule. Figure 8 shows serial sections of a segmental 
A
B C
Figure 6. Transmission electron microscopy of an involuted glomerulus: Electron microscopy conﬁ rmed the observations by light 
microscopy (Figure 3). Involuted glomeruli show a matrix network that interconnect the GBM and Bowman’s capsule (panel A). Vital appearing 
cells are present and cells which cover the GBM show foot process eﬀ acement. The former GBM and Bowman’s capsule are thickened. In normal 
appearing glomeruli of ASD-37/41 injected mice GBM thickness was increased (panel B) whereas GBM thickness was normal in age-matched 
control mice and ASD-3/41 injected mice (panel C) (A x7000, B,C x10,000). 
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lesion. Apparently in the early stage there is formation of matrix along Bowman’s capsule, 
where cells remain present. Adhesions are formed but proliferation of glomerular cells does 
not occur. There is no inﬂ ammatory response outside Bowman’s capsule.
Figure 7. Relation between involuted glomeruli and the tubuli. We have used serial sections and analyzed several small globally sclerosed 
glomeruli in diﬀ erent stages. Atrophic tubuli were not observed and also a connection between the glomerulus and a proximal tubule was not 
found (serial sections are depicted in the gallery starting at the upper left) (silvermethenamine and PAS staining, A-I x350).
138
C
ha
p
te
r 9
Figure 8. Early involuted glomeruli, a segmental lesion. In this ﬁ gure serial sections are shown of a segmental lesion. In the early stage 
there is formation of matrix along Bowman’s capsule. Adhesions are formed but proliferation of glomerular cells does not occur. There is no 
inﬂ ammatory response outside Bowman’s capsule (serial sections are depicted in the gallery starting at the upper left) (silvermethenamine and 
PAS staining, A-L x350).
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DISCUSSION
Most authors distinguish two types of global glomerulosclerosis i.e. the vascular type (also 
referred to as obsolescent type) and the glomerulopathic type (also referred to as solidiﬁ ed 
type) [6]. Vascular glomerulosclerosis is characterised by retraction of the glomerular tuft, the 
absence of tuft adhesions and the prominent ﬁ lling of Bowman’s space with collagen I matrix. 
Glomerulopathic sclerosis is characterised by a solidiﬁ ed non-retracted glomerular tuft, with 
increased matrix, recognizable tuft adhesions and disappearance of vital cells.
We recently have described a new type of global glomerular injury, so called glomerular 
involution, which we observed in biopsies of children with a nephrotic syndrome [1]. These 
glomeruli were characterised by small size, seemingly increased matrix, the persistent pres-
ence of vital cells in the matrix and the notable absence of periglomerular ﬁ brosis and tu-
bulo-interstitial inﬂ ammation. 
We now describe a mouse model of glomerular involution. Injection of mice with anti-APA 
monoclonal antibodies that induced an acute proteinuria resulted in the late development 
of abnormal and small glomeruli. These small glomeruli resembled the involuted glomeruli in 
humans in every detail. Speciﬁ cally, the glomeruli were small, contained seemingly increased 
matrix, vital cells remained present with staining characteristics of podocytes and PECs, and 
periglomerular and tubulo-interstitial ﬁ brosis was absent. Thus, this mouse model can be 
used to study the pathogenesis of glomerular involution in more detail.
We have hypothesized that glomerular involution and glomerulopathic glomerulosclerosis 
diﬀ er with respect to the extent of damage to the PECs and Bowman’s capsule [1]. Tuft adhe-
sions are typically present in FSGS. The tuft adhesions are areas of matrix that connect the 
glomerular tuft and the periglomerular region. These synechia contain matrix. The parietal 
epithelial cells that normally line Bowman’s capsule are absent. It has been suggested that 
misdirected ﬁ ltration is present thru these adhesions, moving ultraﬁ ltrate into the periglo-
merular space, stimulating myoﬁ broblast proliferation [7]. This periglomerular ultraﬁ ltrate 
typically spreads to the peritubular space and is the cause of the local inﬂ ammatory response 
and ﬁ brosis [7]. Thus, misdirected ﬁ ltration provides an explanation linking focal glomerular 
sclerosis to periglomerular and tubulo- interstitial ﬁ brosis. Based on our ﬁ ndings we have sug-
gested that glomerular involution lacks misdirected ﬁ ltration, possibly as the consequence of 
the persistence of vital PECs that remain present along Bowman’s capsule.
In the older literature there has been a discussion if glomeruli can disappear without 
leaving a scar [8]. We suspect that the process of glomerular involution may eventually lead 
to the disappearance of glomeruli, which will be unnoticed in the absence of ﬁ brosis. By 
serial sectioning we have analyzed the relationship between the involuted glomerulus and 
the proximal tubular system. Apparently involuted glomeruli are no longer connected to a 
proximal tubules. Most remarkable is the fact that we did not observe many atrophic tubuli. 
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Again, our observations provide some support for studies by Oliver [9] more than 60 years 
ago who already suggested that tubuli may not degenerate after loss of the glomerulus. We 
have made another interesting observation. We observed thickening of the GBM in normal 
appearing glomeruli of ASD-37/41 injected mice. Thus, thickening of the GBM preceded 
glomerular involution. Thickening of the GBM is characteristically observed in patients with 
diabetes and patients with vascular ischaemia and may point to the role of growth factors in 
the process of involution. Further studies in this mouse model are warranted. 
CONCLUSION
We describe a mouse model which resembles glomerular involution in humans. This mouse 
model will enable further studies into the pathogenesis of glomerular involution.
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PARIETAL EPITHELIAL CELL INJURY: TIPPING THE BALANCE BETWEEN 
GLOMERULOSCLEROSIS AND GLOMERULAR INVOLUTION?
Focal segmental glomerulosclerosis
FSGS is deﬁ ned by the focal and segmental presence of lesions that are characterized by 
mesangial sclerosis, obliteration of glomerular capillaries with hyalinosis and intracapillary 
foam cells, adhesions between the glomerular tuft and Bowman’s capsule, and podocyte 
hypertrophy. It is important to note that FSGS is not a disease entity, but rather a pattern of 
glomerular injury. Various morphological variants have recently been described [1]. It is as 
yet undecided if these variants have a diﬀ erent pathogenesis. In recent years the podocyte 
has become the culprit in the pathogenesis of FSGS [2;3]. One line of evidence comes from 
studies in patients with hereditary FSGS. In many patients mutations of podocytic proteins 
have been discovered [4]. Involved proteins are important in maintaining the slit-pore com-
plex (e.g. nephrin, podocin, CD2AP, α-actinin-4) or function as transcription factors (WT-1, 
LmX1b). Thus, dysfunction of podocytic proteins causes FSGS in humans. Other evidence is 
put forward by animal experiments. Especially studies by Kriz and coworkers have pointed 
to the role of podocytic injury in the pathogenesis of FSGS [5-7]. Notably, the models used 
by Kriz et al were characterized by glomerular hypertension and / or glomerular hyperﬁ ltra-
tion. Podocytic injury was always recognized in the early phase, with later development of 
hypocellular FSGS lesions. In the pathogenesis proposed by these authors the podocyte is 
positioned as a terminally diﬀ erentiated cell which is unable to replicate. Thus, podocytes are 
unable to compensate for injured podocytes that no longer adhere to the GBM and are lost 
in the urine. As a result there is denudation of the GBM, which is covered by parietal epithelial 
cells. Subsequently, a ﬁ rm adhesion forms, which is composed of matrix and allows passage 
of proteins and ﬁ ltrate from the capillaries to the periglomerular space. This latter process, 
also called misdirected ﬁ ltration, is the cause of the periglomerular ﬁ brosis and peritubular 
inﬂ ammation that is typically observed in FSGS.
Obviously, the above-mentioned pathogenesis is not applicable to collapsing FSGS. In col-
lapsing FSGS there is always abundant cellular proliferation in Bowman’s space. Collapsing 
FSGS is typically seen in HIV associated nephropathy, and has been associated with parvovirus 
B19 infection and pamidronate toxicity. Sometimes collapsing FSGS is observed in patients 
with idiopathic FSGS. Initially, most authors suggested that the proliferating cells were podo-
cytes. Their conclusions were based on observations in lightmicroscopy, which showed that 
the proliferating cells covered the capillary loops. In further studies it was noted that the pro-
liferating cells did not express well known podocyte markers such as nephrin, synaptopodin 
or WT-1. These observations have introduced the concept of the dysregulated, proliferating 
podocyte. In this concept podocytes have dediﬀ erentiated, have lost their podocytic markers 
and have regained the ability to proliferate. In the later phase of collapsing FSGS adhesions 
are formed.
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Recent observations of our group in a mouse model of FSGS provided strong arguments 
against the above mentioned pathways of podocyte injury and suggested involvement of 
parietal epithelial cells. Our mouse model of FSGS is the Thy-1.1 transgenic mouse [8-10]. Thy-
1.1 transgenic mice ectopically express the mouse Thy-1.1 antigen on podocytes. Injection of 
anti Thy-1.1 mAbs induces FSGS. The initial lesions show prominent epithelial cell hyperpla-
sia. In this mouse model we observed dediﬀ erentiation of the podocytes as reﬂ ected by the 
loss of some but not all podocyte markers. Most remarkably, we did not observe proliferating 
podocytes and we identiﬁ ed the proliferating cells as parietal epithelial cells. We also found 
that the matrix produced by these cells resembled Bowman’s capsule. These ﬁ ndings sug-
gested that parietal epithelial cells are involved in FSGS.
The parietal epithelial cell in human FSGS
We conducted phenotypic analysis in a nephrectomy specimen of a patient with recurrence 
of idiopathic FSGS after transplantation [11]. In some glomeruli, glomerular epithelial cell 
hyperplasia was observed. The proliferating cells stained positively for cytokeratin and other 
PEC markers, and did not express podocyte markers. Many cells were located adjacent to the 
glomerular tuft, which suggested that these cells could be podocytes that newly expressed 
cytokeratin. However, we have been able to invalidate this conclusion using 3-dimensional 
analysis of the glomeruli. We could show that cytokeratin positive cells on the tuft were al-
ways in continuity with cytokeratin positive cell lining Bowman’s capsule [11]. From these 
studies we concluded that PECs contributed to the cellular lesions in idiopathic FSGS. Similar 
conclusions were reached by Nagata et al and Kihara et al [12;13]. 
We have extended these observations in patients with collapsing FSGS related to HIV and 
pamidronate [14]. Based on double straining for CD10/CK8 and synaptopodin/CK8 we were 
able to demonstrate that the proliferating cells in HIV associated collapsing FSGS were PECs. 
Another important observation in our studies is related to the composition of the newly 
formed matrix. We showed that the staining characteristics of the matrix were similar to 
Bowman’s capsule. Based on our studies we propose that the current views of the develop-
ment of FSGS must be changed. Obviously, injury to the podocyte with resulting proteinuria 
is the ﬁ rst step. However, we never observed non-adherent podocytes or denudation of the 
GBM. Rather, there is injury of the PECs with denudation of Bowman’s capsule. Hereafter ad-
hesions develop as a result of contacts between the podocyte (tuft) and PECs and possibly 
denuded Bowman’s capsule. Activated PECs produce matrix that covers the podocytes. These 
podocytes disappear and eventually a hypocellular scar lesion is formed. Adjacent PECs may 
proliferate, explaining the hypercellular lesions that can be observed in FSGS. Finally, the 
adhesions provoke periglomerular ﬁ brosis and tubulo-interstitial ﬁ brosis, likely thru misdi-
rected ﬁ ltration of plasma proteins, a process elegantly demonstrated by Kriz et al [15]. 
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Glomerular involution, a new type of glomerular injury
We have identiﬁ ed abnormal glomeruli in renal biopsies of children with frequently relapsing 
nephrotic syndrome due to minimal change nephropathy. These glomeruli were character-
ized by their small size, the presence of vital cells in the matrix, and the notable absence of 
periglomerular and tubulo-interstitial ﬁ brosis. We have proposed the term glomerular invo-
lution to describe this abnormality. Involuted glomeruli can be distinguished from vascular 
sclerosis (also referred to as obsolescent glomerulosclerosis) and glomerulopathic sclerosis 
(also referred to as solidiﬁ ed glomerulosclerosis). We have developed a mouse model of glo-
merular involution by repeatedly injecting nephritogenic anti-APA mAbs in mice. These mice 
did not develop FSGS. However, after 12 months we observed small glomeruli that resembled 
the involuted glomeruli that we observed in children. Again, most notable was the complete 
absence of periglomerular and tubulo-interstitial ﬁ brosis. This ﬁ nding is in clear contrast with 
the marked periglomerular ﬁ brosis that always accompanies glomerulosclerosis in the Thy-
1.1 mouse model (Figure 1). The absence of periglomerular ﬁ brosis is clear evidence that 
glomerulosclerosis and glomerular involution diﬀ er in pathogenesis. 
Based on our studies we have developed a new scheme that illustrates the development of 
FSGS and glomerular involution (Figure 2).
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Figure 1. Staining characteristics of the periglomerular region in glomerular involution (panel A) and in FSGS (panel B): Notable 
is the absence of interstitial reaction or inﬂ ammation of the surrounding interstitium in glomerular involution (panel A). This is in clear contrast 
with the marked periglomerular ﬁ brosis in our mouse model of FSGS (panel B).
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Factor affecting podocyte function
PROTEINURIA
Collapsing FSGS
Massive podocyte injury
Massive PEC activation 
and proliferation
Podocytes enclosed by PECs/matrix
and disappearance of podocytes
Massive loss (pamidronate)
Misdirected filtration ?
Signalling
Involution
Mild podocyte injury
Mild PEC activation 
and no proliferation
Podocytes enclosed by matrix
disappearance of podocytes
No misdirected filtration
No signalling
Classical FSGS
Moderate podocyte injury
Moderate PEC activation
and segmental proliferation
Podocytes enclosed by PECs/matrix
Segmental disappearance of podocytes
Misdirected filtration
Signalling
Decrease PODOCYTE / PEC injury
Pamidronate       HIVAN
Figure 10-2
Figure 2. A new scheme that illustrates the development of FSGS and glomerular involution: The proposed scheme describes 
the relation between proteinuria, podocyte injury, PEC activation/proliferation, matrix production, misdirected ﬁ ltration/signalling and the 
development of glomerulosclerosis and glomerular involution.
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DEVELOPMENT OF FGSG AND GLOMERULAR INVOLUTION
PECs are important in FSGS and involution
Podocyte injury is the initial event in the development of glomerulosclerosis and glomeru-
lar involution. Podocyte injury is clinically characterized by proteinuria. Although there is a 
relation between proteinuria and FSGS, the mere presence of proteinuria is not suﬃ  cient to 
cause FSGS. This is well known from clinical examples such as minimal change disease and 
membranous nephropathy. Patients with minimal change disease do not develop FSGS. In 
membranous nephropathy the situation is somewhat more complex, with approximately 40-
50% of patients developing FSGS. The latter patients are more likely to develop progressive 
renal insuﬃ  ciency. Podocyte injury has to reach a certain level to cause FSGS. Mild injury, as 
in minimal change, may not lead to glomerular loss or may lead to glomerular involution in 
case podocytes are repeatedly injured.
How activated / injured podocytes exactly induce FSGS remains unclear. Factors such as 
proteinuria, direct interaction between podocytes or PECs may be involved. Also denudated 
segments of GBM or Bowman’s capsule may provide a growth stimulus. Activated glomeru-
lar cells may produce cytokines and growth factors stimulating cell proliferation and matrix 
production. Naked GBM may especially play a role in ‘toxic FSGS’ or for instance pamidronate 
associated FSGS, when podocytes are rapidly lost due to toxicity.
We propose that if podocyte injury is severe enough, PEC activation and proliferation is the 
next step in the development of FSGS. The extent of PEC proliferation depends on the level 
of podocytic injury. We propose that podocyte / parietal cell injury may diﬀ er in extent or 
severity, thus explaining the divergent histological pictures. Parietal cell injury may lead to 
disappearance of the PECs or loss of cell-cell contacts. As a consequence there is denuda-
tion of Bowman’s capsule. Alternatively, sub lethally damaged PECs may become activated, 
produce matrix and proliferate. 
In classical FSGS parietal injury is moderately severe. The podocytes attach to Bowman’s cap-
sule or form cell bridges with activated PECs, there is mild PEC proliferation and production 
of matrix that covers the podocytes. As a result, the podocytes get enclosed by PECs and 
disappear, thus resulting in the hypocellular adhesion. At the site of this adhesion periglo-
merular inﬂ ammation starts, followed by ﬁ brosis, a process possibly related to misdirected 
ﬁ ltration of proteinaceous ﬂ uid or the production of exocrine factors by glomerular cells. 
The adhesion is inﬁ ltrated by myoﬁ broblasts, matrix accumulates and neighboring capillaries 
disappear, ultimately leading to a sclerosed portion of the glomerulus.
Injury to the podocytes and PECs is more severe in collapsing FSGS, such as seen in HIV 
infection. The podocytes are hypertrophic and activated. There is more prominent prolifera-
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tion of the PECs, thus ﬁ lling Bowman’s space. This process gives the glomerulus the typical 
appearance with collapsed glomerular capillaries. In seldom cases podocyte injury may be so 
severe as to cause their disappearance, with PECs ﬁ lling in their place. Such events may occur 
in pamidronate induced FSGS, characterized by severe injury of the podocytes.
If PEC injury is limited, another pathway toward glomerular involution is followed. In this 
case, there is initially no loss of PECs and cell-cell contacts between PECs remain intact. There 
is no denudated Bowman’s capsule, cell bridges between podocytes and PECs occur, matrix is 
produced but there is no periglomerular inﬂ ammation or ﬁ brosis. Still, podocytes disappear, 
and the loss of podocytes is accompanied by loss of endothelial cells and thus capillaries. 
Also, the injured PECs produce matrix, but do not proliferate and eventually disappear. The 
result is the decrease in size and ultimate disappearance of the glomerulus.
We hypothesize that podocyte and PEC injury are linked. Possibly PEC injury is triggered by 
podocytic proteins (cytokines, growth factors) that are produced during podocyte activation. 
Alternatively, PEC injury may be the mere consequence of proteinuria, whereby the severity 
and the extent of injury is determined by the amount and type of proteinuria. Clinically, it is 
well known that both the amount of proteinuria and the type of proteinuria (as reﬂ ected by 
protein selectivity index) are related to prognosis in proteinuric renal diseases. Whenever ad-
hesions (matrix continuity) between the glomerular tuft and Bowman’s capsule are formed, 
misdirected ﬁ ltration may occur and cause interstitial ﬁ brosis. Alternatively, it cannot be ex-
cluded that factors produced by activated PECs / podocytes directly induce periglomerular 
ﬁ brosis and that during glomerular involution such stimulating factors are not produced.
CONCLUSION
Our proposed scheme describes the relation between podocyte injury, proteinuria and the 
development of glomerulosclerosis and glomerular involution. Our model attributes a cen-
tral role to the PEC. Speciﬁ cally, the reponse of the PEC determines if the initial podocytic 
insult is followed by the development of FSGS or glomerular involution. 
Further studies are needed to clarify the relation between podocyte injury, proteinuria, 
PEC injury and the balance between development of FSGS or glomerular involution. 
From a therapeutic perspective it seems worthwhile to pursue strategies that are capable 
of interfering with PEC activation or injury.
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THE ROLE OF THE GLOMERULAR EPITHELIAL CELLS IN FOCAL SEGMENTAL 
GLOMERULOSCLEROSIS
Proteinuria is an important hallmark of glomerular diseases. In recent years we have described 
a mouse model of acute proteinuria. Injection of a combination of two mAbs directed against 
speciﬁ c epitopes of mouse aminopeptidase-A (APA) induces a massive but transient acute 
albuminuria. This model was used to evaluate possible mechanisms of proteinuria.
Aminopeptidase-A (APA) (EC 3.4.11.7) is a membranebound zinc metalloprotease. In mouse 
kidney, it is predominately expressed on podocytes and the brush borders of the proximal 
tubules. APA is involved in the degradation and uptake of ﬁ ltered peptides. The best-known 
substrate of APA is angiotensin II (Ang II), the most active component of the renin–angioten-
sin system (RAS). 
Injection of a combination of anti-APA antibodies that inhibit the enzyme activity increased 
intrarenal levels of angiotensin II. Angiotensin II is important for the normal development of 
the kidney. The role of APA has not been studied. Therefore, we have used the anti-APA mAbs 
as tools to study the expression of APA in the kidney during nephrogenesis (Chapter 2). In 
addition, we evaluated the eﬀ ect of APA-enzyme inhibition on nephrogenesis by injecting 
anti-APA mAbs in 1-day old mice.
In developing glomeruli APA expression was observed from the comma stage onwards, 
predominantly in the developing podocytes and brush borders of proximal tubular cells. 
Although APA is highly expressed, complete inhibition of APA during nephrogenesis for 9 
days after birth did not aﬀ ect normal development of nephrons. We only observed podocyte 
eﬀ acement at days 9 and 21 which disappeared after 3 months. Our study suggests that APA 
has only a minor role during embryonal development.
An injection of the anti-APA mAbs combination ASD-37/41 induces a massive but transient 
albuminuria which peaked at 8 hr, and declined thereafter. Induction of the albuminuria is 
not related to any of the known systemic mediators of glomerular injury, such as comple-
ment, coagulation factors, monocytes, neutrophils, or platelets. Recently, we demonstrated 
that the induction of albuminuria is not dependent on the presence of angiotensin II. Thus it 
is unlikely that systemic factors or hemodynamic changes are relevant for the development 
of proteinuria in our anti-APA model.
We have performed additional studies to evaluate possible mechanisms involved in the de-
velopment of proteinuria. In the experiments described in chapter 3, we have examined the 
expression of several important podocytic proteins in relation to the time course of the albu-
minuria. We have included cytoskeleton (-associated) proteins, adhesion molecules, slit-dia-
phragm proteins and heparan sulfate proteoglycans, all known to aﬀ ect podocyte integrity. 
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In addition, we measured ultrastructurally foot process retraction (the number of foot pro-
cesses per μm GBM) and the width of the slit pore between the podocytes by morphometric 
methods. An injection of the mAbs combination ASD-37/41 induced a massive albuminuria 
that started at 6 hr, peaked at 8 hr, and decreased thereafter. However, at day 7 after injection 
of the mAbs still some albuminuria was present. Changes in the expression of two slit-pore-
associated proteins, CD2AP and podocin coincided with the start of the albuminuria. The 
normal homogeneous staining along the capillary loops of podocin became more granular at 
6 hr with evidence of a recovery at day 7. At the same time, CD2AP expression changed from 
a normal ﬁ ne granular into a granular pattern at 6 hr that persisted unchanged until day 7. 
At the early time point, no changes in the expression of nephrin were noted. The staining for 
nephrin at 24 hr was slightly less than in previous hours and podocytic actin staining became 
more granular only at a time point that albuminuria was declining (24 hr). The number of 
foot processes per μm GBM was already decreased at 4 hr, with further reduction thereafter. 
The width of the slit pore was unchanged at the time of peak albuminuria and gradually 
decreased thereafter. At day 7, podocytic foot process eﬀ acement was even more prominent 
although albuminuria was only slightly abnormal. Expression of CD2AP was still granular. 
We observed however a change toward normal in the expression of podocin. Our data show 
that the onset of albuminuria in the anti-APA model is related to alterations in CD2AP and 
podocin, proteins that are important for maintaining slit diaphragm structure and podocytic 
function. 
To quantitate the degree of foot process retraction and the width of the slit pore we had to 
calibrate our system and used replicas. Especially calibration of the magniﬁ cation in digital 
images from transmission electron microscopy is not always accurate. We have developed a 
better procedure that allows automated measurement of the calibration on electron micro-
scopical images with high precision. The procedure is described in chapter 4.
We have next focussed on focal segmental glomerulosclerosis. FSGS has become one of the 
most common glomerular diseases and is characterized by focal and segmental occurrence 
of lesions with mesangial sclerosis, obliteration of glomerular capillaries with hyalinosis, intra-
capillary foam cells and formation of adhesions. Based on ﬁ ndings in a mouse model of FSGS 
we questioned if PECs play a role in human FSGS. In chapter 5 we describe the relative role of 
PECs and podocytes in human idiopathic FSGS. We investigated the nephrectomy specimen 
of a patient who suﬀ ered from recurrent FSGS after transplantation. We performed a detailed 
study of lesions by serial sectioning, marker analysis and three-dimensional reconstruction 
of glomeruli. We have studied the expression of markers for podocytes, PECs, mesangial 
cells, endothelium, and myoﬁ broblasts. Also proliferation and composition of the deposited 
extracellular matrix (ECM) were investigated. Our study demonstrated that the proliferating 
epithelial cells in FSGS lesions were negative for podocyte and macrophage markers, but 
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stained for PEC markers such as PAX-2, CK8 and pancadherin. The staining characteristics 
of the matrix deposited by these cells was identical to Bowman’s capsule. Sometimes these 
proliferating cells were observed on the glomerular tuft, but they were always connected to 
cells lining Bowman’s capsule. We have used sophisticated three-dimensional analysis (3-D) 
to prove this.
Taken together, these data argue that proliferating epithelial cells in active FSGS lesions are 
PECs and question the contribution of the socalled ‘dediﬀ erentiated’ podocyte. The concept 
of the dediﬀ erentiated podocyte was based on ﬁ ndings in human immunodeﬁ ciency virus 
(HIV)–induced collapsing FSGS (cFSGS). It is therefore conceivable that podocyte proliferation 
might occur in this condition, probably related to incorporation of viral genome in podocytic 
DNA. Therefore, we also investigated the origin of the proliferating cells in cFSGS associated 
with HIV and pamidronate (chapter 6). Both entities are characterized by global collapse and 
the absence of adhesions. We performed a detailed study of glomerular lesions in biopsies 
of two patients with HIV associated cFSGS and a nephrectomy specimen of a patient with 
pamidronate associated cFSGS. Glomeruli were studied by serial sectioning using light and 
electron microscopy and immunohistochemistry. The proliferating cells were negative for 
the podocyte markers, but stained positive for the PEC markers and the cell proliferation 
marker Ki-67. The proliferating PAX-2 and CK8 positive cells that covered the capillary tuft 
were always in continuity with PAX-2/CK8 positive cells lining Bowman’s capsule. Double 
staining experiments provide additional evidence for the role of PECs. We were able to show 
CK8 positive PECs covering CD10 positive podocytes. The staining of the matrix deposited by 
these proliferating cells was identical to Bowman’s capsule. So, also in HIV and pamidronate 
associated cFSGS most of the proliferating cells are PECs.
Thus our studies show that the parietal epithelial cells constitute the hypercellular lesions 
in cFSGS. The concept of the dediﬀ erentiated-proliferating podocyte needs revision.
Progressive FSGS will eventually lead to global glomerulosclerosis. Global glomerulosclerosis 
is often observed in patients with renal disease or patients with nephrosclerosis. Two types 
of global glomerulosclerosis are described: the obsolescent type and the solidiﬁ ed type. The 
obsolescent type (vascular sclerosis) is characterised by retraction of the tuft and Bowman’s 
space is ﬁ lled with collagenous material. The solidiﬁ ed type (glomerulopathic sclerosis) is 
characterised by global solidiﬁ cation of the tuft, without deposition of collagenous material 
in Bowman’s space.
We noticed the presence of abnormal glomeruli in biopsies of children with a recurrent ne-
phrotic syndrome. The glomeruli were small and globally sclerosed, and we have suggested 
the term involution to describe this process (chapter 7). We have investigated these involuted 
glomeruli in more detail and compared them with the other types of global glomeruloscle-
rosis. Involuted glomeruli were characterised by their reduced size, and a global increase of 
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matrix. However, these glomeruli appeared distinct from obsolescent or solidiﬁ ed globally 
sclerosed glomeruli in view of the continuing presence of glomerular cells. Most remarkable 
was the absence of periglomerular and tubulo-interstitial ﬁ brosis. Our data suggested that 
these glomeruli present an unique form of glomerular injury.
We have extended our studies and evaluated the renal biopsies of 18 children with fre-
quently relapsing or steroid dependent minimal change nephrotic syndrome due to minimal 
change nephropathy (chapter 8). We counted the abnormal glomeruli, and evaluated the 
relation with clinical parameters. We have studied 11 boys and 7 girls. Median age at disease 
onset was 2.8 years (1.6-10.6 years) and at biopsy 5.2 years (2.3-10.9 years). The biopsies con-
tained 19 (5-35) glomeruli. Many biopsies contained small, globally sclerosed glomeruli with 
the characteristics of involuted glomeruli. The medium percentage of involuted glomeruli 
was 6% (range 0-33%). Biopsies of six patients did not show involuted glomeruli. When com-
paring patients without and with involuted glomeruli we observed a signiﬁ cant diﬀ erence 
in the age at renal biopsy (without involution: 3.9 ± 1.1 year, with involution 6.5 ± 2.6 years; 
p<0.05) and the interval between onset of disease and the renal biopsy (0.44 ± 0.43 years vs 
3.8 ± 3.3 years; p<0.01). There were no signiﬁ cant diﬀ erences in gender distribution, maximal 
proteinuria at onset, serum albumin, number of recurrences or selectivity index. There was 
a signiﬁ cant correlation between the percentage of involuted glomeruli and the interval be-
tween onset of disease and renal biopsy (Spearman R=0.64; p<0.01). By logistic regression 
analysis the interval between disease onset and the renal biopsy was the only independent 
signiﬁ cant predictor. 
As described in chapter 9 we have more or less by chance developed a mouse model of 
glomerular involution. We have tried to induce FSGS by multiple injections of anti-APA mAbs 
in mice. We followed the mice for a long time period and evaluated albuminuria and podo-
cyte injury. Speciﬁ cally, we used 6 weeks old mice, injected them on day 1 and again on day 
7. We followed the groups over 12 months and tested the urine samples for albuminuria 
every 4 weeks. The treated mice developed acute albuminuria after each injection. Thereafter 
albuminuria decreased to values slightly above normal. Mice were sacriﬁ ed at months 7, 10 
and 12. Light microscopy of the kidneys revealed up to 17% of small, dense glomeruli. These 
small glomeruli had the same characteristics as the involuted glomeruli described in children 
with minimal change disease. Electron microscopy revealed partial foot process eﬀ acement 
and thickening of the GBM in the early phase of glomerular involution. Our mouse model will 
enable us to investigate in more detail the pathogenesis of glomerular involution. 
In chapter 10 we discuss our ﬁ ndings and propose a new scheme for the development of 
FSGS and glomerular involution. We attribute a central role to parietal epithelial cell injury in 
determining if podocyte injury and proteinuria progress to FSGS or glomerular involution. If 
conﬁ rmed by further studies the PEC might become a new target for therapy.
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DE ROL VAN DE GLOMERULAIRE EPITHEELCEL PODOCYT EN DE PARIETALE 
EPITHEELCEL PEC BIJ HET ONTSTAAN VAN PROTEÏNURIE EN FOCALE 
SEGMENTALE GLOMERULOSCLEROSE.
Eiwitverlies is een belangrijk kenmerk van nierziekten. Wij maken gebruik van een muismo-
del voor de bestudering van mogelijke mechanismen die betrokken zijn bij het ontstaan van 
eiwitverlies. Wij kunnen in een muis proteïnurie opwekken door injectie van een combinatie 
van twee monoklonale antilichamen (ASD-37/41) die gericht zijn tegen verschillende epi-
topen van het aminopeptidase-A (APA) eiwit. APA (EC 3.4.11.7) is een membraangebonden 
zink-metalloprotease, dat in de muizennier voornamelijk voorkomt op de glomerulaire epi-
theelcel, ook wel de podocyt genoemd en op de borstelzoom van de proximale tubulus. APA 
is betrokken bij de afbraak en de opname van geﬁ ltreerde peptiden. Het bekendste substraat 
van APA is angiotensine II (Ang II). Ang II is de meest actieve component van het renine-an-
giotensine systeem. Ang II speelt ook een belangrijk rol bij de normale ontwikkeling van de 
nier. De rol van APA hierbij is tot op heden niet bestudeerd. Wij hebben de anti-APA antilich-
amen gebruikt om de expressie van APA in de nier te bestuderen tijdens de nephrogenese of 
wel ontwikkeling van de nier (hoofdstuk 2). Tevens hebben wij gekeken naar het eﬀ ect van 
de enzymremming van APA tijdens de nephrogenese. Bij deze studie hebben wij muizen van 
1 dag oud, ingespoten met anti-APA monoclonalen. De nefrogenese van de nier voltooit zich 
pas 10 dagen na de geboorte, vandaar dat wij in deze experimenten de ontwikkeling van het 
nefron in verschillende stadia nog uitgebreid kunnen bestuderen. Tijdens de nefrogenese 
bleek APA al vroeg tot expressie te komen en wel vanaf de kommafase. APA expressie was 
met name zichtbaar op de tot ontwikkeling komende podocyt en op de borstelzoom van de 
proximale tubulus cellen. Complete remming van de enzymactiviteit gedurende de eerste 
9 dagen na de geboorte bleek geen eﬀ ect te hebben op de normale ontwikkeling van de 
nephronen. Het enige wat we konden waarnemen was geringe versmelting van de voeten 
van de podocyt, die nog zichtbaar was op dag 9 en 21 na de geboorte. Na 3 maanden waren 
ook deze afwijkingen verdwenen. Onze studie suggereert dat APA geen belangrijke rol speelt 
tijdens de nephrogenese. 
Zoals vermeld leidt toediening van de combinatie van anti-APA monoklonale antistoﬀ en tot 
een massief eiwitlek. Dit eiwitlek is maximaal 8 uur na inspuiting en neemt daarna geleidelijk 
af. De albuminurie wordt niet veroorzaakt door ontstekingsmediatoren zoals complement, 
stollingsfactoren, monocyten, granulocyten of bloedplaatjes. Recent hebben wij aangetoond 
dat het ontstaan van albuminurie onafhankelijk is van de aanwezigheid van Ang II. Daarom 
lijkt het onwaarschijnlijk dat systemische factoren of hemodynamische veranderingen be-
trokken zijn bij het ontstaan van het eiwitverlies in ons anti-APA muismodel. 
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Wij hebben aanvullende studies uitgevoerd om andere mechanismen die betrokken kunnen 
zijn bij de ontwikkeling van het eiwitverlies te onderzoeken. In de experimenten beschreven 
in hoofdstuk 3, hebben wij de expressie bestudeerd van een aantal belangrijke podocytaire 
eiwitten in relatie tot de ontwikkeling van albuminurie. Wij hebben hierbij gekeken naar 
cytoskelet geassocieerde eiwitten, adhesiemoleculen, slit-diafragma eiwitten en heparan-
sulfaat proteoglycanen. Van al deze eiwitten is bekend dat zij de integriteit van de podocyt 
kunnen beïnvloeden. Tevens hebben wij op ultrastructureel niveau het aantal podocytvoet-
jes gemeten per micrometer glomerulaire basaalmembraan (GBM) en wij hebben de afstand 
gemeten tussen de voetjes, de zogenaamde slit-pore. Hiervoor hebben wij gebruik gemaakt 
van beeldanalyse van elektronenmicroscopische opnamen.
Een injectie van de combinatie ASD-37/41 induceerde een massief eiwitlek dat optrad op 6 
uur na inspuiting, piekte op 8 uur en daarna geleidelijk afnam tot een licht verhoogd niveau 
op dag 7. Veranderingen in de expressie van twee belangrijke slit-pore geassocieerde eiwit-
ten te weten CD2AP en podocine, vielen samen met het ontstaan van het eiwitlek. Podocine 
laat normaal een homogene aankleuring langs de capillaire liswand zien maar werd echter 
granulair op 6 uur na inspuiting. Na 7 dagen leek er herstel te zijn. Tevens veranderde de 
CD2AP-expressie van ﬁ jn granulair naar een meer grof granulair patroon op 6 uur; dit bleef 
echter onveranderd op dag 7. Nefrine liet op 6 uur na inspuiting van de antilichamen geen 
verandering zien in expressie maar na 24 uur nam de eiwitexpressie licht af. Het actineskelet 
van de podocyt werd eveneens meer granulair, echter pas na 24 uur. Dit was enigszins op-
merkelijk aangezien het eiwitverlies toen al fors was afgenomen. Het aantal podocytvoetjes 
per GBM-lengte was al afgenomen na 4 uur en de voetjesversmelting nam verder toe in de 
tijd. De slit-pore was onveranderd tijdens de piek van het eiwitlek maar werd smaller in de 
daaropvolgende dagen. De podocytversmelting was het duidelijkst op dag 7, hoewel de al-
buminurie op dat moment bijna verdwenen was. Het expressiepatroon van CD2AP was nog 
steeds granulair in tegenstelling tot het expressiepatroon van podocine wat weer homogeen 
werd. Onze data suggereren dat veranderingen in CD2AP en Podocine een rol kunnen spelen 
bij het ontstaan van de albuminurie in ons APA-model. Deze eiwitten zijn belangrijk bij de 
instandhouding van het slit-diafragma. 
Bij het meten van het aantal podocytvoetjes per lengte-eenheid en de slit-pore breedte 
speelt de calibratie van het meetsysteem een belangrijke rol. Hierbij maken we gebruik van 
meetreplica’s. Hiermee kunnen we de vergroting die gegenereerd wordt in het transmissie 
electronenmicroscoop precies berekenen. Het omzetten van het replicabeeld in een vergro-
tingsfactor hebben wij in een vernieuwde meetprocedure verder ontwikkeld en gedeeltelijk 
geautomatiseerd. Hierdoor kunnen we de replicavergroting nauwkeuriger en sneller bereke-
nen. Deze procedure is beschreven in hoofdstuk 4. 
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Vervolgens hebben wij ons gericht op de ontwikkeling van focale segmentale glomerulo-
sclerose (FSGS). FSGS is een van de meest voorkomende glomerulaire ziekten. FSGS wordt 
gekenmerkt door het voorkomen van afwijkingen in een deel (segment) van de glomerulus, 
waarbij slechts een beperkt aantal glomeruli (focaal) zijn aangedaan. Karakteristiek voor FSGS 
zijn de mesangiale sclerose en het samenvallen van glomerulaire capillairen, met hyalinose 
van de vaatwand en vorming van schuimcellen. Meest kenmerkend zijn de verbindingen tus-
sen de capillaire kluwen en het kapsel van Bowman, de zogenaamde adhesies of senechiën. 
Bij sommige vormen van FSGS wordt een toename van het aantal cellen in de ruimte van 
Bowman gezien. In het algemeen werd aangenomen dat het podocyten betrof, die gededif-
ferentieerd waren en weer proliferatieve eigenschappen hadden verworven. Wij hadden in 
een muizenmodel voor FSGS aanwijzingen gevonden dat de PEC een belangrijke rol zou kun-
nen spelen bij FSGS. Daarom onderzochten wij de rol van de parietale epitheelcel (PEC) bij de 
ontwikkeling van FSGS in de mens. Allereerst bestudeerden wij een nefrectomie preparaat 
van een patiënt, waarbij de FSGS was teruggekeerd in de transplantaatnier (Hoofdstuk 5).
Wij hebben seriële coupes kunnen bestuderen en een driedimensionale reconstructie van 
glomerulaire laesies uitgevoerd. De prolifererende cellen hadden alle kenmerken van PECs. 
Podocytmarkers werden niet aangetroﬀ en. Toch gaven de lichtmicroscopische beelden de 
indruk dat we te maken hadden met podocyten omdat soms de proliferende cellen op de 
capillaire kluwen lagen en geen contact leken te maken met de pariëtale cellen van het kap-
sel van Bowman. Door middel van driedimensionale analyse van de glomerulus konden wij 
echter aantonen dat deze cellen altijd in contact bleken te staan met pariëtale cellen langs 
het kapsel van Bowman. De nieuw gevormde matrix had de kenmerken van het kapsel van 
Bowman. Deze studie toonde dus aan dat pariëtale epitheelcellen prolifereren en verant-
woordelijk zijn voor de epitheelcelhyperplasie bij idiopathische FSGS. Pariëtale epitheelcel-
len produceren de matrix die een rol speelt bij de ontwikkeling van de sclerotische laesies. 
Het concept van de prolifererende, gedediﬀ erentieerde podocyt is ontwikkeld in studies van 
collapsing FSGS (cFSGS) in combinatie met een HIV infectie. Daarom hebben wij de herkomst 
van de prolifererende cellen in collapsing FSGS, geassocieerd met HIV of pamidronaat, on-
derzocht (Hoofdstuk 6). Wij bestudeerden nierbiopten van 2 patienten met HIV en een ne-
frectomie preparaat van een patient met pamidronaat-geïnduceerde FSGS. Het bleek dat alle 
prolifererende cellen negatief waren voor podocytmarkers (synaptopodine en CD10), maar 
wel aankleurden voor PECmarkers (PAX-2 en CK8) in combinatie met de proliferatiemarker 
KI-67. Deze PAX-2 en CK8 positieve prolifererende cellen bekleden de capillaire kluwen en 
bleken wederom altijd in contact te staan met PAX-2/CK8 positieve cellen op het kapsel van 
Bowman. Met dubbelkleuringen zijn wij erin geslaagd onze conclusies te versterken. We kon-
den aantonen dat CK8 positieve PECs lagen op CD10 positieve podocyten. De prolifererende 
cellen produceerden matrix die wederom identiek bleek te zijn aan de matrix van het kapsel 
van Bowman. Dus ook in de cFSGS die geassocieerd is met HIV en pamidronaat blijken de 
meeste prolifererende cellen PECs te zijn. Onze studies tonen aan dat de pariëtale epitheelcel 
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een belangrijke rol speelt in de pathogenese van FSGS en zowel bijdraagt aan de cellulaire 
hyperplasie als aan de matrixproductie. Onze studies suggereren dat het concept van de 
gedediﬀ erentieerde prolifererende podocyt moet worden aangepast. 
Uiteindelijk zal progressieve FSGS leiden tot complete (globale) glomerulosclerose. Globale 
glomerulosclerose wordt vaak gezien bij patiënten met nierziekten of patiënten met nephro-
sclerose. Wij kunnen twee typen van globale glomerulosclerose onderscheiden, te weten de 
vasculaire vorm en de glomerulopathische vorm. Vasculaire sclerose wordt gekarakteriseerd 
door het inkrimpen van de capillaire kluwen. Hierdoor ontstaat er een leegte in de ruimte van 
Bowman, die wordt opgevuld met collageen materiaal (met name collageen type I). Glome-
rulopathische sclerose wordt gekarakteriseerd door een algehele sclerose van de capillaire 
kluwen. Beide vormen van glomerulosclerose worden gekenmerkt door het voorkomen van 
periglomerulaire en tubulo-interstitiële ﬁ brose.
In biopten van kinderen met een recidiverend nefrotisch syndroom ontdekten wij abnormale 
glomeruli. Deze glomeruli waren globaal afwijkend, maar duidelijk te onderscheiden van de 
twee bekende vormen van globale glomerulosclerose. Deze glomeruli, door ons in Hoofd-
stuk 7 beschreven als involuerende glomeruli, werden gekenmerkt door de geringe grootte, 
de vorming van matrix waarbij vitale cellen tussen de matrix aanwezig bleven. Het meest 
opvallend was de totale afwezigheid van periglomerulaire en tubulo-interstitiële ﬁ brose. Wij 
veronderstellen dat deze glomeruli een uiting zijn van een nieuwe vorm van glomerulaire 
beschadiging. In hoofdstuk 8 hebben wij onze studies uitgebreid door bestudering van nier-
biopten afkomstig van een groep van 18 kinderen, die leden aan een frequent recidiverend 
of steroïd afhankelijk nefrotisch syndroom ten gevolge van minimale laesies nefropathie. Wij 
hebben van deze totale groep (11 jongens en 7 meisjes) het aantal abnormale glomeruli in 
kaart gebracht en dit gerelateerd aan klinische parameters. De gemiddelde leeftijd bij het 
optreden van de ziekte was 2,8 jaar (1,6 -10,6 jaar). De gemiddelde leeftijd waarop het nier-
biopt werd genomen was 5,2 jaar (2,3 – 10,9 jaar). De biopten bevatten gemiddeld 19 (5 
– 35) glomeruli. Veel biopten bevatten kleine glomeruli met de karakteristieken van involue-
rende glomeruli. Het gemiddelde percentage van involuerende glomeruli was 6% (0 – 33%). 
6 biopten bleken geen involuerende glomeruli te bevatten. Bij vergelijking van de patiënten 
met en zonder involuerende glomeruli viel op dat kinderen met involuerende glomeruli ou-
der waren op het moment van de biopsie. Ook was het tijdsinterval tussen het ontstaan van 
de ziekte en de nierbiopsie langer. Er waren geen andere signiﬁ cante verschillen. Met behulp 
van logistieke regressieanalyse bleek het tijdsinterval tussen het ontstaan van de ziekte en 
het nemen van het nierbiopt de enige onafhankelijke voorspellende factor te zijn. 
In hoofdstuk 9 beschrijven wij dat wij min of meer bij toeval een muismodel van glomerulaire 
involutie hebben ontwikkeld. Het oorspronkelijke doel was om door twee opeenvolgende 
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injecties van anti-APA monoclonale antilichamen een muismodel voor FSGS te ontwikkelen. 
Wij vervolgden deze muizen gedurende 12 maanden en onderzochten de urine elke maand 
op albuminurie. De behandelde muizen ontwikkelden een acute albuminurie na elke injectie. 
De proteïnurie nam vervolgens geleidelijk af, maar bleef signiﬁ cant hoger dan in de controle 
groep. Abnormale glomeruli werden gezien in muizen van de experimentele groep vanaf 
maand 7. Het percentage geinvolueerde glomeruli nam toe tot maximaal 17% op maand 
12. Deze abnormale glomeruli bleken identiek te zijn aan de involuerende glomeruli zoals 
beschreven bij de kinderen met minimale laesie nefropathie. Onderzoek met behulp van 
elektronenmicroscopie liet podocytvoetversmelting en verdikking van de GBM in de vroege 
fase van glomerulaire involutie zien. Dit muizenmodel kan ons helpen om de pathogenese 
van glomerulaire involutie nader in kaart te brengen.
In hoofdstuk 10 bediscussiëren wij onze bevindingen. Wij hebben een nieuw schema op-
gesteld met betrekking tot de ontwikkeling van FSGS en glomerulaire involutie. In dit ver-
nieuwde concept kennen wij een belangrijke rol toe aan de pariëtale epitheelcel. Schade 
aan deze cel en het kapsel van Bowman, bepaalt de balans tussen progressie tot FSGS of 
ontwikkeling naar glomerulaire involutie.
Indien verder onderzoek de rol van de PEC bevestigd, dan wordt deze cel mogelijk een 
belangrijk doelwit van therapeutische strategieën. 
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